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Abstract 
 
Epidemiological evidence has shown that dietary factors, as part of lifestyle behaviours, have 
significant positive effects on the onset and progression of neurodegenerative disorders including 
dementia and other chronic diseases. Plant-rich diets especially, have been shown to have significant 
protective effects on overall health. This is due to the presence of phytochemicals, minerals, vitamins 
and dietary fibre in these foods. Phytochemicals are classified under carotenoids and polyphenols; 
which include flavonoids, phenolic acids, and stilbenes/lignans. Anthocyanins are a subclass of 
flavonoids responsible for the dark red-purple colours in fruits and vegetables. In the last decades, 
there has been an increased research interest in anthocyanins which is attributed to their antioxidant 
characteristics - the ability to reduce oxidative stress in living cells. The association between 
anthocyanin from dietary sources and cognitive function is yet to be fully established. Available 
evidence suggests that anthocyanins may exert protective effects on cognition, including memory and 
executive processing, either through a direct effect on brain function or indirectly by reducing blood 
pressure. In order to determine the clinical effects of anthocyanins, a better understanding is required 
of the uptake and metabolism of these bioactive compounds found in fruits and vegetables. Intact 
anthocyanins are believed to reach the large intestine and colon where they undergo intensive 
metabolism and transformation with observed modulatory effects on gut microbiome. Following 
further degradation, they are absorbed into the bloodstream, with some of the subsequent metabolites 
showing potential to be more biologically active than the intact anthocyanins. 
 
The primary aim of this doctoral thesis was to determine the health benefits associated with both acute 
and longer-term effects of consumption of dietary anthocyanins, delivered in a fruit variant, Queen 
Garnet plum (QGP), on cognition, blood pressure and other health parameters in younger (acute) and 
older adults (acute and longer-term). In order to contextualise the findings for dietary guidance to the 
target population, the anthocyanin intake of the Australian population was assessed using a novel 
anthocyanin food composition database developed during the course of this research. This thesis 
addresses the following research questions: 
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1. What is the current level of evidence on the beneficial health effects of plums that contain 
considerable amount of anthocyanins?  
2. Does consumption of anthocyanin-containing plum juice have an acute effect on various 
domains of cognitive functioning, and blood pressure, and is there significant difference in 
the gastro-intestinal metabolism of anthocyanins between young and older adults, assessed 
using urinary metabolite biomarkers? 
3. What is the current level of evidence on the effects of anthocyanins on the gut microbiota in 
relation to health outcomes? 
4. What are the longer-term effects of anthocyanin-containing plum juice consumption on 
cognition, cardiovascular responses, inflammatory biomarkers (Brain-Derived Neurotrophic 
Factor (BDNF) and C - reactive protein (CRP)) and gut microbiota in older adults? 
5. What is the current dietary anthocyanin intake and sources thereof in the Australian 
population included in the National Nutrition and Physical Activity Survey (NNPAS) 
component of the Australian Health Survey (AHS), and is there an association between 
intake and blood pressure in older adults aged 50+ years?  
 
Five different studies were designed to answer the above research questions. A systematic literature 
review assessed the current level of evidence on the beneficial health effects of plums known for their 
high levels of anthocyanins. Results showed that consumption is associated with improved cognitive 
function, bone health parameters and cardiovascular risk factors. Most of the human trials used the 
dried version of plums (prunes) rather than fresh fruit thus limiting translation to dietary messages of 
the positioning of plums in a healthy diet. 
 
A crossover study assessed the acute effects of different dose-timing of Queen Garnet plum juice 
consumption on cognition, blood pressure, as well as urinary phenolic profile. Queen Garnet plum 
juice significantly reduced blood pressure but dose-timing did not appear to be a significant factor in 
the potential acute BP-lowering effect. Native QGP anthocyanins, as well as methylated / 
glucuronidated metabolites were detected in the urine of participants but there were no significant 
differences between age groups or dose-timing. No effect was observed on cognition. 
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A second systematic literature review was carried out to determine the level of current evidence on the 
effect of anthocyanin treatment/intake on changes in the gut microbiota population, and to compare 
different techniques used in microbiota determination. With very limited clinical trials done in this 
area, results showed that anthocyanins induced a significant proliferative effect on Bifidobacterium 
spp., known for their wide use in probiotics and for the treatment of Irritable Bowel Syndrome (IBS). 
There was also an observed inhibition of Clostridium histolyticum, which has been shown to be 
pathogenic in humans. Comparison of different techniques used for microbiota determination showed 
that depth of analysis, with respect to a comprehensive, high-resolution microbiota analysis or 
analysis of the main microbiota taxa. and budgeted cost are important considerations for future 
research. 
 
A second clinical trial (8-week randomised controlled crossover study) aimed to assess the longer-
term effect of fruit anthocyanins from the Queen Garnet plum juice in comparison to a control 
(cordial) juice on cognition, cardiovascular responses, gut microbiota, and inflammatory biomarkers 
in healthy older adults aged 55+ years. Participants consumed 200mL of plum juice (≈ 50mg/L of 
anthocyanins) or cordial daily for 8 weeks in a cross-over design. Across treatment periods, there was 
no significant difference on the different domains of cognition measured, blood pressure or anti-
inflammatory biomarkers. No intervention effect was found for genera or classes of gut microbes, but 
there was a trend towards significance in total bacterial count between the control arm and the 
intervention arm (P= 0.06). 
 
Finally, in response to the lack of a region-specific food anthocyanin database, a first stage (fruits and 
vegetables) development of anthocyanin food composition database specific to Australian foods was 
undertaken. Original analytical values for Australian foods were combined with borrowed values from 
the USDA Database for the Flavonoid content of selected foods and the European Phenol-Explorer 
database. This novel database was applied to the dietary intake data obtained in a representative 
national sample of Australians in the Nutrition and Physical Activity component of the 2011-12 
Australian Health Survey.  Mean intake of anthocyanins in the Australian population was 24.17 ± 0.32 
mg/day which is above average in comparison to the world composite database (18.05±21.14 mg/d). 
Across age-groups, berries were the top food sources: mainly blackberry (5-65%); cherry (2-24 %); 
 
 
v 
 
blueberry (2-13%) and raspberry (3-12%). There was a significant inverse association between 
anthocyanin intake and systolic BP (β= -0.04, p<0.01) and diastolic BP (β= -0.01, p<0.01), in models 
that adjusted for covariates (age, gender, BMI, high blood pressure diagnosis, smoking status and 
physical activity) in adults aged 50+years.  
 
The significance of this body of research can be grouped into three categories including; 
• Knowledge inquiry: Acute study (to determine metabolism, dose-effect on acute BP) and 8 
week Cross over randomised clinical trial of QGP juice.  
• Knowledge synthesis: Systematic literature reviews.  
•  Knowledge translation: Contextualisation and translation of the clinical trials findings to 
dietary messages as well as framing of dietary messages in the context of usual dietary 
practices through assessment of usual intake of anthocyanins in Australians (secondary 
analysis of national nutrition survey data, using a novel anthocyanin food composition 
database).  
 
Collectively, this body of research is an original contribution to science. Knowledge gaps in relation 
to the acute and longer-term health effects of dietary anthocyanins were summarised and addressed. In 
addition, an Australian anthocyanin food composition database was developed. In a larger context, 
this body of research further highlights how bioactive components in food (phytonutrients) can impact 
health outcomes in humans. As projections indicate rapid increases in the prevalence of cognitive 
impairment and other chronic diseases, dietary interventions offer adjunctive measures to potentially 
reduce their incidence and progression in the absence of successful conventional treatments. 
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1 Chapter 1 
1.1 INTRODUCTION 
 
This chapter provides the background of this thesis from scientific literature. It introduces 
anthocyanins and describes their beneficial health effects, as well as provides an overview of their 
metabolism and absorption, and the plausible mechanisms involved. Dietary anthocyanin sources and 
available methods of anthocyanin-intake measurement in epidemiological studies are described which 
highlight the gaps in literature and informed the objectives of this thesis. The primary and secondary 
objectives of this thesis, as well as the conceptual framework for the thesis, are presented in this 
chapter.  
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1.1.1 Anthocyanins 
 
Incorporating fruits and vegetables into the usual human diet has been shown to exert protective 
effects on health. These observed effects have been attributed to the presence of phytochemicals, 
minerals, vitamins, and dietary fibre in these food groups [1]. Phytochemicals are classified under 
carotenoids and polyphenols; which include phenolic acids, flavonoids, and stilbenes/lignans. The 
polyphenols are the largest class of phytochemicals [2]. These bioactive compounds, independently as 
chemical extracts, and as a group in fruits and vegetables have been associated with reduced 
premature mortality [3], weight loss [4], and reduced risk of cardiovascular diseases [5] and some 
cancers [6]. 
 
Flavonoids are the most common group of polyphenols and are further divided into six sub-classes 
namely: flavones, flavonols, flavanones, isoflavones, flavanols, and anthocyanins [7] (Fig. 1-1). In the 
last decades, there has been increased interest in anthocyanin-based research [8]. This increased 
research interest has been attributed to the antioxidant characteristics of anthocyanins i.e. the ability to 
reduce oxidative stress in living cells, which has been shown to prevent certain chronic diseases [8].  
Anthocyanins are water soluble plant pigments that are particularly conspicuous in fruits and flower 
tissues as they are responsible for the diverse range of red, blue and purple colours. High levels of 
anthocyanins have been observed in some common fruits and vegetables including blueberries, black 
grapes, raisins, blackberries, plums, purple cabbage, eggplant, purple cauliflower and purple potatoes 
[9]. In plants, anthocyanins are known to protect the chloroplast from photodegradation by absorbing 
high energy quanta, while scavenging free radicals and reactive oxygen species (ROS). They are 
usually present in plants as glycosides (i.e. sugar molecule bound to anthocyanin compounds via a 
glycosidic bond) or acylglycosides of their respective aglycone anthocyanidins [9]. Anthocyanins are 
one of the most versatile subgroups of flavonoids. The key characteristic which differentiates 
anthocyanin glycosides from the rest of the flavonoid group is their ability to form flavylium cations 
[10]. Flavylium cations are species of a multistate of different molecules reversibly interconverted by 
external inputs such as pH, light and temperature [11]. In nature, about 17 different anthocyanins have 
been discovered but only six (cyanidin, delphinidin, petunidin, peonidin, pelargonidin and malvidin) 
have been shown to be of dietary importance and are ubiquitously distributed in the food supply [10].  
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Figure 1-1: Diagram showing the classification of polyphenols and food sources.  
Source: [12]  
 
The richest dietary sources of anthocyanins are berries, cherries, apples, red and purple grapes, plums 
and pomegranates [13, 14] while red wine and certain vegetables (e.g.  cabbage, onions and radishes) 
are also significant sources [15]. Although there is inconclusive evidence regarding  the  health 
benefits  of anthocyanins, promising findings relate to their  anti-inflammatory activity [16], as well as 
their role  in risk factors for CVD [16], weight management [16],  alleviation of elevated blood sugar 
[16] and impaired cognitive functioning  [17]. The exact manner in which they exert these protective 
effects is yet to be fully established as this research area is still emerging [18]. 
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1.1.1.1 Beneficial health effects of anthocyanins 
 
Anthocyanins are regarded as an important component of the human nutrition [19]. Historically, 
before scientific evidence,  they have been used to treat diverse ailments including hypertension, 
pyrexia, liver disorders, kidney stones and urinary tract infection [8]. Even though research evidence 
shows their beneficial health effects [20, 21],  research in these areas is inconclusive, on-going studies 
continue to show promising results. Antioxidant activity has been described as one of the most 
important aspects of anthocyanins in relation to disease prevention [22]. Evidence shows that the 
antioxidant capacity (molecules able to donate a free electron or hydrogen atoms to reactive free 
radicals) of a molecule is significantly correlated to its ability to oxidise easily [21]. This ability of 
anthocyanins to capture free radicals by donation of phenolic hydrogen atoms has been identified as 
the potential reason for their anti-inflammatory activity [22]. Some studies have suggested that the 
anthocyanin content in fruits is directly proportional, to some degree, to their corresponding 
antioxidant activity and in turn related to the protective effects exhibited by the fruits and vegetables 
against degenerative and chronic diseases [23-25].  
 
1.1.1.2 Absorption and metabolism  
 
Absorption and metabolism are important aspects of understanding the association between 
anthocyanins and their reported beneficial health effects. Following consumption, the initial 
absorption of most polyphenols, including anthocyanins, occurs in the small intestine before moving 
on to the colon where further metabolism and absorption takes place [26]. Evidence from both animal 
studies and randomised clinical trials (RCTs) have shown that some anthocyanins (delphinidin 3-O-
rutinoside, cyanidin 3-O-rutinoside, delphinidin 3-O-glucoside, and cyanidin 3-O-glucoside) are 
directly absorbed and excreted in their intact glycosylated forms [27], while anthocyanin arabinosides 
have been observed to be the most resistant to absorption and microbial degradation in the intestines 
[28]. The primary site of anthocyanin absorption and transformation is the duodenum and jejunum 
with approximately 10-50% of ingested content being absorbed in these regions of the small intestine, 
mainly as aglycones (the product when a glycoside is replaced by a hydrogen atom) after 
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deglycosylation of the original compound [29, 30]. After the glycosides enter the enterocytes in the 
small intestine, hydrolysis by cytosolic β-glucosidase (CBG) occurs to get rid of glycosidic moieties. 
In the enterocyte cytosol, polyphenol aglycones are either transferred to the blood stream via passive 
diffusion or transformed to phase II metabolites via phase II pathways [30]. Enteric and enterohepatic 
recycling usually leads to isomeric modification before partitioning of anthocyanin metabolites into 
the urine [31] (Fig. 1-2). The initial absorption of anthocyanins in the intestine is determined, to a 
large degree, by their hydrophobicity. It has been shown that glycosides that are more hydrophilic 
than their resultant aglycones cannot readily cross the enterocyte cellular membrane via passive 
diffusion [16]. Following the initial absorption from the small intestine, the resulting metabolites, and 
some of the initial intact glycosides travel through the hepatic portal vein to the liver where further 
metabolism takes place. Anthocyanin interconversion in vivo is due to xenobiotic and gut bacterial 
metabolism involving addition and removal of methyl and hydroxyl groups. Enteric and enterohepatic 
recycling leads to isomeric modification of anthocyanins before separating some of the resulting 
metabolites into urine (Fig.1-2) 
 
The exact mechanism involved in anthocyanin absorption and metabolism has not yet been confirmed. 
Two mechanisms have been described; one of these mechanisms is the cleavage of glycosidic 
moieties by lactase-phlorizin hydrolase (LPH), a brush border enzyme on the surface of enterocytes. 
This is known to be very reactive toward flavonoid-O-β-D-glycoside [32]. The second mechanism, 
first described by Hollman et al. [33], proposes that intact absorption of anthocyanin glycosides could 
actually occur in the small intestine, using the sodium-dependent glucose transporter 1 (SGLT1). Prior 
to this theory, it was believed that the typically large and highly polar molecules were not absorbed 
after oral consumption but underwent hydrolysis to their aglycones by bacterial enzymes in the lower 
part of the intestine [34]. However, current evidence shows that polyphenol conjugates with sugar 
moieties that move into the colon are those that are resistant to the action of LPH/CBG [35]. A study 
on the bioavailability and bioactivity of flavonoids and phenolic acids showed that the absorption and 
metabolism of different cranberry phenolics occurs at different locations and in different quantities 
along the gastrointestinal tract (GIT) [36]. An animal study on the metabolism of flavonoids via 
enteric recycling metabolism observed that the quantity of genistein (a soy isoflavone) and apigenin (a 
flavone analogue of genistein) that was absorbed differed across various regions of the intestine [37]. 
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For genistein, the highest absorption occurred in the duodenum (44% of perfused amount). The 
absorption in the duodenum and the colon (35%) was significantly higher than the quantity absorbed 
in the jejunum (16%) and the terminal ileum (21%). In addition, the metabolism of these two 
compounds followed a similar trend; apigenin was metabolised faster than genistein, with the highest 
metabolism of the two compounds occurring in the jejunal microsomes and more readily in the colon, 
and negligible amount of metabolites observed in the perfusate. The study findings suggested that the 
rate of metabolism of different flavonoids in the intestinal microsomes could be higher than what is 
observed in the liver microsomes [37]. 
 
Other physio-chemical properties such as molecular size and configuration also regulate the 
absorption of anthocyanins. Anthocyanins with higher molecular weights tend to have poorer 
absorption in the body [38]. In food, anthocyanins exist mainly as glycosylated derivatives, the 
chemical structure of which has been shown to significantly facilitate their absorption through the gut 
barriers [39]. These glycosylated derivatives are able to survive the acidic environment of the stomach 
[40] which means that they remain intact for longer. Inter-individual variation is another important 
factor that determines the rate of absorption, metabolism and excretion of anthocyanins. Inter-
individual variation suggests that some individuals are better absorbers than others, possibly due to 
particular polymorphisms for intestinal enzymes or transporters [41]. To control for this in clinical 
trials, crossover study designs are usually employed meaning that for each of the trials, participants 
act as their own control [42].  
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Figure 1-2: Schematic outline of anthocyanin inter-conversion in vivo due to xenobiotic and gut 
bacterial metabolism involving addition and removal of methyl and hydroxyl groups. Enteric and 
enterohepatic recycling will lead to isomeric modification before partitioning of anthocyanin 
metabolites into urine. 
Source (Published with permission): [31]. 
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1.1.1.3 Bioavailability 
 
Bioavailability is defined as “the rate and extent to which the active ingredient or active moiety is 
absorbed from a drug product and becomes available at the site of action” [43]. For anthocyanins, 
which are provided from food and ingested orally, bioavailability would be simply defined as the 
amount or fraction of the ingested quantity that is absorbed. 
 
In addition to the health benefits of dietary anthocyanins, there is also increased interest in their 
bioavailability. This is due to very low levels observed in the circulatory system following 
consumption. Studies have shown that the body treats metabolites of anthocyanins and polyphenols in 
general as xenobiotics (chemical or substance that is foreign to the biological system) by getting rid of 
them from the body system. This, aside from the issues of their low absorption, may explain the 
reduced rather than accumulated levels noticed in the circulatory system over time [44].  
 
Bioavailability studies aim to determine which subclasses of dietary anthocyanins are better absorbed 
and which are associated with the formation of active metabolites [42]. Anthocyanins which are 
commonly found in some diets are usually the primary dietary phenolic components for people who 
regularly eat berries and drink red wine [43]. Studies on the bioavailability of anthocyanins have 
reported low plasma concentrations ranging from 10-50nmol/L with Cmax mean time of 1.5h (range 
0.75-4h ) [45] while the Cmax mean time for anthocyanin metabolites to appear in the urine is 2.5h 
(range 2-4h) [46]. The exact reason for the low bioavailability, reported as less than 1% of ingested 
anthocyanins, is not known [45] but low recovery in the plasma and urine has been attributed to 
dietary anthocyanins undergoing intensive metabolism after ingestion and the subsequent metabolites 
are the main transport forms in vivo [31, 47-49]. Taking into account the different metabolites of 
anthocyanins, the percentage recovery of consumed anthocyanins found in plasma and urine has been 
estimated as being 15% and higher [47].  Generally, endogenous factors such as; molecular weight, 
glycosylation, metabolic conversion and interaction with colonic microbial flora are the main factors 
that determine anthocyanin bioavailability[50].  Another important factor is the food-matrix. 
Available evidence shows that dietary fibre (such as hemicellulose), divalent minerals, and viscous 
and protein-rich meals have the potential to inhibit anthocyanin bioavailability while digestible 
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carbohydrates, dietary lipids as well as additional antioxidants able to enhance their 
bioavailability[50]. In the colon, intact anthocyanin compounds are broken down to smaller different 
metabolites, including phenolic acids and aromatic catabolites [51, 52]. The metabolism and action of 
anthocyanins in the colon is a bidirectional relationship with the gut microbiota able to enhance the 
metabolism of anthocyanins in the gut [52] and the anthocyanins able to have a proliferative/inhibitory 
effect on gut microbiota [53].  Available evidence indicates that colonic metabolites make up a 
significant portion of the overall metabolic profile following anthocyanin consumption [54, 55]. In 
vitro studies have demonstrated that these colonic metabolites exert more vascular and anti-
inflammatory effects in comparison to the metabolites that are formed and absorbed in the small 
intestine [52]. This highlights the importance of the microbiota–gut-brain axis with evidence showing 
that the gut microbiota may have a significant association with mental illnesses [56]. Following the 
metabolism of anthocyanins in the gut, subsequent changes in the gut microbiota composition have 
been shown to relate with their neuroinflammatory properties [57]. 
 
1.1.1.4 Mechanism of Action  
 
There are a number of plausible mechanisms that have been proposed to explain how anthocyanins 
exert beneficial effects on cognition and other health parameters. Ageing, which is associated with a 
reduction in the neuronal population and loss of synaptic plasticity leads to reduced cognitive function 
over time. Spencer (2010) [18], suggested that anthocyanins may exert protective effects on cognition 
through their ability to act directly (interaction with neuronal signalling and synaptic function in the 
brain) or indirectly (influence on blood flow and neuroinflammation [58]) on the brain’s innate 
architecture for memory (Fig.1-3). The structural characteristics of in vivo metabolites of anthocyanins 
determine, to some extent, their access to the brain with smaller, lipid-soluble, nonionized compounds 
able to cross the blood-brain-barrier [59]. Hence it is unclear whether anthocyanins modulate brain 
plasticity directly or indirectly [58]. Interestingly, substantial evidence continues to support clinically 
significant beneficial effects of anthocyanins on blood pressure [55, 60, 61]. Blood pressure as part of 
the vascular system is therefore important for maximum functioning of the brain, as any dysfunction 
in this process would ultimately affect cognitive function and behaviour [53]. The presence of 
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vascular risk factors, as a result of chronic inflammation, impact on brain degeneration, leading to 
cognitive decline [62]. For example, alterations in mean arterial pressure over time are associated with 
brain degeneration [62]. Prospective studies report  an association  between hypertension in mid-life 
and incidence of dementia at an older age [63] and a higher systolic and diastolic blood pressure 
(>160mmHg and >95mmHg, respectively) 10-15 years earlier was significantly associated with the 
onset of Alzheimer’s disease [64]. It has been suggested that anthocyanin effects on blood pressure 
may be facilitated by the actions of absorbed anthocyanin metabolites on arterial nitric oxide (NO) 
bioavailability by either activating endothelial nitric oxide synthase (eNOS) and/or inhibiting 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in the endothelium [58]. This shows 
the significance of increase in cerebral blood flow (CRF) in the observed beneficial effects [65]. As 
the effectiveness of the brain function is dependent on 20% of the body’s total oxygen supply and 
other nutrients supplied via the vascular system [66], the activity of anthocyanins on brain function is 
highly dependent on the ability of their metabolites to cross the blood brain barrier (BBB) and enter 
the brain [67]. A number of studies have observed the presence of anthocyanin metabolites in brain 
tissues following oral administration [68-71] . In addition, it has been suggested that anthocyanins 
may also exert beneficial effects on cognition and memory by activating MAP (Mitogen Activated 
Protein) kinases and PI3 kinase pathways in the hippocampus of aged animals [72] as well as 
modulating mRNA BDNF (Brain-Derived Neurotrophic Factor ) levels [73].  
 
Evidence from the last decade has shed more light on the possible mechanism of action of 
anthocyanins. An updated review on the health benefits of anthocyanins and their molecular 
mechanisms suggest that some crucial signalling pathways as well as cellular processes, such as cell 
cycle, apoptosis, autophagy, and biochemical metabolism, are involved in the observed beneficial 
health effects of anthocyanins [74]. Extensive research on the molecular mechanism of anthocyanins 
in vivo suggests that anthocyanins may have the potential to inhibit a number of signalling pathways 
that are involved in endothelial function, inflammatory processes as well as tumour proliferation and 
apoptosis. Delphinidin 3-O-glucoside and cyanidin 3-O-glucoside have been demonstrated to improve 
endothelial function through the activation of the NO-cGMP (Nitric Oxide Cyclic guanosine 
monophosphate) signalling pathway in hypercholesteraemic individuals [75]. The NF-kB (Nuclear 
Factor kappa-light-chain-enhancer of activated B cells) pathway regulates inflammatory processes. 
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The plausible role of anthocyanins in inflammatory processes has also been studied. Anthocyanin-rich 
extract from wild blueberry reduces the activation of NF-kB in the presence of the pro-inflammatory 
stimulus IL-1b in human Caco-2 intestinal cells [76]. In addition, anthocyanins induce cell cycle arrest 
in colon cancer cells by increasing the expression of p21WAF1 and p27KIP1 (cyclin-dependent 
kinase inhibitors) and decreasing the expression of cyclin A and cyclin B (proteins that function in 
regulating progression through the cell cycle) [77]. The Wnt signalling pathway is crucial for the 
regulation of cell proliferation, differentiation, and survival. A primary component of the Wnt 
pathway is b-catenin (a protein that is involved in the regulation and coordination of cell–cell 
adhesion and gene transcription). The over activation of b-catenin in the cytosol is related to cancer 
metastasis, which is normally regulated by dephosphorylated glycogen synthase kinase 3b (GSK3b). 
Results from an in vitro study showed that anthocyanin extract from the Korean wild berry, Meoru, 
significantly inhibited liver cancer Hep3B cell migration and invasion by reducing the expression of 
phospho-GSK3b and b-catenin[78]. 
 
In addition, anthocyanin metabolites have become the main point of interest as recent evidence shows 
that anthocyanins are absorbed and transported in the body in the form of their resultant metabolites 
[74].  Protocatechuic acid (PCA), a major anthocyanin metabolite has been shown to significantly 
slow the progression of esophageal cancer in rats [79]. While other anthocyanin metabolites, gallic 
acid, 3-O-methylgallic acid, and 2,4,6-trihydroxybenzaldehyde, showed a significant reduction in cell 
viability, cause cell cycle arrest and apoptosis in colon cancer Caco-2 cells [80], which emphasizes the 
potential benefits of anthocyanin metabolites in vivo.  
With a number of plausible mechanisms that have been described here, there is still need for extensive 
confirmatory research on the beneficial health effects of anthocyanins and their possible mechanisms 
of action. 
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Figure 1-3 Plausible mechanism of anthocyanin effect on memory and learning via direct or indirect 
routes  
Source (Published with permission): [58] 
 
1.1.1.5 Sources of dietary anthocyanins 
 
Anthocyanins are commonly found in a diverse range of red, blue and purple fruits. High levels of 
anthocyanins have been observed in blueberries and as a result, blueberries have been the major focus 
of anthocyanin-based research [81].  A number of other fruits also contain similarly high levels of 
anthocyanins but have not been widely investigated in anthocyanin research. One such fruit is the 
AKT-Protein kinase B (aka Akt); PKA-Protein Kinase A; ERK1/2- Extracellular signal-regulated kinase 1/2; eNOS-Endothelial 
nitric oxide synthase; NO- Nitric oxide; BBB-Blood-brain-barrier; BDNF- Brain-derived neurotrophic factor; ARC- Activity-
regulated cytoskeleton; nNOS- Neuronal nitric oxide synthase; CREB- cAMP response element binding (protein); NMDAR- N-
methyl-D-aspartate; TrkB- Tropomyosin receptor kinase B 
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plum, a drupe fruit which belongs to the subgenus prunus (Family Rosaceae). The subgenus can be 
differentiated from other subgenera (peaches, cherries, etc.) as the shoots have a terminal bud and 
unclustered single side buds. The flowers combine in groups of one to five on short stems, and 
the fruit have a crease running down one side and a smooth seed. Between 19 and 40 different species 
of plum exist. Of these, only two; the hexaploid European plum (prunus domestica) and the diploid 
Japanese plum (prunus salicina and hybrids) are of commercial significance across the globe [82].  
In the last decade, there has been an increased interest in plum-based research because of the fruit’s 
high levels of polyphenols, and more recently identification of its high anthocyanin content [75]. The 
major anthocyanins found in the plum are cyanidin (3-rutinoside, 3-glucoside and 3-xyloside) and 
peonidin (3-rutinoside  and 3-glucoside) [83]. The increased interest in plum-based research has also 
resulted in fruit breeders cultivating different varieties through hybridisation. One of these hybrids is 
the Australian Queen Garnet plum (QGP), a hybrid of the Japanese plum developed through a 
breeding program funded by the Queensland Government in Australia. The QGP is known for its 
exceptionally high anthocyanin levels, reaching up to 277 mg/100 g fruit [84]. Although fruit 
anthocyanin levels increase progressively during fruit development and ripening, the anthocyanin 
levels in the QGP is more than two times the total anthocyanin content of regular plums (range of 5 to 
173mg/ 100g across harvest years for regular plums [13]) and other common fruits. Preliminary 
studies using this variant of plum have demonstrated antithrombotic activity in humans [85] and a 
beneficial  effect on metabolic syndrome in rat models, as well as  in vivo and in vitro bioactivity [86].   
The proposed research will contribute to the current evidence on the beneficial health effects of plums 
in general, and for the clinical studies, the Australian QGP will be utilised for its higher levels of 
anthocyanins, as well as its accessibility to the research team.  
 
1.1.1.6 Anthocyanin food levels and measurement  
 
The ability to measure anthocyanin accurately and specifically is essential in order to investigate the 
association between anthocyanin intake and health outcomes. Accurate measurement of anthocyanins 
in food sources, as well as through dietary assessment of individual intake and biomarkers that 
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indicate absorption and excretion is required. In addition, no consistent biomarkers exist as the ‘gold 
standard’ proxy for dietary intake. 
 
For the levels of anthocyanin in major food groups, a number of international databases have been 
developed including the American USDA Database for the Flavonoid Content of Selected Foods [87] 
and the European Phenol-Explorer [88]. These databases are freely accessible and usually employed 
globally to determine individual anthocyanin intake. The problem though is that these databases have 
been developed overseas and are tailored mainly to foods accessible in those regions of the world. 
Nutritional content of foods is known to be affected by region, climate and soil conditions [89, 90]. 
The ability to be able to accurately determine anthocyanin intake across various populations in 
different regions would involve developing food composition databases tailored to specific regions. 
As part of this research, a first stage development of an anthocyanin database for Australian foods was 
carried out. This, together with borrowed values from the USDA Database for the Flavonoid content 
of selected foods and the European Phenol-Explorer, was used to measure dietary intake of 
anthocyanins in the Australian population.  
 
1.1.2 Problem statement 
 
Anthocyanin research has mainly focused on (blue) berries because of their high anthocyanin content 
with less focus on other anthocyanin-containing (different anthocyanin profile) fruits and vegetables 
which has limited research conclusions and generalisability to dietary messaging. 
Further understanding of the metabolism and mechanism of action of anthocyanins and their 
metabolites in the body as well as how dose (timing) might affect this process and whether it is age-
dependent remains to be addressed.  
 
In addition, the absence of specific food composition databases for anthocyanins, and larger flavonoid 
subclasses, tailored to countries and regions to measure anthocyanin intake in epidemiological studies 
continues to limit research evidence and diminishes population estimates. 
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1.1.3 Hypothesis 
 
Following the problem statement, this research hypothesises that supplementing the diet with plum 
anthocyanins will have significant positive effects on cognitive function and other health parameters 
in older adults, while being age- and dose-dependent.  
To test this hypothesis the following objectives were developed. 
 
1.1.4 Research Objective 
 
To determine the acute and longer-term effects of consumption of dietary anthocyanins (delivered 
from plum juice) on cognition and other health parameters in older adults.  
1.1.4.1 Specific Objectives: 
 
1) To collate and synthesise the current level of evidence on the beneficial health effects of plum – 
an anthocyanin-rich fruit.  
2) To determine if consumption of anthocyanins from QGP juice has an acute impact on various 
domains of cognitive functioning, blood pressure, and urinary phenolic profile. 
3) To determine the longer-term effects of anthocyanin consumption from QGP juice on cognition, 
blood pressure, inflammatory biomarkers (BDNF, CRP) and gut microbiota in older adults. 
4) To collate and synthesise the current evidence on the effects of anthocyanins on gut microbiota.  
5) To determine the anthocyanin intake of older Australian adults from the National Nutrition and 
Physical Activity component of the Australian Health Survey 2011-13 (a nationally 
representative sample) in order to obtain current dietary levels of anthocyanin intake and the 
common food sources thereof. 
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1.1.5 Conceptual Framework 
 
To test the above hypothesis, acute and longer-term effects of high anthocyanin QGP juice on 
cognition and other health parameters will be studied in younger and older adults. To achieve this, 
four studies were developed to answer the above research objectives. These studies were classified 
under three theoretical research frameworks (Figure 1-4); current evidence synthesis, evidence 
generation, and evidence translation. 
 
With the dramatic increase in the prevalence of dementia and other CVDs, research continues to find 
ways to improve the overall wellbeing of the general population especially in older adults. Modifiable 
risk factors including nutrition have become an area of interest stem the global epidemic of chronic 
diseases, especially cognitive impairment. Evidence is emerging that anthocyanins, known to be 
natural antioxidants may exert beneficial effects on memory and cognition, as well as improve 
metabolic risk factors (blood pressure, insulin resistance etc.).  
 
Two systematic reviews were conducted to synthesise existing knowledge and identify gaps in the 
literature on the beneficial health effects of plums and the effects of anthocyanins on gut bacteria. 
 
Intervention studies aimed to investigate the effect of acute and chronic consumption of different 
doses of anthocyanin-rich QGP juice on cognition and blood pressure as main outcome measures, and 
other health parameters including anthocyanin metabolite excretion, inflammatory biomarkers and gut 
microbiota as secondary outcomes. A crossover study determined the acute effect of the high 
anthocyanin QGP on cognition, blood pressure and metabolism (urinary excretion of polyphenolics) 
in younger and older adults, while an 8-week RCT also assessed these effects, including inflammatory 
biomarkers and gut microbiota, over the longer term in generally healthy older adults.  
 
The lack of an Australian food composition database related to the anthocyanin content (and 
flavonoids generally) of local foods hampers interpretation of food-based research. Substitution of 
values from the U.S. Department of Agriculture (USDA) database and/or the European Phenol-
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Explorer database have been used in past studies, but this project further refined research 
methodology in this area by developing an anthocyanin database tailored to Australian foods (fruits  
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 Figure 1-4: Research Conceptual framework 
METHODOLOGICAL 
STUDIES/APPLICATION 
RESEARCH STUDIES 
 
Phase 2: Evidence Generation 
Phase 1: Current Evidence Synthesis
 
Phase 3: Evidence Translation 
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and vegetables as a first step). This developed database was applied to nationally representative 
nutrition survey data in order to determine anthocyanin intake in the Australian population. This 
methodological component of the project will contribute to application of clinical trials data to 
translation of the findings into practical dietary guidance.  
 
1.1.6 Significance and Summary  
 
The role of nutrition as a protective factor in chronic diseases is a promising research area; however, 
results have been inconclusive. It is important to establish a reliable and robust body of evidence. A 
review on the health effects of plum will summarise the available evidence to date and identify gaps in 
the published literature for future plum-based anthocyanin research. 
 
This thesis will make a significant contribution to the area of anthocyanin research. Knowledge 
synthesis in the systematic reviews will identify gaps for current and future research while the 
proposed clinical trials would expand the clinical evidence on the health benefits of anthocyanins from 
a different, less popular anthocyanin source – plum juice. Additionally, differences in anthocyanin 
metabolism between young and older adults will be investigated in the acute trial in order to inform 
future clinical trials in older people who may be at an increased risk of cognitive impairment.  
 
The development of an Australian anthocyanin database will facilitate better estimation of the current 
dietary anthocyanin intake of the Australian population and thereby contribute to dietary 
methodology. In doing so, it will address some of the gaps in the literature related to the estimation of 
dietary anthocyanin intake, as is required in studies to determine their beneficial health effects. 
 
In summary, this doctoral thesis addresses significant gaps in the literature, with each study providing 
novel and significant contributions to the body of evidence in anthocyanin research and advances the 
scientific knowledge thereof.  
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2 Chapter 2 
2.1 A SYSTEMATIC REVIEW ON THE HEALTH EFFECTS OF 
PLUMS (PRUNUS DOMESTICA AND PRUNUS SALICINA)  
 
Plum as a source of anthocyanin has contributed to the evidence on the beneficial health effects of 
anthocyanins but the major focus of this bioactive component in food has been blueberries (for their 
significantly higher anthocyanin content). Little is known about the effectiveness of plum 
supplementation, as a source of anthocyanin, on health parameters. A systematic review of literature 
was carried out to summarise the available evidence on the impact of plums (prunus species; 
domestica and salicina) on disease-related risk factors and health outcomes. Findings from this review 
highlighted the low level of evidence for plum-anthocyanin research, with the primary focus on 
cognitive function in animal models, and bone health parameters in human clinical trials. This review 
concluded that evidence on the health effect of plums has not been extensively studied and that the 
available evidence needs confirmation with further well-designed studies. 
 
 
The majority of this chapter forms the substantive content of a published article: Appendix C 
 
Igwe, E.O. and Charlton, K.E., 2016. A systematic review on the health effects of plums (Prunus 
domestica and Prunus salicina). Phytotherapy Research, 30(5), pp.701-731.  
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2.1.1 Introduction 
 
The European plum (prunus domestica) is believed to have been discovered about 2000 years ago 
with its origin somewhere near the Caspian Sea. The fruit was introduced into the U.S. in the 17 th 
century by pilgrims while the Japanese plum has its origin in China but derived its name from the 
country where it was mostly cultivated and developed; Japan. The Japanese plum (prunus salicina and 
hybrids) was introduced into the U.S in the late 19th century. Today, the main producers of 
commercially grown plums are the United States, Serbia, China, and Romania. [91]. The nutritional 
composition of the two species is considered similar (Table 2-1). 
 
Prunes are the dried version of plums and are known for their laxative effect which is commonly 
attributed to its high fibre content [92]. Earlier studies  attributed the laxative effect of prunes to the 
presence of phenolics (chlorogenic acid) [93] and sorbitol [94] that are in the fruit, together with its 
high fibre content [95]. In the U.S., prunes are referred to as dried plums. This name change was 
effected in a bid to promote prunes as a health food instead of being associated with old age [96]. 
Prunes are produced industrially by drying plums at 85-90oC for 18 hours. This process is believed to 
have originated thousands of years ago also near the Caspian Sea, the same region where the 
European plums were discovered. With migration and civilisation, prunes spread throughout Europe. 
Today, California, USA is the leading producer of prunes (dried plums) worldwide [97]. 
 
In classifying whole and natural foods based on their unique nutritional composition, anthocyanin 
content has become a widely utilised method of classification [98]. The high levels of phenolic 
compounds including flavonoids, and particularly the subclass of anthocyanins observed in the plum 
has resulted in a dramatically increased interest in plum based research since the 1990s [99, 100]. A 
number of health benefits have been associated with the plum fruit and these include improved bone 
health, cognition and memory, antioxidant anti-inflammatory effects, and easement of constipation. 
These health promoting properties have been attributed to the plum’s antioxidant capacity as a result 
of the high phenolic content [101-105]. These beneficial health effects have been reported from 
studies that have used different research designs (in vitro, animal studies and clinical studies) and have 
investigated both plums, and related products and extracts [106]. 
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The aim of this systematic literature review was to determine the level of current evidence on the 
beneficial health effects of plum and its associated products. 
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Table 2-1:  Major nutritional composition of European (P. Domestica) and Japanese (P. Salicina) 
plums (per 100g) 
 
Component European plum (p.domestica) and Japanese plums (p.salicina) 
Fresh plums Dried prunes Plum juicea 
 
Water/moisture (g) 
 
87.23 
 
30.92 
 
84.02 
Energy (kj) 192 1006 243 
Carbohydrate (g) 11.42 63.88 15.15 
Protein (g) 0.70 2.18 0.51 
Fat (g) 0.28 0.38 0.02 
 
Sugars, total 
Glucose (g) 
Fructose (g) 
Sucrose (g) 
 
 
5.07 
3.07 
1.57 
 
 
25.46 
12.45 
0.15 
 
14.22 
23.3a 
11.8a 
3.7a 
Total Dietary fibre (g) 1.4 7.1 0.9 
 
Minerals 
Calcium (mg) 
Iron (mg) 
Magnesium (mg) 
Phosphorus (mg) 
Potassium (mg) 
Sodium (mg) 
Zinc (mg) 
Copper (mg) 
Manganese (mg) 
Fluoride (µg) 
 
Vitamins 
Ascorbic acid (C) (mg) 
Thiamine (B1) (mg) 
Riboflavin (B2) (mg) 
Niacin (B3) (mg) 
Pantothenic acid (B5) (mg) 
Pyridoxine (B6) (mg) 
Total Folate (µg) 
Vitamin A, RAE (µg) 
Vitamin E (mg) 
Vitamin K1 (µg) 
 
Carotenoids 
Carotene, beta (µg) 
Carotene, alpha (µg) 
Cryptoxanthin, beta (µg) 
Lutein + zeaxanthin (µg) 
 
Phenolic compoundsb 
Total (mg) 
Neochlorogenic acid (mg) 
Chlorogenic acid (mg) 
Anthocyanins (mg) 
Catechins (mg) 
 
 
6 
0.17 
7 
16 
157 
0 
0.10 
0.057 
0.052 
2.0 
 
 
9.5 
0.028 
0.026 
0.417 
0.135 
0.029 
5 
17 
0.26 
6.4 
 
 
190 
0 
35 
73 
 
 
111 
81 
14.4 
7.6 
5.4 
 
 
43 
0.93 
41 
69 
732 
2 
0.44 
0.281 
0.299 
4.0 
 
 
0.6 
0.051 
0.186 
1.882 
0.422 
0.205 
4 
39 
0.43 
59.5 
 
 
394 
57 
93 
148 
 
 
184 
131 
44 
- 
- 
 
 
10 
0.34 
8 
15 
154 
1 
0.11 
0.054 
0.033 
- 
 
 
2.8 
0.023 
0.059 
0.473 
0.072 
0.027 
3 
50 
0.18 
4.3 
 
 
554 
0 
102 
49 
 
 
121c 
198.5a 
46.5a 
0.172c 
- 
Table adapted from [106] and [107], a[106] (plum juice concentrate/100mL), b[108], c [105], - No available data. Amount 
reported per 100g weight [109]; data are a mix of Japanese and European plums  
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2.1.2 Materials and methods 
 
A systematic literature review was conducted according to the guidelines of the PRISMA (Preferred 
Reporting Items for Systematic Reviews and Meta-Analysis) statement and checklist [110] (Figure 2-1). A 
number of electronic databases were searched: Scopus, Web of Science, Cochrane library, CINAHL, 
MedLine, and ScienceDirect up to June 2015 with a combination of search terms, including, plum or prune 
or prunus or prunus domestica or prunus salicina and health effects used as keywords (see appendix B for 
sample search strategy (Medline)). 
 
Inclusion criteria for journal articles included: 
1. Studies carried out in vitro, on animal and clinical studies. 
2. Studies that utilised the fresh, dried, juice version or extracts of the plum species prunus 
domestica or prunus salicina. 
3. All studies assessing any health outcome associated with plum consumption/treatment. 
4. Studies reported in English. Only studies reported in English were included due to language 
barrier, reasons of time efficiency and cost of translation not being feasible. 
 
Exclusion criteria for journal articles included: 
 
1. Studies on the quantification of the nutritional composition and antioxidant properties of plums.  
2. Studies that utilise a different species of plums e.g. the Japanese apricot also known as Japanese 
plums in the prunus mume specie. 
3. Studies assessing properties related to plum cultivation, harvest and the commercial aspects of 
the plum fruit. 
 
Articles were assessed for peer-reviewed status using Ulrich’s Web (available at: 
http://ulrichsweb.serialssolutions.com.ezproxy.uow.edu.au/). A hand search yielded one additional article 
which was relevant to this review. 
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For the clinical trials, all the relevant studies retrieved were classified as either confirmatory or exploratory 
studies. They were rated for their quality using relevant criteria from The Delphi List, Cochrane Back 
Review Group and The CONSORT Statement (Appendix A). The strength of evidence of study design was 
assessed using the Australian NHMRC (National Health and Medical Research Council) hierarchy levels 
of evidence with rankings from level I - IV. The NHMRC evidence hierarchy has 6 levels according to 
type of research question with systematic review of level II studies classified as levels I and randomised 
controlled trials, classified as level II. Studies ranging from a pseudo-randomised controlled trial to a 
comparative study without concurrent controls are classified as levels III-1 to III-3, and case series with 
either post-test or pre-test/post-test outcomes classified as level IV  [111].  
 
2.1.3 Results 
 
A total of 73 studies were eligible for inclusion in this review (Fig.2-2), most of which were conducted in 
the last decade. Of these, 18 investigated bone health (2 in vitro, 12 animal studies and 4 human clinical 
trials), and 20 investigated its anti-cancer and anti-inflammatory properties (13 in vitro studies, 6 animal 
studies and 1 human clinical trial). Eleven studies reported on plums’ antioxidant properties and their effect 
on cognition (2 in vitro studies, 5 animal studies and 4 human clinical trials) while nine studies investigated 
the effect of plums on different components of the metabolic syndrome (cholesterol, high blood pressure 
and anti-thrombosis; 3 animal studies and 6 human clinical trials). For prunes commonly known laxative 
effect and satiety, 8 clinical studies in humans, including 2 randomised clinical trials were carried out. Five 
studies examined its anti-allergic, anti-microbial and immune-enhancing properties (2 in vitro studies and 3 
animal studies) and 2 clinical studies examined its effects on liver function and risk factors for kidney stone 
formation. Some of the findings reported from the in vitro studies such as parameters related to improved 
bone health and anti-inflammatory properties have also been confirmed in animal and human studies [112-
115]. Tables 2-2 to 2-8 summarise the experimental and clinical studies and Appendix A summarises the 
quality of the clinical studies included in this review.  
 
The quality of the clinical studies included is at best of moderate quality. There were 6 confirmatory 
studies of moderate quality (1 on bone health, 2 on different components of metabolic syndrome, and 3 on 
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satiety and laxative effect) and 19 exploratory studies. Evidence on the health effect of plums has not been 
extensively studied and the available evidence needs further confirmation. 
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Figure 2-1: Figure 2-2 PRISMA flow diagram for study selection process 
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2.1.3.1 Bone health 
 
Based on results from 18 studies (2 in vitro, 12 animal studies and 4 clinical trials) reported in this review, 
promising evidence exists on the effect of plum on bone health. This body of evidence has mostly been in 
agreement and also confirmed in human trials. Bu et al. (2008) [116] in their in vitro study involving two 
groups investigated the effect of dried plum polyphenols on osteoclastogenesis in which one group was 
stimulated with lipopolysaccharide (LPS) to induce inflammation and the other group stimulated with 
hydrogen peroxide (H2O2) to induce lipid peroxidation. It was observed that the LPS stimulated sample 
produced NO (nitric oxide) detectable at 8h which further increased at 16hr while the H2O2 stimulated cells 
did not produce NO. This increase in NO associated with LPS was downregulated by different doses (10, 
20, 30µg/mL) of plum polyphenol at both 8h and 16h. The authors concluded that dried plum polyphenols 
directly inhibit osteoclastogenesis which leads to reduced osteoclast activity by downregulation of NFATc1 
(Nuclear factor of activated T-cells, cytoplasmic 1) and inflammatory mediators. The results from the 
above in vitro experiment have also been confirmed in animal studies [103, 117-119]. However, one study 
[119] differed slightly by studying  the mechanism of action of dried plum alteration of bone metabolism in 
comparison to the longer-term effects of dried plum on systemic biochemical markers of bone metabolism 
and alteration in gene expression [103, 117, 118]. Regulators of osteoblast and osteoclast differentiation 
and osteoblast activity were studied over a period of 6 weeks. Compared to the anabolic therapy using PTH 
(parathyroid hormone) that significantly increased systemic and local indicators of bone formation with no 
effect on systemic marker of bone resorption, dried plum supplementation suppressed bone turnover with 
no effect on the indices of bone formation at the endocortical surface. In another study by the same 
research team, dried plum supplementation initially suppressed cancellous bone turnover but demonstrated 
a biphasic response over time, exerting positive effects on bone mass and bone structure [120]. Plum 
extract has also been shown to be effective in increasing bone calcium retention by 20% [104]. 
 
Rendina et al. (2013) [112] compared dried plum to other dried fruits (apple, apricot, grape and mango) and 
observed that only the dried plum had an anabolic effect on trabecular bone in the vertebra and prevented 
bone loss in the tibia. This demonstrates a potentially unique effect of plum that was absent in the other 
fruits studied. This anabolic effect of dried plum supplementation has also been observed by others in 
animal models [113]. Prevention of age-associated bone loss was evident because of this anabolic effect, 
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while bone volume increased, and already lost bone was restored. Investigating further, Monsefi et al. 
(2013) [114] observed the effect of plum extract on bone parameters in the offspring of pregnant mice as 
well as in non-pregnant mice. Plum extract was orally administered to the sample population and results 
showed that in the non-pregnant mice, there was an increase in the femoral and tibial lengths and serum 
calcium content, while the foetuses and new-borns of the pregnant mice had higher osteogenesis index 
which was calculated by dividing the ossified length by the total length of each bone. 
 
Ovarian hormone deficiency which is evident in postmenopausal women is a known major risk factor for 
osteoporosis [121]. For this reason, effect of plum consumption on bone health in human trials has been 
carried out mostly on postmenopausal women. A dietary supplementation trial compared the effects of 
consumption of dried plum (100g) with dried apple (75g) for 3 months on markers of bone turnover in 
postmenopausal women [115]. The difference in the amount of dried plum and dried apple compared was 
related to comparable quantities of energy, carbohydrates, fat and fibre, obtainable from 100 g of dried 
plum. Baseline and post-treatment values of serum and urinary biochemical markers of bone status showed 
that only dried plums significantly increased serum levels of insulin-like growth factor-1 (IGF-1) and bone 
specific alkaline phosphatase (BSAP) activity.  
 
A similar longer term randomised controlled study compared the effects of dried plum and dried apple on 
osteopenic postmenopausal women for one year [122]. In addition to similar results in [115], the authors 
observed that dried plum significantly increased bone mineral density (BMD) of the ulna and spine.  
In a slightly different study examining the effects of resistance training and dried plum consumption on 
strength, body composition, blood markers of bone, and inflammation in breast cancer survivors, results 
showed that even though breast cancer survivors increased upper and lower body strength, no 
improvements were observed in their body composition and Bone Mineral Density (BMD)[123]. 
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Table 2-2: Evidence on the effect of plums and its associated products on bone health 
 
Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed 
In vitro studies 
Bu et al., 2008 [116] 
 
 
 
Bu et al., 2009 [124] 
 
 
 
 
Animal studies 
Smith et al., 2014a 
[119] 
 
 
Deyhim et al., 2005 [117] 
 
 
 
Franklin et al., 2006 [103] 
 
 
 
Bu et al., 2007 [118] 
 
 
 
 
Smith et al., 2014b [120] 
 
 
Rendina et al., 2013 [112] 
 
 
USA 
 
 
 
USA 
 
 
 
 
 
USA 
 
 
 
USA 
 
 
 
USA 
 
 
 
USA 
 
 
 
 
USA 
 
 
USA 
 
 
Dried plum 
extract 
(P.Domestica) 
 
Polyphenols 
extracted from 
dried plum 
(P.Domestica) 
 
 
Dried plum 
(P. Domestica) 
 
 
Dried plum 
(P. Domestica) 
 
 
Dried plum 
(P. Domestica) 
 
 
Dried plum 
(P. Domestica) 
 
 
 
Dried plum 
(P. Domestica) 
 
Dried plum 
(P. Domestica)  
 
RAW 264.7 murine macrophage cells. 
 
 
 
MC3T3-E1 cells pre-treated with dried plum 
polyphenols (0, 2.5, 5, 10 and 20 μg/mL) and 24 
h later stimulated with TNF-α (0 or 1.0 ng/mL). 
 
 
 
6wk dietary supplementation of dried plum 
(5%, 15% or 25%) in adult, osteopenic 
ovariectomized rats. 
 
Dietary supplementation of dried plum (5%, 
15% and 25%) in adult, osteopenic 
ovariectomized (OVX) rats for 40days. 
 
Dietary supplementation of dried plum (5%, 
15% and 25%) in orchidectomized rats for 
90days. 
 
Dietary supplementation of dried plum (25%) in 
osteopenic orchidectomized rats for 90days. 
 
 
 
Dietary supplementation of dried plum (25%) in 
adult mice for 4 or 12 weeks. 
 
8wk dietary supplementation of dried plum 
(25%) in adult, osteopenic ovariectomized mice. 
 
NA 
 
 
 
NA 
 
 
 
 
 
NA 
 
 
 
NA 
 
 
 
NA 
 
 
 
NA 
 
 
 
 
NA 
 
 
NA 
 
 
Inhibition of osteoclastogenesis under 
inflammatory and oxidative stress 
conditions possibly by polyphenol content. 
 
Improvement of osteoblast activity and 
function by up-regulating Runx2, Osterix 
and IGF-I and increasing lysyl oxidase 
expression, and reduction in 
osteoclastogenesis signalling. 
 
Restoration of bone Mineral Density by 2 
higher doses and bone turnover 
suppression. 
 
Bone quality improvement (restoring bone 
density) with all doses. 
 
 
Prevention of osteopenia in androgen 
deficient male rats. 
 
 
Reversion of bone loss due to 
orchidectomy. 
 
 
 
Improvement in bone mass and structure. 
 
 
Bone loss prevention with anabolic effect. 
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Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed 
 
 
Halloran et al., 2010 [113] 
 
 
 
Rendina et al., 2012 
[125] 
 
 
 
Pawlowski et al., 2014 
[104] 
 
 
 
Monsefi et al., 2013 
[114] 
 
Arjmandi et al., 2010 
[126] 
 
 
 
 
 
 
Johnson et al., 2011 
[127] 
 
 
 
 
USA 
 
 
 
USA 
 
 
 
 
USA 
 
 
 
 
Iran 
 
 
USA 
 
 
 
 
 
 
 
USA 
 
 
 
Dried plum 
(P.Domestica) 
 
 
Dried plum 
(P.Domestica) 
 
 
 
Dried plum 
powder extract 
(P.Domestica) 
 
 
Plum extract 
(P.Domestica) 
 
Dried plum 
(P.Domestica) 
 
 
 
 
 
 
Dried plum 
(P.Domestica) 
 
 
 
Dietary supplementation of dried plum (15% or 
25%) in adult and aged (old) male mice for 6 
months. 
 
Dietary supplementation of dried plum (5%, 
15% or 25%) in ovariectomized adult mice for 4 
weeks. 
 
 
Dietary supplementation of plum extract (9% or 
20%) in ovariectomized rats for 6 intervention 
(10days) and washout (10 days) cycles. 
 
 
Oral administration of plum extract (1.6 g/kg) in 
distilled water in pregnant mice for 30 days. 
 
180 3-month-old female Sprague-Dawley rats 
assigned to 15 groups (n=12) and either 
ovariectomized (14 groups) or sham-operated 
(Sham, one group) then placed on different 
dietary treatments including one supplemented 
with 5% Fructooligosaccharides (FOS) and 
7.5% dried plum (DP) for 60 days.  
 
72 3-month-old female Sprague-Dawley rats 
assigned to 6 groups (n=12/group) and either 
ovariectomized (5 groups) or sham-operated 
(Sham, one group) then placed on a semi 
purified, powdered casein-based diet for 45 
days to induce bone loss. Thereafter the groups 
were placed on different dietary treatments 
including one supplemented with 5% 
Fructooligosaccharides (FOS) and 7.5% dried 
 
 
NA 
 
 
 
NA 
 
 
 
 
NA 
 
 
 
 
NA 
 
 
NA 
 
 
 
 
 
 
 
NA 
 
 
 
 
 
 
 
 
 
 
Restoration of lost bone and increase in 
bone volume. 
 
 
Improvement of bone structure and 
biomechanical properties and suppression 
of lymphocyte TNF-α production by higher 
doses. 
 
Improvement in bone calcium retention. 
 
 
 
 
Increased osteogenesis index in foetuses of 
mice treated with plum extract. 
 
Diets supplemented with 5% FOS and 7.5% 
DP was most effective in reversing both 
right femur and fourth lumbar bone mineral 
density and fourth lumbar calcium loss 
while significantly decreasing trabecular 
separation. 
 
 
In combination with soy protein, dried plum 
and fructooligosaccharides had the most 
pronounced effect in increasing lumbar 
bone mineral density. 
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Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed 
plum (DP) for 60 days.   
 
Clinical trials 
Hooshmand et al., 2011 
[122] 
 
 
 
 
 
 
 
 
 
 
Arjmandi et al., 2002 
[115] 
 
 
 
 
 
 
 
 
 
 
 
Hooshmand et al., 2014 
[128] 
 
 
 
 
 
 
 
USA 
 
 
 
 
 
 
 
 
 
 
 
USA 
 
 
 
 
 
 
 
 
 
 
 
 
USA 
 
 
 
 
 
 
 
 
Dried plum 
(P.Domestica) 
 
 
 
 
 
 
 
 
 
 
Dried plum 
(P.Domestica) 
 
 
 
 
 
 
 
 
 
 
 
Dried plum 
(P.Domestica) 
 
 
 
 
 
 
 
Hypothesis: Dried plums reverses bone loss in 
osteopenic postmenopausal women.  
n=160 osteopenic postmenopausal women 
Study design/Methods: Randomized 
controlled trial. Postmenopausal women 
randomly assigned to treatment groups of dried 
plum (100g/d) or dried apple (75g) daily for 1 
year. Blood and urine samples collected. 
Sample size power: not stated. 
Dose: 100g/day. 
Duration: 1 year. 
 
Hypothesis: Addition of dried plums to the 
diets of postmenopausal women would 
positively influence markers of bone turnover. 
n=58 postmenopausal women. 
Study design/Methods: Randomized 
controlled trial. Postmenopausal women 
randomly assigned to treatment groups of dried 
plum (100g/d) or dried apple (75g) daily for 3 
months. Blood and urine samples collected. 
Sample size power: not stated 
Dose: 100g/day. 
Duration: 3 months. 
 
Hypothesis: Dried plum has an effect on 
circulating levels of sclerostin and bone 
metabolism measured in serum levels of 
RANKL (receptor activator of NF-kB ligand) 
and OPG (osteopotegerin).  
n=160 women with mild bone loss. 
Study design/Methods: RCT. Subjects 
randomly assigned to one of 2 groups of dried 
 
II 
Confirmatory 
 
 
 
 
 
 
 
 
 
 
II 
Exploratory  
 
 
 
 
 
 
 
 
 
 
 
II 
Exploratory  
 
 
 
 
 
 
 
Statistically significant increase in 
bone mineral density of ulna and 
spine with decreased serum levels 
in bone turnover markers (bone-
specific alkaline phosphatase and 
tartrate-resistant acid 
phosphatase-5b) observed. 
 
 
 
 
 
Statistically significant increase 
in serum levels of insulin-like 
growth factor-1 (IGF-1) and 
bone-specific alkaline 
phosphatase associated with 
increased rates of bone 
formation. 
 
 
 
 
 
 
Increase in bone mineral density 
of the ulna and spine and also 
the RANKL and OPG levels. A 
reduction in in serum sclerostin 
was also observed. 
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Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed 
 
 
 
 
 
 
Simonavice et al., 2014 
[123] 
 
 
 
 
 
 
 
 
 
 
 
USA 
 
 
 
 
 
 
Dried plum 
(P.Domestica) 
 
plum or dried apple and provided with 500mg 
Caplus 400 IU (10µg) vitamin D.  
Sample size power: not stated. 
Dose: 100g dried plum per day. 
Duration: 1 year. 
 
Hypothesis: 6-month intervention with 
resistance training (RT) and a combination of 
resistance training and dried plum (DP) would 
improve total and regional (lumbar spine, 
femur, and forearm) BMD. Increase lean body 
mass, skeletal muscular strength and decrease 
fat body mass. Additionally, it was 
hypothesized that the biochemical analyses for 
both groups would reveal increased levels of 
bone formation markers, decreased levels of 
bone resorption markers, and decreased levels 
of inflammation markers, with the RT+DP 
group having the most improvements in these 
areas in breast cancer survivors. 
n=23 female breast cancer survivors. 
Study design/Methods: Case-control. Subjects 
stratified into 1(RT) or 2(RT+DP) treatment 
groups.  
Sample size power: not stated 
Dose: 90g dried plum per day 
Duration: 6 months. 
 
 
 
 
 
 
II 
Exploratory 
 
 
 
 
 
 
No difference between groups 
or any group-by-time interaction 
observed for any of the 
variables. 
*Only clinical trials were ranked for level of evidence 
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2.1.3.2 Antioxidant and anti-inflammatory activity 
 
The antioxidant property of plums has mostly been attributed to its high phenolic content [129, 130]. 
Research on this health effect has mostly been carried out with the ripe plum fruit or its products. However, 
evidence has shown that immature plums may contain higher levels of polyphenols with more significant 
antimicrobial, antioxidant, and antitumor properties in comparison to mature plums [131]. Studying the 
antioxidant effect of immature plum extract (IPE) on selected cancer cells in vitro, it was observed that 
even though the IPE was effective in inhibiting growth of the cancer cells (Human hepatocellular 
carcinoma HepG2 cells, Kato III gastric cancer cells, HeLa human cervical carcinoma cells, U937 
leukaemia cells, and MCF 7 hormone-dependent breast cancer cells). This inhibitory effect was not 
observed in the hormone dependent breast cancer cells and as the fruit ripened, there was a reduction in its 
inhibitory effect [131]. Another study [102] aimed to identify the phenolic fraction responsible for the 
potential chemo-preventive and/or chemotherapeutic action in plum. The authors observed that all extract 
fractions were effective in exerting antioxidant effect on studied cancer cell lines, with the flavonols and 
procyanidins more effective than the phenolic acids and anthocyanins. In addition, a similar study 
suggested that the synergistic effect of the total phenolic content of the plum extract significantly increased 
its antioxidant activity [130]. 
 
Investigating this antioxidant effect on human colon cancer cells using prune [132] and plum extract [130], 
there was no significant reduction in the viable cell number of the human normal colon fibroblast cells 
while inducing apoptosis of cancer cells. Similar results were also observed with breast cancer cell lines 
[102]. These results have also been confirmed in animal studies with immature plum extract (IPE) 
inhibiting the growth of hepatoma HepG2 cells as well as exerting a protective effect against 
benzo(α)pyrene induced liver toxicity by decreasing serum aminotransferase and hepatic contents of lipid 
peroxide [133]. In addition, an anti-ulcer effect has also been observed in Wistar albino rats. Following a 7-
day feed with 100, 150 or 200mg kg-1 of plum extract, peptic ulcer was induced by pyloric ligation. Results 
from gastric ulcerative index estimation showed that the group pre-treated with plum extract had a 
significantly reduced gastric volume and a significantly lower ulcerative index [134]. This anti-ulcer effect 
has also been observed in an acute setting following oral treatments including prune polysaccharides which 
showed a reduction and inhibition of the gastric lesion area. [135]. Further investigation on the effect of 
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plum on colon cancer risk factors showed that even though dietary supplementation with dried plum 
showed no inhibitory effect on aberrant crypt foci formation at the initiation stage of cancer and early 
progression, it was able to inhibit several risk factors associated with colon carcinogenesis. These include 
reduction in faecal total and secondary bile acid concentration, decrease in colonic β-glucuronidase and 7α-
dehydroxylase activities and increased antioxidant activities [136]. 
 
Even though similar results have been observed in in vitro and animal studies, results from human trials 
have not been in agreement. A study that investigated the plasma antioxidant capacity changes after a meal 
observed that consumption of a meal containing dried plum or dried plum juice did not alter plasma 
antioxidant capacity (hydrophilic and lipophilic ORACFL) [137]. Contrary to this, another study observed 
that 9 different fruit juices, including plum juice, exhibited significant antioxidant effects in human plasma 
within 30 mins of consumption by suppressing reactive oxygen species generation [129]. Similar effects 
were also observed in young, middle-aged and elderly adults after consumption of 195g of plum twice a 
day for 5 days [138] and QGP juice in an acute setting [107].  
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Table 2-3: Evidence on the anti-cancerous and anti-inflammatory properties of plums and its associated products 
 
Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed 
In vitro studies 
Yu et al., 2009 [101] 
 
 
 
 
 
Noratto et al., 2009 
[102] 
 
 
 
 
Lee et al., 2009 
[139] 
 
 
 
Fujii et al., 2006 
[132] 
 
 
 
Lea et al., 2008 
[130] 
 
Hooshmand et al., 2015 
[140] 
 
 
 
 
 
 
Korea 
 
 
 
 
 
USA 
 
 
 
 
USA 
 
 
 
 
Japan 
 
 
 
 
USA 
 
 
USA 
 
 
 
 
 
 
 
 
Immature Plum 
extract (IPE) 
(P.Salicina) 
 
 
 
Mature red-
fleshed plum 
extract 
(P. Domestica) 
 
Plum extract 
(P.Salicina) 
 
 
 
Prune extract 
(P. Domestica) 
 
 
 
Plum extract 
(P. Domestica) 
 
Dried Plum 
polyphenol 
extract 
(P. Domestica) 
 
 
 
 
 
Human hepatocellular carcinoma HepG2 
cells, Kato III gastric cancer cells, HeLa 
human cervical carcinoma cells, U937 
leukaemia cells, and MCF 7 hormone-
dependent breast cancer cells. 
 
MCF-7; the estrogen-positive human breast 
cancer cell line, MDA-MB-453; the estrogen 
negative human breast cancer cell line, and 
MCF-10A; the breast epithelial cells. 
 
Chicken spleen, RP9 tumour cells and HD11 
macrophages. 
 
 
 
Caco-2 human colon carcinoma cell line, 
KATO III human stomach carcinoma cell line 
and CCD-18Co normal human colon 
fibroblast cell line 
 
SW1116, HT29, Caco-2 human colon cancer 
cells and NCM460 human colon cells. 
 
Stimulation of macrophage RAW 264.7 cells 
with either 1µg mL-1 (for measurement of NO 
production) or 1ng mL-1 (for measurement of 
COX-2 expression) of lipopolysaccharide 
(LPS) to induce inflammation and treated 
with different doses of dried plum 
polyphenols. 
 
 
NA 
 
 
 
 
 
NA 
 
 
 
 
NA 
 
 
 
 
NA 
 
 
 
 
NA 
 
 
NA 
 
 
 
 
 
 
 
 
Cell growth inhibition by IPE i.e. induction 
of cancerous cell apoptosis. 
 
 
 
 
Inhibition of breast cancer cell 
proliferation and significantly reduced 
toxicity on the normal cells. 
 
 
Stimulation of spleen lymphocyte 
proliferation and NO production by 
cultured macrophages and inhibition of 
tumour cell growth. 
 
Induction of cell apoptosis of cancer cells 
but not normal cells. 
 
 
 
Growth inhibition and induction of 
differentiation on colon cancer cells. 
 
Reduction in Nitric oxide and 
malondialdehyde production with highest 
dose treatment (1000 µg mL-1). Reduction 
in LPS-induced expression of COX-2 by 
the 100 and 1000 µg mL-1 dose. 
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Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed 
 
 
Kim et al., 2003 
[141] 
 
 
 
Nishida et al., 2014 
[142] 
 
 
 
 
 
Nishida et al., 2015 
[143] 
 
 
 
Popov et al., 2014 
[144] 
 
 
 
 
Vizzotto et al., 2014 
[145] 
 
 
 
 
Yu et al., 2007 
[131] 
 
 
 
 
USA 
 
 
 
 
Japan 
 
 
 
 
 
 
Japan 
 
 
 
 
Russia 
 
 
 
 
 
USA 
 
 
 
 
 
Korea 
 
 
 
 
 
 
Plum 
polyphenol 
extract 
(P. Domestica) 
 
Plum pectin 
extract 
(P. Domestica) 
 
 
 
 
Plum pectin 
extract 
(P. Domestica) 
 
 
Plum pectic 
polysaccharide 
extract 
(P. Domestica) 
 
 
Plum 
polyphenol 
extract 
(P. Domestica) 
 
 
Immature, mid-
mature and 
mature plum 
extract 
(P.Salicina) 
 
 
Treatment of two cancer cell lines (HepG2 
human liver cancer cells and DLD1 human 
colon cancer cells) with polyphenol extract of 
plum. 
 
Incubation of heparan sulfate in differentiated 
Caco-2 cells with pectin extracted from 
plums. 
 
 
 
 
Incubation of differentiated Caco-2 cells 
(cultured in 6-well plates at a cell density of 
1.0x105 cells/well), with pectin, extracted 
from plums. 
 
0.05mL of plum pectic polysaccharide added 
to peritoneal cell suspension and incubated in 
a 96-well flat-bottom tissue culture plate in 
the absence or presence of phorbol-12-
myristate-13-acetate at 37oC for 15 mins. 
 
Oestrogen independent MDA-MB-435, 
estrogen dependent MCF-7 breast cancer cell 
lines and one non-cancerous breast line MCF-
10A exposed to varying concentrations of 
plum extracts for 24 hours. 
 
6 human cell cancer lines (Hep G2 human 
hepatocellular carcinoma cells and Kato 111 
human gastric carcinoma cells, Hela human 
cervical carcinoma cells, U937 human 
leukemia cells, MCF 7 hormone-dependent 
human breast cancer cells, and MDA-MB-231 
 
NA 
 
 
 
 
NA 
 
 
 
 
 
 
NA 
 
 
 
 
NA 
 
 
 
 
 
NA 
 
 
 
 
 
NA 
 
 
 
 
 
 
Antiproliferative activities on both cancer 
cell lines in a dose dependent manner. 
 
 
 
There was an obvious change in the 
sulphated structures of HS following pectin 
administration. Also, pectin upregulated 
human HS 6-O-endosulfatase-2 (HSulf-2) 
expression and inhibited HSulf-1 
expression. 
 
Pectin-treated differentiated Caco-2 cells 
promoted growth of IEC-6 cells and also 
an upregulation of relative mRNA and 
protein expression levels of Wnt3a protein. 
 
Reduction in the adhesion of peritoneal 
leukocytes. Inhibition of the production of 
superoxide anion radicals by reducing 
xanthine oxidase activity. 
 
 
Dose-dependent cytotoxic effect against 
MDA-MB-435, weak activity against 
MCF-7 and small or no activity against 
MCF-10A observed. 
 
 
Cytotoxic effects observed, and apoptosis 
observed in MDA-MB-231 cells mediated 
by the immature plum extract. 
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Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed 
 
 
 
 
 
Yu et al., 2009b 
[146] 
 
 
 
 
 
 
Animal Studies 
Kim et al., 2008 
[133] 
 
 
 
 
Cantu-Jungles et al., 
2014 [135] 
 
 
 
 
Noratto et al., 2015 
[147] 
 
 
Mishra et al., 2012 
[134] 
 
 
 
Yang and Gallaher, 
 
 
 
 
Korea  
 
 
 
 
 
 
 
 
Korea 
 
 
 
 
 
Brazil 
 
 
 
 
 
USA 
 
 
 
India 
 
 
 
 
USA 
 
 
 
 
 
Immature plum 
extract 
(P.Salicina) 
 
 
 
 
 
 
Immature plum 
extract (IPE) 
(P.Salicina) 
 
 
 
 Polysaccharides 
from prunes 
 (P. Domestica) 
 
 
 
Plum juice 
(P.Salicina) 
 
 
Plum extract 
(P. Domestica) 
 
 
 
Dried plum 
(P. Domestica) 
hormone-independent human breast cancer 
cells) incubated with varying concentration of 
plum extract. 
 
Incubation of PMA-induced HepG2 human 
hepatocellular carcinoma cells with Immature 
plum extract. 
 
 
 
 
 
 
Intraperitoneal injection of IPE (2.5 or 5 g/kg 
bw/day) dissolved in phosphate buffered 
saline for 5 days in male mice with 
benzo(α)pyrene induced liver toxicity. 
 
 
Inducement of acute gastric ulcer in rats using 
intragastric administration of ethanol P.A. 
after 4 different oral treatments including 
polysaccharides from prunes fraction (3 and 
10 mg/kg). 
 
Administration of plum juice in drinking 
water to obese Zucker rats ad libitum for 11 
weeks. 
 
Inducement of peptic ulcer by pyloric ligation 
in Wistar albino rats after administration of 
plum extracts (100, 150 or 200mgkg-1) for 7 
days. 
 
Dietary supplementation of dried plum (4.75 
or 9.5%) in male Wistar rats for 10 days 
 
 
 
 
NA 
 
 
 
 
 
 
 
 
NA 
 
 
 
 
 
NA 
 
 
 
 
 
NA 
 
 
 
NA 
 
 
 
 
NA 
 
 
 
 
 
Antimigrative property in (phorbol 12-
myristate 13-acetate) PMA-induced 
HepG2 cells observed. A strong inhibitory 
effect on the PMA-induced MMP-9 
secretion through suppression of the 
transcriptional activity of the MMP-9 gene 
independently of the TIMP gene in HepG2 
cells was also observed.  
 
Chemopreventive efficacy by inhibiting the 
induction of CYP1A1 expression and 
reducing the activity of glutathione 
peroxidase, superoxide dismutase and 
catalase. 
 
Reduction and inhibition of gastric lesion 
area by prune polysaccharides fractions. 
 
 
 
 
Antiadipogenic and anti-inflammatory 
effects. Reduction in blood glucose, 
triglycerides and HDL cholesterol levels. 
 
Antioxidant and anti-ulcerogenic activity. 
 
 
 
 
Inhibition of risk factors associated with 
colon carcinogenesis (reduction in faecal 
 
 
39 
 
Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed 
2005 [136] 
 
 followed by administration of 2 doses (1wk 
apart) of azoxymethane and dietary 
supplementation for 9 more weeks. 
 
 
 
 
total and secondary bile acids 
concentration, reduction in colonic β-
glucuronidase and 7α-dehydroxylase 
activities and increased antioxidant 
activity). 
 
Gallaher and Gallaher, 
2009 [148] 
 
Clinical trial 
Kasim-Karakas et al., 
2002 [149] 
 
USA 
 
 
 
USA 
 
 
Dried plum 
(P. Domestica) 
 
 
Dried plum 
(P. Domestica) 
 
Dietary supplementation of dried plum (4.75 
or 9.5%) and cholesterol in apolipoprotein E-
deficient mice for 5months. 
 
Hypothesis: Prune intake may alter the 
metabolism of estrogens because prunes are a 
rich source of both soluble and insoluble fibre 
and cinnamates and decrease intestinal transit 
time. 
n=19 healthy premenopausal women  
Study design/Methods: Crossover study. 
After consuming habitual diets for 3 
menstrual cycles (control run-in period), 
participants replaced dietary simple sugars 
with prunes for another 3 menstrual cycles 
(intervention period).   
Sample size power: not stated 
Dose: 100g dried plum per day 
Duration: 6 months. 
 
 
 
 
 
 
III-2 
Exploratory  
 
Development of atherosclerosis Impeded. 
 
 
 
Decrease in the independent excretion of 
2OHE1 and 16αOHE1 observed but not 
statistically significant change in the 
2OHE1 - 16αOHE1 ratio following prune 
supplementation. 
 
*Only clinical trials were ranked for level of evidence 
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2.1.3.3 Cognitive improvement 
 
Cognitive improvement associated with consumption of plum has not been extensively studied in humans. 
Most of the available evidence is from animal studies. This effect on cognition has mainly been attributed 
to the antioxidant property of plums as a result its high polyphenolic content. In a study in which four 
groups of mice were fed a high cholesterol diet, with either 2% or 5% plum powder supplementation, a 
significant difference was observed in the time taken to complete the Morris water maze task between the 
group fed just the high cholesterol diet and the control group, as well as both the 5% and 2% plum powder 
supplementation groups [150]. A similar study reported slightly contradictory results when comparing the 
effects of 100% plum juice and 2% dried plum powder supplementation to modify age-related deficits in 
cognitive function in aged rats. It was observed that there was an improvement in cognition with the plum 
juice, but not with the dried plum powder [105]. 
 
Using plum extract to supplement the diets of three groups of mice with different doses (75, 100, 
150mg/kg), there was a statistically significant difference in the number of trials to acquisition in the 
passive avoidance test (evaluates learning and memory) between the control group and the plum extract 
treated groups. The retention test also showed that the treated groups had increased STLr (step through 
latency in the retention) in comparison to the control group [151]. These results are in line with similar 
animal studies [152, 153] that demonstrate a beneficial health effect of plum on cognition. 
 
Examining the effect of chlorogenic acid from plums on anxiety-related behaviours in mice using the 
light/dark test, the elevated plus maze and the free exploratory test, results showed a decrease in anxiety 
related behaviours (anxiolytic-like effect) and protection of granulocytes (white blood cells) from oxidative 
stress. Plum consumption protected against oxidative stress induced by radiation with special attention to 
spatial learning [154]. A different study observed that plum possesses prophylactic ability against 
radiation-induced metabolic disorders, and its consumption also improved spatial learning. Exposed mice 
that had received plum performed better by taking less time to reach the coloured platform in the circular 
water tank apparatus (proxy for spatial learning and memory) [152].  Similarly, the effect of plum 
consumption for 2 months on cognitive performance and expression of cerebral neurodegeneration-related 
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protein in streptozotocin-induced diabetic rats has also been studied. Cognitive performance, assessed 
using the Morris water maze, showed that the plum supplemented diet had a significant beneficial effect on 
spatial memory and learning.  There was also a significant reduction in expression of cerebral beta-amyloid 
which is evident in Alzheimer’s disease. Significant decreases in hyperglycaemia, insulin resistance and 
oxidative stress in the sample of rats were also observed [153].
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 Table 2-4: Evidence on the antioxidant property and effect on cognition of plums and its associated products 
 
Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed 
 
In vitro studies 
Bouayed et al., 2009 
[155] 
 
 
 
 
Donovan et al., 1998 
[156] 
 
 
Animal Studies 
Shukitt-Hale et al., 
2009 [105] 
 
 
 
 
(Shahidi et al., 2013 
[151] 
 
 
Kao-Ting et al., 2013 
[153] 
 
 
 
Sharma and Sisodia, 
2013 [152] 
 
 
 
 
 
France 
 
 
 
 
 
USA 
 
 
 
 
USA 
 
 
 
 
 
Iran 
 
 
 
Taiwan 
 
 
 
 
India 
 
 
 
 
 
 
Phenolics from 
plums  
(prunus 
domestica) 
 
 
Prune/ prune 
juice extract 
(prunus 
domestica) 
 
 Plum juice/dried 
plum powder 
(P. Domestica) 
 
 
 
Plum extract 
(P. Domestica) 
 
 
Dried plum 
powder 
(P.Salicina) 
 
 
Plum extract 
(P. Domestica) 
 
 
 
 
 
Polyphenolics extracted from 7 varieties of 
plum and quantified. Their antiradical 
activities and protection against oxidative 
stress evaluated in peripheral blood 
granulocytes. 
 
Human LDL from plasma prepared from 
blood collected from healthy volunteers. 
 
 
 
Two groups of aged rats with either 
consumption of a mixture of water and 
plum juice (100%) (Group 1) or dietary 
supplementation with dried plum powder 
(2%) (group 2) for 8 weeks 
 
Plum extracts (75, 100, 150 mg/kg) 
administration by oral gavage to male mice 
once a day for 7 days 
 
Dietary supplementation of dried plum 
powder (2%) in 
nicotinamide/streptozotocin-induced 
diabetic rats for 2 months 
 
Administration of optimum dose of plum 
extract in distilled water to mice for 15 
days pre/post whole-body exposure to 10 
Gy gamma-radiations 
 
 
 
NA 
 
 
 
 
 
NA 
 
 
 
 
NA 
 
 
 
 
 
NA 
 
 
 
NA 
 
 
 
 
NA 
 
 
 
 
 
 
Antioxidant activity and protection of 
blood granulocytes from H2O2-induced 
oxidative stress by preventing 
granulocytes from intracellular ROS 
accumulation. 
 
Inhibition of LDL oxidation. 
 
 
 
 
Improved cognitive function assessed by 
Morris Water Maze. 
 
 
 
 
Improvement in learning and memory in 
mice assessed by the passive avoidance 
test. 
 
Improvement in cognitive performance, 
antioxidant activity and improvement in 
insulin sensitivity. 
 
 
Antioxidant capabilities and improved 
spatial learning. 
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Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed 
Bouayed et al., 2007 
[154] 
 
Clinical trials 
 
Prior et al., 2007 
[137] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ko et al., 2005 
[129] 
 
 
 
 
 
 
 
 
 
France 
 
 
 
 
USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Korea 
 
 
 
Chlorogenic acid 
from prunus 
domestica 
 
 
Dried plum/dried 
plum juice 
(P. Domestica) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plum juice 
(P.Salicina) 
Administration of chlorogenic acid 
(20mg/kg) to mice and antioxidant effect 
on peripheral blood granulocytes. 
 
 
Hypothesis: Changes in AOC following 
consumption of plum juice may be used to 
assess its potential to alter in vivo 
antioxidant status and provide estimates of 
dietary antioxidants necessary to prevent 
postprandial oxidative stress. 
n=6 healthy volunteers.  
Study design/Methods: Randomized 
cross-over study. Fasting blood sample 
collected, and participants fed test juices 
and blood samples collected at 1, 2, and 4 
h post juice consumption.  
Sample size power: not stated 
Dose: 315 mL of dried plum juice (DPJ); 
or dried plums (DP) (131 g blended in 315 
mL water 
Duration: 2 weeks (with 2 weeks washout 
period) 
 
Hypothesis: Consumption of fruit juices 
could scavenge ROS generated in human 
plasma. 
n=10 healthy men.  
Study design/Methods: Cross-over study. 
Consumption of single dose of 150mL of 
plum juice. Blood samples collected at 0, 
30, 60, 90, and 120 minutes after 
consumption  
Sample size power: not stated 
Dose: A single dose of 150mL 
Duration: 1 day (with 1-day washout 
NA 
 
 
 
 
II 
Exploratory 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IV 
Exploratory 
 
 
 
Decrease in anxiety related behaviours 
(anxiolytic-like effect) and protection of 
granulocytes from oxidative stress by 
chlorogenic acid in vitro. 
 
No effect on plasma hydrophilic (H-) or 
lipophilic (L-) antioxidant capacity 
measured as Oxygen Radical Absorbance 
Capacity (ORACFL). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Improved antioxidant activity in human 
plasma measured by dichlorofluorescein 
(DCF) fluorescence. 
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Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed 
period) 
 
González-Flores et al., 
2011 [138] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Netzel et al., 2012) 
[107] 
 
Spain 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Australia 
 
Plum 
(P.Salicina) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plum juice 
(P.Salicina) 
 
Hypothesis: There is a possible 
antioxidant effect associated with diets 
enriched with Japanese plums (Prunus 
salicina Lindl. cv. Crimson Globe) in 
young, middle-aged and elderly 
individuals. 
n=18(6 per young, middle aged and older 
group).   
Study design/Methods: Consumption of 
plums (390 g/d) divided into two 
portions: lunch dessert (195g) and dinner 
dessert (195g) for 5 days. First-void 
morning urines were collected before 
treatment (basal values), the immediate 
day after the last ingestion of plums 
(assay) and 1 day afterwards (post-assay). 
Sample size power: not stated 
Dose: 2 portions 390g (195g each) daily. 
Duration: 5days. 
 
Hypothesis: There is a possible 
antioxidant effect associated with QGPJ 
ingestion on the urinary antioxidant 
capacity and the concentration of 
malondialdehyde, a biomarker for 
oxidative stress. 
n=2 healthy male subjects 
Study design/Methods: Crossover study. 
Consumption of 400 mL of QGPJ or 400 
mL of water  
Sample size power: not stated 
Dose: single dose of 400mL. 
Duration: 1 week (1week washout 
period). 
IV 
Exploratory 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IV 
Exploratory 
 
Statistically significant increase in 
antioxidant capacity and urinary 6-
sulfatoxymelatonin (aMT6-s). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Increase in urinary antioxidant capacity 
and decrease in malondialdehyde 
excretion (biomarker for oxidative 
stress). 
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2.1.3.4 Cardiovascular disease risk factors 
 
Insulin resistance, a major risk factor for metabolic syndrome and selected cancers presents a  major public 
health concern [157]. Studying the beneficial health effects of plums on CVD risk factors, Noratto et al. 
[147] compared the effect of plum juice with peach juice and a placebo group which received the same 
amount of sugar in either peach or plum juice in obese Zucker rats. Their results showed that the plum juice 
group had the lowest weight gain and also that plum polyphenols exerted the highest anti-adipogenic and 
anti-inflammatory effects in fat tissues. This provides evidence of the reduction of mRNA (messenger 
Ribonucleic acid) levels of PPAR (peroxisome proliferator activated receptor) associated with plum intake. 
 
Negishi et al. (2007) [158] studied the effect of prune extract on blood pressure elevation in stroke-prone 
spontaneously hypertensive rats for 5 weeks. They observed that prune extract supplementation in diet 
suppressed the elevation of systolic blood pressure but not diastolic blood pressure. A study by Gallaher 
and Gallaher (2009) [148] on  apoE-deficient mice, known to be susceptible to  rapid development of 
atherosclerotic lesions when fed cholesterol, investigated the ability of dried plum supplementation to 
reduce atherosclerosis. The percentage arterial tree atherosclerotic lesion area was significantly lower in 
groups fed the dried plum supplemented diet (4.75%), either with or without cholesterol, compared to the 
group fed cholesterol without dried plum supplementation. 
 
In human trials, results have been inconclusive. Chai et al. (2012) [159] studied the effect of daily dried 
plum consumption in comparison to dried apple on cardiovascular disease risk factors in postmenopausal 
women over a 1-year period. Results showed that serum total cholesterol levels were significantly lower in 
the dried apple group in comparison to the dried plum group only at 6 months. There was also a 
cholesterol-lowering effect for serum total and low-density lipoprotein cholesterol at 12 months, but this 
was not significant. Neither dried apple nor dried plum had a significant effect on the serum levels of 
atherogenic cholesterol. Contrary to this observation, Tinker et al. (1991) [92] observed that in adult men 
with mild hypercholesterolemia, supplementation with prunes significantly lowered plasma low-density 
lipoprotein cholesterol compared  to a grape juice control group. A significantly lower faecal bile acid 
concentration of lithocholic acid was also reported. 
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Regarding  the effect of prunes on high blood pressure, Ahmed et al. (2010) [160] conducted  a study with 
three groups of pre-hypertensive patients who were randomized to  receive on a daily basis, either a single 
dose of prunes (11.5g), a double dose (23g) or a glass of water (control) for 8 weeks. Participants who 
received either the single dose or a glass of water on empty stomach in the morning showed significant 
reduction in both systolic and diastolic BP, while the double dose was associated with only a reduction in 
systolic blood pressure. The control (water) group also had significant increase in serum HDL that was not 
seen by prune treated groups. The authors attributed this placebo effect to the common factor between 
intervention and control- water. 
 
Santhakumar et al.,(2015) [85] observed an inhibition of  platelet aggregation induced by adenosine 
diphosphate, collagen and arachidonic acid from plum juice supplementation with Queen Garnet plum that 
has higher anthocyanin concentrations than the usual variant. 
 
2.1.3.5 Laxative effect  
 
With a focus on the laxative effect of prunes, Piirainen et al. [161] studied the effect of prunes on 
individuals with mild gastrointestinal symptoms. This study observed that consumption of prune juice 
reduced the occurrence of difficulty in defaecation. Similarly, consumption of a daily portion of plum juice 
before a meal in adults with chronic constipation softened the stool, provided immediate relief and 
participants showed more preference to prune juice than apple juice [162]. Similar results were also 
observed with dried plum in patients with mild to moderate constipation by Attaluri et al. [163] in which 
the effect was attributed to a synergistic effect provided by sorbitol, dietary fibre and polyphenols.  
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Table 2-5: Evidence on the effect of plums and its associated products on the different components of metabolic syndrome 
 
Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed/Conclusion 
Animal studies 
Negishi et al., 2007 
[158] 
 
 
Kuo et al., 2015 
[150] 
 
 
 
Lucas et al., 2000 
[164] 
 
 
 
 
Clinical trials 
(Tinker et al., 1991 
[92] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Japan 
 
 
 
Taiwan 
 
 
 
 
USA 
 
 
 
 
 
 
USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prune extract 
(P. Domestica) 
 
 
Plum powder 
(P.Salicina) 
 
 
 
Dried Plums 
(P. Domestica) 
 
 
 
 
 
Dried Plums 
(P. Domestica) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dietary supplementation of prune extract 
(25%) in stroke-prone spontaneously 
hypertensive (SHRSP) rats for 5 weeks 
 
Dietary supplementation of plum powder 
(2% or 5%) in high cholesterol diet in mice 
for 5 months 
 
 
Dietary supplementation (5% or 25% dried 
plum) with dried plum in 48 ovariectomized 
(ovx) 90-day old female Sprague-Dawley rats 
for 45 days. 
 
 
 
Hypothesis: a) Prunes as a source of fibre 
can lower plasma cholesterol in men with 
mild to moderate hypercholesterolemia (5.2-
7.5 mmol cholesterol/L). b)  Faecal bile acid 
excretion is increased in response to the 
ingestion of prunes as a source of fibre which 
may help explain the cholesterol lowering 
effect of fibre.  
n=41 free living men with mild 
hypercholesterolemia.  
Study design/Methods: Crossover study. 8 
wk period split into two experimental diet 
periods; each lasting 4 wk. Subjects 
randomly assigned a diet sequence, starting 
with either consumption of a grape juice-
control supplement (GJ control) or a prune 
 
NA 
 
 
 
NA 
 
 
 
 
NA 
 
 
 
 
 
 
II 
Confirmatory 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Suppression of High (systolic) blood 
pressure. 
 
 
Amelioration of some symptoms of 
neurodegenerative conditions like 
increased cholesterol and β-amyloid (Aβ) 
concentration in the brain by both doses. 
 
With elevated serum total cholesterol 
brought about by ovariectomy, 25% prune 
diet prevented this increase without 
affecting HDL cholesterol concentration 
and also reduction in liver total lipids was 
observed. 
 
Plasma LDL- cholesterol was statistically 
significantly reduced after the prune 
period than the control, faecal bile acid 
conc. of lithocholic acid was also 
statistically significantly lower with prune 
consumption and both faecal wet and dry 
weights were statistically significantly 
higher with prune consumption. 
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Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed/Conclusion 
 
 
 
 
 
Chai et al., 2012 
[159] 
 
 
 
 
 
 
 
 
 
 
 
 
 
Afaghi et al., 2009 
[165] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Iran 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dried Plums 
(P. Domestica) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prunes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
supplement. 
Sample size power: not stated 
Dose: 12 prunes (~100 g/d) 
Duration: 8 weeks. 
 
Hypothesis: Regular intake of apple 
favourably improves lipid profiles, reduces 
atherogenic risk ratios, lowers C-reactive 
protein (CRP) levels, and decreases levels of 
oxidative stress marker in postmenopausal 
women 
n=160 postmenopausal women  
Study design/Methods: Case-control study.  
Subjects randomly assigned to treatment 
groups of dried apples (75g) or dried plum 
(100g/d)  
Sample size power: 95% 
Dose: 100g/day 
Duration: 1 year. 
 
Hypothesis: 8 fruits (Golab apples, Green 
apples, fresh apricots, prunes, cherries, 
blueberries, Golden no-seed grapes, and Red 
sultanas) are low GI and recommendable for 
diabetics and weight loss. 
n=8 
Study design/Methods: Crossover study.  8 
subjects (healthy, young men aged 20-28, 
normal weight with body mass index: 20-25 
Kg/m2) randomly assigned to one of 8 fruits 
and blood glucose measured at 0, 15, 30, 
45,60, 90 and 120 mins after consumption. 
Sample size power: 95% 
Dose: 143g 
Duration: Not stated - Different occasions 
after overnight fasting. 
 
 
 
 
 
II 
Exploratory 
 
 
 
 
 
 
 
 
 
 
 
 
 
II 
Exploratory 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No statistically significant difference 
between treatment groups in altering 
serum levels of atherogenic cholesterols 
observed. For the dried apple group, total 
cholesterol was statistically significantly 
reduced at 6mth. 
 
 
 
 
 
 
 
 
 
Serving size of prunes was low glycemic 
load (GL) fruit. Prunes among other tested 
fruits were low GI and can be 
recommended for diabetics and weight 
loss management. 
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Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed/Conclusion 
 
Ahmed et al., 2010 
[160] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Santhakumar et al., 
2015 [85] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pakistan 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Australia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prunes 
(P. Domestica) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plum juice 
(P.Salicina) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypothesis: Use of prunes is useful in 
cardiovascular disorders to bring about 
changes in blood pressure or prevention of 
atherosclerosis. 
n=259 pre-hypertensive patients (BP 
=120/80–139/89 mmHg) 
Study design/Methods: RCT. Patients 
randomly assigned to 3 groups of A-single 
dose, B-double dose or C- control group. 
Blood pressure was recorded fortnightly, and 
blood samples were taken at 0 and 8 weeks. 
Sample size power: Not stated. 
Dose: group A-11.5gm. Group B-23gm. 
Control- glass of water. 
Duration: 8 weeks. 
 
Hypothesis: Anthocyanin-rich Queen Garnet 
Plum Juice may ameliorate platelet activation 
related thrombogenesis and maintain 
haemostatic function by: (1) reducing platelet 
aggregation and activation through 
blocking/inhibiting various platelet activation 
pathways; (2) prolonging clotting time and 
reducing fibrinogen concentration; and (3) 
exhibiting favourable effects on lipid profile 
and inflammation. 
n= 21 
Study design/Methods: Randomised, double 
blind, placebo Crossover Trial. Healthy 
volunteers randomly assigned to 3 
supplement groups of A-Queen Garnet plum 
juice, B-prune juice or C- colour matched 
placebo. Blood samples were collected at 
least 8h pre-prandial and mid-stream fasting 
urine samples collected. 
 
II 
Confirmatory 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II 
Exploratory  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reduction of blood pressure (6mmHg 
drop) by single dose of prunes daily group 
and the controls with the double dose of 
prunes showing a reduction in just systolic 
BP. There was an increase in serum HDL 
of the control group whereas test groups 
had significantly reduced serum 
cholesterol and LDL. The data predicts 
cardiovascular protective effects of 
prunes. 
 
 
 
 
 
 
QGPJ supplementation inhibited platelet 
aggregation induced by adenosine 
diphosphate (ADP), collagen and 
arachidonic acid. There was reduction in 
platelet activation-dependent surface-
marker P-selectin expression of activated 
de-granulated platelets. Increase in 
activated partial thromboplastin clotting 
time and reduction in plasma-fibrinogen 
and malondialdehyde levels, a plasma 
biomarker of oxidative stress. Prune juice 
supplementation did not affect blood cell 
counts, lipid profile, or inflammation 
markers 
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Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed/Conclusion 
 
 
 
 
 
Santhakumar et al., 2015 
[166] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Australia 
 
 
 
 
 
Plum juice 
(P.Salicina) 
 
 
Sample size power: Not stated. 
Dose: 200mL/day of each juice. 
Duration: 28 days with 2 weeks washout 
period. 
 
Hypothesis: Anthocyanin-rich QGPJ may 
impart anti-thrombotic effects via (a) 
inhibition of platelet aggregation by 
simultaneously targeting different platelet 
activation pathways (adenosine diphosphate: 
ADP-P2Y12/P2Y1; collagen: GPVI/α2β1 
and arachidonic acid: cyclooxygenase-1–
COX-1), (b) reducing platelet hyper-
activation and de-granulation by blocking 
surface receptors responsible for activation, 
and (c) favourably altering coagulation 
parameters and lipid profile.  
n= 13 
Study design/Methods: Randomised, double 
blind, placebo Crossover Trial. Healthy 
volunteers randomly assigned to 2 
supplement groups of A-Queen Garnet plum 
juice or B-a flavoured and coloured 
formulated cordial placebo. Oxidative stress 
was induced by constant load exercise bout 
for 1h at 70% of their VO2PEAK Blood 
samples were collected at fasting state and at 
least 8-12h pre-prandial on day 1 and day 29. 
Sample size power: Not stated. Dose: 
200mL/day of each juice. 
Duration: 28 days with 2 weeks washout 
period. 
 
 
 
 
 
II 
Exploratory 
 
 
 
 
 
QGPJ supplementation inhibited 
adenosine diphosphate-induced platelet 
aggregation both without and under 
exercise induced oxidative stress, as well 
as inhibition of arachidonic acid-induced 
aggregation under oxidative stress. Also, 
there was reduced platelet activation 
dependant P-selectin expression both 
without and under oxidative stress. 
Favourable effects on coagulation 
parameters both with and without 
oxidative stress were also observed for 
QGPJ. 
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Table 2-6: Evidence on the satiety and laxative effect of plums and its associated products 
Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed 
Clinical trials 
Piirainen et al., 2007 
[161] 
 
 
 
 
 
 
 
 
 
 
 
(Cheskin et al., 2009 
[162] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Finland 
 
 
 
 
 
 
 
 
 
 
 
 
USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prune juice 
(prepared from 
plum juice 
concentrate, 
prune puree, 
water and 7% 
fructose) 
(P. Domestica) 
 
 
 
 
 
Plum juice 
(P. Domestica) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypothesis: prune juice alone may have a 
laxative effect on the bowel function of those 
adults with certain gastrointestinal symptoms 
but are otherwise healthy. 
n=54 volunteers with mild GIT symptoms. 
Study design/methods: 1-week baseline 
period, 2-week prune juice (consumption) 
period followed by 1week follow-up period 
with daily record of bowel habit 
Sample size power: not stated. 
Dose: 125 mL twice a day. 
Duration: 4 weeks. 
 
Hypothesis: Plum juice supplementation diet 
would induce significant improvements in 
bowel frequency, and consistency, and 
possibly decrease appetite compared to 
baseline as well as placebo and psyllium 
treatments. 
n=36 adults with chronic constipation 
symptoms. 
Study design/Methods: Randomized 
controlled crossover trial. Consumption of a 
daily portion of plum juice in comparison to 
psyllium and apple juice in adults with 
chronic constipation symptoms. 
Sample size power: Not stated. 
Dose: 8 ounces (237mL) per day. 
Duration: 14days. 
 
 
 
 
 
IV 
Confirmatory 
 
 
 
 
 
 
 
 
 
 
 
II 
Confirmatory 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Laxative effect with increased flatulence. 
 
 
 
 
 
 
 
 
 
 
 
 
Constipation relief and stool softening 
evident with consumption of plum juice. 
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Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed 
Attaluri et al., 2011) 
[163] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Farajian et. al., 2010 
[167] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Greece 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dried plum 
(P. Domestica) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prunes 
(P. Domestica) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypothesis: Dried plums are as effective as 
psyllium in the treatment of adults with 
chronic constipation. 
n=40 patients with chronic constipation. 
Study design/Methods: Single blind, 
randomized cross-over study. Consumption 
of a daily portion of dried plums or psyllium 
for a treatment period of 3 weeks after which 
participants continued on their usual 
remedies for constipation for another 6 
weeks. For the duration of the study, subjects 
maintained daily symptom and stool diaries. 
Sample size power: 80%. 
Dose: 50 g twice a day with meals. 
Duration: 14 weeks (with 1-week washout 
period between treatments). 
 
Hypothesis: A preload including dried 
prunes consumed as a snack before a meal, 
compared to an isoenergetic bread product 
preload, would reduce; a) meal time energy 
intake, 
b) appetite for dessert offered after lunch and, 
c) energy intake for the next 24 h. 
n=45 normal weight subjects. 
Study design/Methods: Randomized cross-
over study. Fasting participants offered a 
standardized breakfast followed by a preload 
of either dried prunes or bread product after 2 
hours. 3 hours after the preload, a 
standardized lunch and desert was provided. 
Subjects also rated their hunger, thirst, desire 
to eat, motivation to eat and satiety on 100 
mm line visual analogue scales (VAS) just 
before and right after the preload 
consumption, every 45 min up till the 180th 
II 
Confirmatory 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II 
Exploratory 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effective treatment with dried plum on 
mild to moderate constipation observed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reduced consumption of dessert with 
lower energy intake observed. An 
Increased satiety at all time points between 
snack and meal was also observed. 
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Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed 
 
 
 
 
 
 
 
 
 
Furchner-Evanson et al., 
2010 [168] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Howarth et al., 2010 
[169] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dried plum 
(P. Domestica) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dried plum 
(P. Domestica) 
 
 
 
 
 
 
 
 
 
min. On completion of the test day, detailed 
record of all foods and beverages intake for 
the next 24 h was collected.  
Sample size power: not stated. 
Dose: 5 prunes (40g) before meals on each 
testing day. 
Duration: 2 days (with 1-week washout 
period). 
 
Hypothesis: Snack choices similar in fat, 
protein, carbohydrate and sugar contents 
while differing in fibre content have an effect 
on satiety, subsequent food intake and plasma 
glucose, insulin and ghrelin responses. 
n=19 healthy female subjects 
Study design/Methods: Randomized 
crossover study with at least 1-day washout. 
Subjects randomly assigned to receive 4 
different test foods including dried plums. 
Blood samples collected at baseline and 
every 15mins in 1hr then 90 and 120 mins. 
Sample size power: Not stated. 
Dose: served in a 238kcal (1000kj) portion. 
Duration: not stated. 
 
Hypothesis: Snack selection (dried plums vs 
common carbohydrate-rich low-fat cookies) 
influences daily energy consumption, nutrient 
intake and metabolic responses. 
n=26 healthy female subjects 
Study design/Methods: Randomized 
crossover study with 2 weeks washout. 
Subjects randomly assigned to receive either 
dried plums or low-fat cookies for 2 separate 
2-week feeding. A 7-day bowel habit 
questionnaire was completed. 
 
 
 
 
 
 
 
 
 
II 
Exploratory  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II 
Exploratory 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Satiety index AUC greater for dried plum 
trial. Consumption of the dried plum 
elicited lower plasma glucose and insulin 
AUC and tended to promote a greater 
plasma ghrelin AOC. 
 
 
 
 
 
 
 
 
 
 
 
No change observed with energy intake or 
weight. In comparison to cookie, dried 
plum promoted greater intake of fibre, 
potassium, riboflavin, niacin and calcium. 
There was an observed reduction in total 
fat as well as cholesterol intake with dried 
plum snacks. Dried plum did not alter 
plasma triglyceride concentration, but 
softer stool consistency was observed with 
dried plum consumption. 
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Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed 
 
 
 
 
 
Lucas et al., 2004) 
[170] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pasalar et al., 2013 
[171] 
 
 
 
 
 
 
USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Iran 
 
 
 
 
 
Dried plum 
(P. Domestica) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prunes 
(P. Domestica) 
 
     
Sample size power: 80% 
Dose: served in a 100-kcal portion twice a 
day. 
Duration: 4weeks. 
 
Hypothesis: Gradual incorporation of 100g 
of dried plum into the daily diet of healthy 
postmenopausal women would not cause 
significant changes in self-reported bowel 
habits including frequency of defecation, 
faecal bulk, and stool consistency.  
n=58 
Study design/Methods: RCT. 
Postmenopausal women randomly assigned 
to treatment groups of dried plum (100g/d) or 
dried apple (75g) daily for 3 months. A 7-day 
bowel habit questionnaire was completed. 
Sample size power: not stated 
Dose: 100g/day. 
Duration: 3 months. 
 
Hypothesis: Prunes and flixweed (herbal 
Iranian traditional medicine) are effective in 
the prevention of constipation among Iranian 
pilgrims who attended the Hajj ceremony in 
2010 in the kingdom of Saudi Arabia for 3 
weeks.  
Study design/Methods: RCT. 170 Iranian 
Hajj pilgrims randomly assigned to two 
groups of case and control. Case group 
received measured doses of prunes and 
flixweed daily before lunch and dinner and 
control group had their meals with no 
intervention. 
Sample size power: not stated 
Dose: 40-50g/day with 10-15g of flixweed. 
 
 
 
 
 
II 
Exploratory 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II 
Exploratory 
 
 
 
 
 
With both dried plum and apples, no 
statistically significant differences for any 
of the parameters used to assess bowel 
function, showing the absence of any 
negative side effects associated with prune 
consumption. 
 
 
 
 
 
 
 
 
 
 
Using Rome III criteria to define 
constipation (less than three times of 
defecation/week, with straining, difficulty 
in defecation, unproductive urges, feeling 
of anorectal obstruction, hand manoeuvre 
to facilitate stool extraction and feeling of 
incomplete evacuation), a statistically 
significant difference was observed 
between the groups with the case group 
less constipated. 
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2.1.3.6 Antiallergic and antimicrobial property 
 
On the anti-allergy capability of plum, it was observed that supplementing the animal diet with prune 
extract following injection of mite allergen for 3 weeks, there was a significant reduction in the number of 
sneezing events, total and mite allergen-specific immunoglobulin E levels even though there were no 
identifiable anti-allergic components in the prune extract [172]. Studying the antibacterial property of 
plums, it was  observed that when tested on 5 different gram positive bacteria, ethanol extracts of prunes 
exhibited an antibacterial property [173]. A similar effect was also observed by a different study [174] 
 
2.1.3.7 Other Effects  
 
Other reported beneficial health effects of plum include its effect on liver function in healthy individuals. 
In a clinical trial, there was a significant reduction in serum alanine transaminase and serum alkaline 
phosphatase (clinical biomarkers of liver health) with no changes observed in serum aspartate transaminase  
and bilirubin [175]. Studying the effect of plum juice on urinary stone risk factors, results showed no 
significant effect on urinary composition [176]. However, another study using the Australian Queen Garnet 
plum reported an increase in urinary antioxidant capacity [107]. In normal weight individuals, a preload of 
prunes in comparison to a bread product before a meal has been observed to result to lower energy intake at 
later meals, including lunch and the desert (910 kcal ± 233 on prunes day vs 971 kcal ± 249 on bread 
product day; p = 0.010), as well as increased satiety at all time points tested between the snack and meal 
[167]. Similar results have also been observed in other studies [168, 169]. 
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Table 2-7: Evidence on the anti-allergic, anti-microbial and immune-enhancing property of plums and its associated products 
 
Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed 
In vitro Studies 
Cevallos-Casals et al., 
2006 [174] 
 
Yaqeen et al., 2013 
[173] 
 
 
 
 
 
 
Animal studies 
(Karasawa et al., 2012) 
[172] 
 
 
 
(Lee et al., 2008 
[177] 
 
 
 
Noratto et al., 2014 
[178] 
 
 
 
USA 
 
 
Pakistan 
 
 
 
 
 
 
 
 
Japan 
 
 
 
 
USA 
 
 
 
 
USA 
 
Plum extract 
(P.Salicina) 
 
Prune extract 
(P. Domestica) 
 
 
 
 
 
 
 
Prune extract 
(P.Salicina) 
 
 
 
Plum powder 
(P.Salicina) 
 
 
 
Plum Juice 
(P. Domestica) 
 
Plum extract placed in a well with diluted 
bacteria inoculum. 
 
Ethanol extracts of prunes tested against nine 
bacteria; five Gram positive bacteria 
{Staphylococcus aureus, Streptococcuc 
intermedias. Bacillus cereus. Bacillus 
pumilus) and four Gram negative bacteria 
{Eschrichia coli, Proteus mirabilis Shigella 
flexneri. Salmonella typhi and Klebsiela 
pneumoniae). 
 
Dietary supplementation with 25% ovalbumin 
and 1% prune extract over 6 weeks in rats 
injected 20L of distilled water containing 20g 
of mite allergen between the 3rd to 6th week 
 
Dietary supplementation with 0.5% or 1.0% 
plum in one day old chickens and oral 
inoculation with 5000 sporulated oocysts of E. 
acervulina at day 12 post-hatch. 
 
Administration of plum juice in obese Zucker 
rats for 11 weeks. Body weight recorded once 
a week. 
 
NA 
 
 
NA 
 
 
 
 
 
 
 
 
NA 
 
 
 
 
NA 
 
 
 
 
NA 
 
 
Inhibitory effects against Escherichia coli 
0157:H7 and Samonella Enteritidis. 
 
Antibacterial activity observed. Several 
bacteria groups (e.g. Lactobacillus and 
members of Ruminococcacea) were found 
to be more abundant in the plum group. 
There was also a distinct contrast between 
the microbiota of control and treatment 
groups. 
 
 
Reduction in allergic response in 
comparison to control group 
 
 
 
There was a reduction in faecal oocyst 
shedding and chickens fed the plum 
supplemented diets exhibited greater spleen 
cell proliferation 
 
Increase in body weight gain, levels of 
MRNAs for interferon-ϒ and interleukin-
15.  
*Only clinical trials were ranked for level of evidence 
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Table 2-8: Evidence on the effect of plum and its associated products on liver function and kidney stone risk factors 
 
Reference Location Plum product 
investigated 
Sample/Method Level of 
evidence* 
Effects observed 
Clinical trials 
Ahmed., et al., 2010[175] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Keßler et al., 2002 [176] 
 
 
Pakistan 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Germany 
 
Prune juice 
(P. Domestica) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plum juice 
(P. Domestica) 
 
Hypothesis: Prune juice does not alter liver 
function.  
n=107 healthy volunteers  
Study design/Methods: Case-control study. 
Participants randomly assigned to 3 different 
groups of A (single dose of 1 pack of prunes = 
11.43kg i.e. 3 prunes), B (control; a glass of 
water) and C (double dose of grp A) 
consumed daily. Blood samples were taken on 
Week Zero and Week 8 for liver function tests 
(LFTs) i.e. serum alkaline phosphatase (ALP), 
bilirubin, aspartate transaminase (AST) and 
alanine transaminase (ALT). 
Sample size power: not stated 
Dose: 3prunes (~11.43g) or a double dose of 
6 prunes (~22.86g) per day. 
Duration: 8 weeks. 
 
Hypothesis: Plum-, cranberry- and 
blackcurrant juice may have an influence on 
the urinary composition and therefore on 
multiple risk factors of kidney stone 
formation.  
n=12 healthy male subjects.  
Study design/Methods: Participants control-
fed a standardized diet daily with plum juice. 
24h urine sample collected. 
Sample size power: not stated 
Dose: 330mL of plum juice. 
Duration: 5days 
 
II 
Exploratory 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II 
Exploratory 
 
Liver function test showed significant 
reduction of serum alanine transaminase 
and serum alkaline phosphatase but no 
effect on serum aspartate transaminase and 
bilirubin 
 
 
 
 
 
 
 
 
 
 
 
 
 
No significant effect on urinary 
biochemical or physiochemical parameters 
 
*Clinical trials ranked using [111] Levels of Evidence Hierarchy where I is a systematic review (highest rating) and IV is a case series or cross-sectional study (lowest rating) and also classified as exploratory or 
confirmatory  studies.
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2.1.4 Discussion 
 
This systematic literature review identified 73 peer-reviewed journal articles on the health effects of plum 
and its associated products. All identified studies were grouped according to outcome measures but 
differed considerably based on the plum fraction studied, study design, as well as intervention methods. 
Despite an increase in plum-based research that has emerged over the past decade, the level of evidence 
remains low. Of 25 clinical studies in human, nine studies included randomisation to a plum 
supplementation group but only one of these studies adequately described the method of randomisation and 
blinding. Nonetheless, results from some of the study outcomes are consistent. Considering bone health as 
the main study outcome, the polyphenols present in the plum appear to be responsible for the benefits. 
However, it has been suggested that even though dried plum polyphenols have some bone modulating 
properties, the synergistic effect of these polyphenols, together with potassium and vitamin K, is required 
to produce potent effects on bone mass and microarchitecture and to reverse OVX (ovariectomy)-induced 
bone loss in mature animals [179].  Regardless, compared to other dried fruits (apple, apricot, grape and 
mango), only the dried plum exhibited an anabolic effect on trabecular bone in the vertebra and prevented 
bone loss [112]. 
 
Some of the findings from the in vitro studies have been confirmed in animal studies but remain to be 
confirmed in human clinical trials.  Most of the available human trials used a dried version of plums 
(prunes) rather than fresh fruit, thus limiting translation to dietary messages of the positioning of fresh 
plums in a healthy diet.  The drying process significantly decreases (more than 90%) anthocyanin and 
flavanol content of plums [180]. The effect of other processing methods on the antioxidant properties of 
plums has been studied [181]. Blanching decreased the tannins and antiradical efficiency of the fruits but 
increased the total polyphenol content, while osmotic dehydration had no effect on the total polyphenol and 
ferric reducing power. This increase in total polyphenol content was attributed to the thermal disruption of 
the polyphenol–protein complexes [182]. Fresh plums also have higher free radical scavenging capacity  
(superoxide and peroxy radicals) and antioxidant activity  than  dried plums  [183]. However,  prunes are 
known to contain higher levels of phenolic compounds than most dried fruits and also possess higher 
radical scavenging activity, even possibly the highest in dried fruit and vegetable products present in 
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human diet [184]. Further studies are required to compare the health effects of fresh plum, plum juice and 
dried plum in human trials. 
 
Extraction methodology is also an important factor in plum based research as different solvents have 
shown some disparity in extracts. Estimating the antioxidant  capacity of the whole plum fruit, results 
showed  that in extracting the bioactive compound in plum, the ethyl acetate and butanol fraction showed 
the most antioxidant potential in comparison to the hexane and aqueous fraction [185].  
 
Evidence included in this systematic review was gathered from studies that differed in a number of ways 
including population studied, study design, outcome measures, and methods of randomisation. This limits 
comparison between studies. Limitations related to different study designs are particularly evident in the 
animal studies that show inconsistent results. For example, in one of the studies with cognitive outcomes, a 
significant effect was observed using the Morris water maze task in mice fed a high cholesterol diet that 
had been supplemented with 2% dried plum [150]. On the contrary, another study [105] showed that plum 
juice, but not dried plum powder (2% concentration), was effective in alleviating cognitive deficits in aged 
rats. This may possibly be explained by a difference in the dosage of bioactive compounds provided in the 
two studies, or the food matrix of this supplement, or both [186] but remains to be elucidated in dose 
response studies. In addition, even though the nutritional content of study fruits and beverages were 
described, the anthocyanin contents were lacking. Of all the studies included in this systematic review, only 
five [85, 137, 138, 166, 187]  provided anthocyanin content which ranged from 0-112mg/100mL. The 
absence of anthocyanin content, an active component, of interventions also limits results comparison across 
studies. 
 
There have been no reports on the side effects associated with daily consumption of plum and its associated 
products. Studies have shown that consumption of dried plum over a long period has no significant effect 
on the levels of insulin and glucose or bowel function [170, 188]. Plums are known to contain considerable 
levels of oxalates which occur naturally and may increase the risk of kidney stone formation [189]. High 
levels of oxalate in the body inhibit the absorption of calcium, thereby resulting in precipitation of calcium 
which can result in stone formation in the kidney and bladder [190, 191]. However, plum juice 
consumption did not seem to have any significant effect on the risk factors associated with kidney stone 
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development [176]. In as much as these potential side effects have not been reported with usual plum 
consumption, it is important for future studies to identify the upper level of safe intake.  
 
With increased interest in plum research which has led to the development of a plum hybrid (QGP), it is 
important that similar studies be performed with this hybrid, as well as with other hybrids of plum as they 
become available, to confirm these observed effects and to allow generalisation of plum research findings. 
Other parts of the plum fruit that are usually discarded or used in animal feed may also provide both 
nutritive and non-nutritive food components that confer health benefits. For e.g. the plum pomace, a by-
product (pulpy residue) obtained during plum juice production has been reported  to contain 38-49%  
dietary fibre and have antioxidant  and anti-inflammatory properties that have been demonstrated  in vitro  
[192]. 
 
2.1.5 Conclusion 
 
In conclusion, this systematic review has identified an emerging body of evidence that demonstrates the 
beneficial health effects of plum consumption. The largest amount of evidence to date relates to prevention 
and management of osteoporosis, which shows promising evidence as an adjunctive therapy. However, 
many of the study designs were of low quality therefore it is important that well designed human trials are 
conducted to confirm these observed effects. Consideration of the nutritional composition of plums and 
prunes and the effects of processing on their bioactivity is also important for future research. Elucidation of 
the mechanism of action of plum polyphenols, identification of potential adverse effects, and the effects of 
dosage on outcomes is necessary to inform dietary guidelines for chronic disease prevention and 
management.
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3 Chapter 3 
3.1 ANTHOCYANIN-RICH PLUM JUICE REDUCES AMBULATORY 
BLOOD PRESSURE BUT NOT ACUTE COGNITIVE FUNCTION 
IN YOUNGER AND OLDER ADULTS: A PILOT CROSS-OVER 
DOSE-TIMING STUDY 
 
This chapter describes a pilot acute cross-over study that was conducted to investigate the impact of plum juice 
on cardiovascular-related responses, cognitive function, and urinary anthocyanin excretion profiles. A sample of 
24 (12 healthy older (65y+) and 12 younger (18-45y) adults) were recruited for this study. Participants received, 
randomly, either a 1x300mL or 3x100mL QGP juice (QGPJ) over 3h on two different occasions with a 2-week 
washout period. A battery of cognitive tasks was administered at 0h and 6h on each study day. BP and urinary 
anthocyanin/metabolite excretion profiles were measured over 24h. Area under the curve for BP was calculated 
(0-6h). Regardless of dose, QGPJ did not impact acute cognitive function. There was a significant reduction in 
BP responses in both age groups which was more obvious in the older age group on the single dose for SBP, 
DBP, Mean Arterial Pressure and Heart Rate (p-values=0.035, 0.028, 0.017 and 0.006 respectively). Dose-
timing did not appear to be a significant factor in the potential acute BP-lowering effect. Native QGP 
anthocyanins, as well as methylated/glucuronidated metabolites were detected in urine with no significant 
differences between age groups or dose-timing. Results from this study suggests that dose-timing does not seem 
to be an important factor in a QGPJ intervention. 
 
 
The majority of this chapter is the substantive content of the published article: (Appendix E) 
 
Igwe, E.O., Charlton, K.E., Roodenrys, S., Kent, K., Fanning, K. and Netzel, M.E., 2017. Anthocyanin-rich 
plum juice reduces ambulatory blood pressure but not acute cognitive function in younger and older adults: a 
pilot crossover dose-timing study. Nutrition Research, 47, pp.28-43. 
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3.1.1  Introduction 
 
Research on the beneficial health effects of fruit anthocyanins continue to show promising evidence both in 
vitro and in vivo. However, its effect on cognition in humans has yet to be studied extensively. In Australia, 
dementia which is preceded by a phase of mild cognitive impairment continues to have a substantial financial 
burden on individuals as well as the economy [193]. In addition, high BP continues to pose significant health 
risks. According to the World Health Organization (WHO), the prevalence of high BP in adults aged 18 years 
and over was around 22% in 2014. This accounted for about 9.4 million deaths or  7% of  all deaths [194]. In 
Australia, between 2011 and 2012, almost one-third (31.6%) of all adults were  diagnosed with hypertension, 
which was more prevalent at older ages, with almost 9 in 10 (87.7%) people aged 85 years and older being  
hypertensive [195]. In  global strategies to address neurodegenerative and CVD prevalence, the significant role 
of modifiable dietary risk factors, including an increased intake of fruits and vegetables is acknowledged [6]. 
Small (2-5mmHg) but steady decreases in mean BP have been shown to significantly decrease the incidence of 
cardiovascular events [196]. Given the magnitude and burden of chronic diseases, cost-effective strategies, 
including dietary intervention, are needed for the prevention and management of chronic diseases. Plant-based 
foods are integral to a healthy human diet and a plant-rich diet has been found to be associated with prevention 
of a vast array of diseases [197].  
 
To fully grasp the mechanism of action of dietary anthocyanins in vivo, it is important to first understand their 
absorption and metabolism. Even though anthocyanins have shown favourable health boosting effects in human 
cell culture, experimental animal and human epidemiological studies, clinical trials are needed to confirm these 
findings [27, 198, 199].  
 
Inadequate understanding of the uptake, metabolism distribution and excretion of anthocyanins has limited the 
design of clinical trials that investigate their effect on health outcomes. The body of evidence on the protective 
effects of flavonoid-rich foods against CVD is based mainly on epidemiological studies, thus evidence remains 
inconclusive and acute effects have not been well defined.  Systematic reviews of available experimental studies 
[200, 201] have highlighted an absence of knowledge regarding a ‘threshold dose’ or appropriate ‘dose-timing’ 
required to induce physiological protective effects. This is because the impact of anthocyanin dose has not been 
studied extensively in humans and different experiments have used varied preparations e.g. juice, puree and 
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whole fruit. Consequently, studies administer unfeasibly large doses of anthocyanin-rich foods in order to 
elucidate a physiological response, and the selection of dose-timings is often unsubstantiated [202-204]. While 
splitting a large daily dose of anthocyanin-rich food into three or more servings per day may reflect a more 
feasibly tolerated serve, there is often no justification in studies as to the reason each dose was selected, and no 
consideration generally given to the physiological effects thereof. Even though results from published studies 
have mostly been in agreement, evidence shows that beyond a point, the bioavailability of anthocyanins 
decreases with increasing dose [205]. For cyanidin-based anthocyanins, the maximum absorption has been 
reported to be about 350µmol/L or less, peaking between 1.5-2.5h [206]. This is also believed to differ 
according to the structure of different anthocyanins found in differing concentrations in foods, the attached 
sugar moiety and because of wide inter-individual variation in anthocyanin metabolism. All of these factors 
limit translation of research findings into practical dietary messages [207]. Taking these factors into 
consideration, there is a need to better understand the acute effects of anthocyanins provided from different 
foods and beverages, in order to identify any consistent potential health benefits.   
 
The aim of this study was to determine the acute impact of differing doses of QGPJ on cognition and other 
health parameters in young and older adults over a six-hour period.  This study also determined and compared 
the anthocyanin/metabolite profiles of human urine after oral consumption of high anthocyanin QGPJ in healthy 
young and older adults. 
It is hypothesised that the consumption of high anthocyanin QGPJ will have an acute impact by: 
1. Improving various domains of cognitive functioning and blood pressure; 
2. Demonstrating the bioavailability of QGP anthocyanins as assessed by their urinary excretion over a 
24h period; 
3. Showing differences in the absorption rate and metabolism of anthocyanins between young and older 
adults, assessed in urinary biomarkers (24h). 
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3.1.2 Methods 
 
This study was conducted according to the guidelines laid down in the Declaration of Helsinki and all 
procedures involving human subjects were approved by the University of Wollongong Human Research Ethics 
Committee NSW, Australia (HE14/343). Written informed consent was obtained from all participants.  
 
Study design 
The study was an acute cross-over bioequivalence/non-inferiority study (with at least a two-week washout 
period between clinic visits) to assess the acute impact differing dose-timings of high-anthocyanin plum juice 
consumption on acute cognition and blood pressure over 24h. This study was considered a bioequivalence/non-
inferiority design due to the dosage for the two crossover arms being the same (a single 300mL and 3x100mL 
over 3h) with the aim to determine whether three 100mL of plum juice taken over three hours would have a 
different pattern of effect on BP in comparison to a single 300ml dose. Results from this pilot study will be used 
to subsequently inform the methodology as well as sample size calculation for a future crossover randomised 
clinical trial. This is in line with the assumptions of bioequivalence studies, whereby the future trial will be 
designed as a crossover study [208-210]. (See Chapter 5). 
 
Sample size 
Twenty-four participants were recruited, including 12 younger (18-45y) and 12 older (65+y) adults in order to 
compare responses between younger and older adult individuals. The sample size was determined according to 
recommendations for planning a pilot study that investigates bioavailability and bioequivalence of components 
within food. A sample size of 24 (12 per group), for a pilot study, is recommended based on feasibility, gains in 
precision about the mean and variance, as well as guidelines for evidence required by regulatory bodies such as 
the Food and Drug Administration (FDA) [208-210]. For a pilot crossover study, feasibility can be explained as 
the number of possible period crossover trials (2,3,4 or 6) with balanced Williams square design (defined as a 
balanced allocation to period trials in a small sample size). [208, 211]. One of the major aims of pilot studies is 
to provide an estimate of the variance as this could be used in power sample size calculations for a larger follow 
up study, in this case a larger RCT (Chapter 5). To determine the precision of the variance, the sensitivity of the 
appropriately powered study to the estimate of the (unknown) variance would be ascertained. Thus, the sample 
size of a pilot study is required to be adequate to have appropriate degrees of freedom in a sensitivity analysis in 
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a larger follow-up study. Sim and Lewis (2012) [211] have demonstrated calculations based on this assumption 
and showed that there were negligible gains in variance precision when the degrees of freedom exceeded 20. 
Other authors, including Julious (2005) [208] and Van Belle [212] have demonstrated that for sample sizes 
below n=30, calculations based on confidence interval, assuming a unit variance of s=1, gains in precision for 
each increase of 1 in the sample size was no longer significant once the sample size reached 12 [208, 212]. 
Thus, the current study target sample size of 24 (12 per arm) could be considered adequate for the purpose of a 
crossover pilot study. 
 
A general recommendation for sample size calculation by the ICH is that the number of participants in a clinical 
trial should always be large enough to provide valid answers to the questions posed [209]. For pilot 
bioavailability and food investigating studies, the U.S Food and Drug Administration (FDA) guidance on 
bioequivalence studies states that: “A minimum of 12 evaluable subjects should be included in any 
bioequivalence study” [210]. Following these recommendations, a sample size of 24 was chosen for this pilot 
study. 
 
 
Participants 
All participants were recruited from the University of Wollongong (UOW), Australia and the surrounding 
Wollongong, NSW areas through poster advertising. Potential participants had the opportunity to discuss the 
study over the phone prior to clinic visits and were screened to determine eligibility. Recruited eligible 
participants were randomised to a dose-timing allocation and cognitive assessment order by a computer-
generated block randomisation by an independent statistician. Participants attended two 6-h clinic visits at the 
Illawarra Health and Medical Research Institute (IHMRI) at the University of Wollongong, NSW, Australia 
between June and September 2015. 
 
Exclusion criteria 
Exclusion criteria included self-reported uncontrolled hypertension, any unstable physical or mental health 
condition, inability to provide informed consent, consumption of specific daily health supplements related to 
flavonoids, and inability to communicate in the English language.  
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Data collection 
On the first study day, a questionnaire was administered to determine participants’ socio-demographic 
characteristics. The validated International Physical Activity Questionnaire (IPAQ) [213] was used to  
determine habitual level of physical activity and blood pressure measurements were taken using an ambulatory 
blood pressure monitor (ABPM) (SpaceLabs Inc., Issaquah, WA, Australia; Model 90207).  
 
Dietary instruction and intervention meals  
The QGPJ was used as the vehicle to provide a specific and consistent anthocyanin dose to study participants. 
The plum juice was produced from a single seasonal batch and processed to juice by research partners at the 
Department of Agriculture and Fisheries (DAF), Queensland Government. The study beverage was stored at -
20oC and thawed (in the refrigerator) 24h prior to use on the days participants came into the study facility  [107].  
Prior to each study day, participants were advised to avoid consumption of purple/red fruits and vegetables 
including wine, juices, jams and smoothies in the 24h periods immediately before and after interview day. 
Verbal compliance to this was received prior to the study. On each study day participants arrived between 08:00 
and 09:30 hours at the clinic facility following a 12h fast. A spot urine sample was collected, and a battery of 
cognitive tests administered by two interviewers who had been trained by a senior psychologist (SR). 
Thereafter, a standardized breakfast (Weet-Bix, milk and sugar) that was low in flavonoids was provided. QGPJ 
was provided with breakfast in random order, as either (i) a single dose of 300mL (369 mg total anthocyanins) 
[13] or (ii) 3 x 100mL servings (123mg total anthocyanins/serving) of the same plum juice at 0, 1 and 3h. A 
standardized snack (ham and cheese sandwich) was provided at 4h and two (250mL) bottles of water provided 
for the 6h duration spent in the study facility to be consumed ad libitum. 
 
Ambulatory 24h blood pressure and anthropometric measurements 
BP was measured using Ambulatory Blood Pressure Monitors (ABPM) for improved monitoring over 24 h, in 
comparison to standard digital blood pressure monitors used in similar studies over a 6-hour period [61, 214]. 
Upon arrival at the testing facility participants were fitted with an ABPM (SpaceLabs Inc., Issaquah, WA, 
Australia; Model 90207). The ABPM took BP measurements over the next 24h; every 15 minutes while at the 
testing facility (first 6h) and thereafter once per hour whilst at home. The ABPM uses an oscillometric method 
for the detection of systolic and diastolic blood pressure and has been shown to be more accurate than casual or 
in-office BP measurements [215]. Participants were encouraged to go about their usual daily activities but were 
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advised to stand still and relax their arm whenever the monitor recorded measurements i.e. cuff inflation and 
deflation. After 24 hours, the monitor was removed and collected from participants’ homes and data 
downloaded from the monitor for analysis. 
 
Height (m) and weight (kg) were measured using a stadiometer (Seca, Hamburg, Germany) and an electronic 
scale (Omron HN286 Digital Personal Body Weight Scale, (Omron, Australia)) respectively, to two decimal 
places and BMI (weight/ (height2)) was calculated. 
 
Cognitive tasks  
Five short cognitive interviewer-administered tests [216, 217] were administered by trained investigators at 
baseline and 6h on both testing occasions to determine any acute changes in cognition (Table 3-1). The total 
duration of the battery of tasks was approximately 30min. To control for cross-over effects, there were 4 
versions of the cognitive battery so that each participant had a different version at baseline and at 6h, and in the 
cross-over arm. Accuracy and response time were recorded for each task. These tasks were chosen based on 
available evidence from the literature on cognitive tasks and corresponding cognitive domains that appear 
sensitive to anthocyanin supplementation in acute settings [201]. 
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Table 3-1: Cognitive assessment task description 
 
Instrument  Cognitive 
Domain  
    Application  Scoring 
 
Trail making 
test [218] 
 
Higher 
executive 
function  
 
Participants alternate between 
two simple tasks at once. 
 
The difference in the number of 
seconds required to complete the 
task compared to a non-
switching version.  
The Rey 
Auditory Verbal 
Learning test 
[219] 
  
Verbal 
learning and 
memory   
Participants learn and recall a list 
of words over 5 trials.  
Each correct word that is 
identified is associated with a 
score. 
Pattern & letter 
comparison task 
[220] 
Speed of 
processing 
 
  
Participant compares strings of 
patterns or letters to determine if 
it is the same or different.  
Participants complete as many 
examples as possible in 30 
seconds and scores are tallied. 
Reaction time 
task[221]  
General 
alertness and 
speed of 
processing 
 
A left or right arrow-shaped 
stimulus is displayed on the 
computer screen and participants 
will be required to press the 
corresponding mouse button (left 
or right) as displayed on the 
screen. 
 
Scoring will be based on correct 
and incorrect responses and 
latency (response speed).    
 
Stroop task 
[222] 
Executive 
function 
Participants say the colour of a 
word, not what the word says. 
E.g. for the word, RED, they are 
expected to say "Blue." 
Amount of time taken to 
complete each set of words. 
 
Urine sample collection and preparation 
Urine samples were collected at baseline prior to QGPJ consumption, and thereafter collected in sterilised urine 
containers over the following time periods:  0-2h; 2-6h; 6-12h and 12-24h after QGPJ consumption. The volume 
of collected urine samples were measured per container, recorded and an aliquot of 30mL of urine sample plus 
9mL of formic acid (100%) stored in 50mL tubes, with additional 10mL urine for storage. The urine samples 
were stored at -800C for batch analysis. Intact (non-metabolized) QGP anthocyanins (cyanidin-3-glucoside and 
cyanidin-3-rutinoside), as well as their main/common conjugated and methylated metabolites such as peonidin-
glycosides and –glucuronides, were determined by HPLC-PDA-MS at the Queensland Allianz for Agriculture 
and Food Innovation Laboratory, University of Queensland. The methodology was as described by Netzel et. al. 
(2012) [187]. Acidified urine samples were thawed and maintained for 60 min at room temperature before Solid 
Phase Extraction (SPE) to obtain the maximal yield of the coloured flavylium cations. The SPE cartridge was 
activated with 10 mL of methanol and equilibrated with 10 mL of 12 mM aqueous HCl before use. 
Subsequently, 5 mL of acidified urine was applied to the equilibrated cartridge. The cartridge was then washed 
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with 10 mL of 12 mM aqueous HCl, and anthocyanins were eluted with 2 mL of 12 mM HCl in methanol. The 
extracts were filtered (0.2 µm syringe filters; Palls, Cheltenham, VIC, Australia) before UHPLC-PDA-ESI-
MS/MS analysis. 
 
 
3.1.3 Data Analysis 
 
Data was analysed using IBM SPSS Statistics for Windows, Version 21.0. (IBM Corp., Armonk, NY, USA). 
Descriptive statistics of participant characteristics was performed across age groups. Normal distribution of the 
continuous variables was assessed using the Shapiro Wilk test, histogram, Q-Q plot and skewness and kurtosis.  
 
Linear mixed modelling was used to estimate the effect of different timed doses of QGPJ on BP between the 
two age groups, while adjusting for correlation due to repeated observations on each participant over 24h. Age-
group and dose (with interaction term) were entered in the model as fixed effects while controlling for age and 
gender. Maximum likelihood method of estimation was used with a diagonal covariance structure. As BP 
measurements were collected over 24h, there were a few missing data (less than 1%) and as a result linear 
mixed modelling was chosen for analysis as it handles missing data better than the widely used ANCOVA.  
 
Area Under the Curve (AUC) was calculated as a summation measure for the first 6h of BP measurements [223, 
224] and the baseline observation carried forward (BOCF) approach was used for missing data (less than 1%). 
To determine if the plum juice had a significant effect on BP, a z-test was used to analyze the AUC for the BP. 
A series of t-tests was used to determine whether there was any significant difference between baseline BP and 
different time points up to 6h. The period between 0 and 6h represents the time that the participants spent at the 
study facility under standard resting conditions.  
 
One-way analysis of variance (ANOVA) was used to determine differences in performance within each group at 
baseline and 6h post-intervention and two-way ANOVA was used to determine the difference in cognitive 
performance at baseline and 6h between the two age groups and dosing regimens as well as anthocyanin 
excretion between the two age groups. 
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3.1.4 Results 
3.1.4.1 Subject characteristics  
Twenty-four participants (12 younger and 12 older adults) were recruited to participate in the study and 
sociodemographic characteristics are shown in Table 3-2. Participants were of Caucasian descent (n=21), 
African descent (n=2) and Asian descent (n=1). All participants attended both visits and there were no 
withdrawals throughout the study protocol. The average washout period for participants was 20 days (14-26 
days), a deviation from the original 2-week washout period due to schedule clashes and illness. The washout 
period chosen for our study was 2 weeks. This was informed by the FDA recommendation which states that for 
bioequivalence studies, “The washout time should be approximately 10x the plasma apparent terminal 
elimination half-life, to provide for 99.9% of the administered dose to be eliminated from the body.” [225]. For 
the anthocyanin, cyanidin-3-glucoside, which is the main anthocyanin in QGPJ [85, 107], the half-life has been 
shown to range between 12 and 51h [49]. 
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Table 3-2: Descriptive statistics 
Characteristics 
 
Younger adults (n=12) 
n (%) 
Older adults (n=12) 
n (%) 
p-value 
Gender 
Male  
Female 
 
 
4 (33.3) 
8 (66.7) 
 
3 (25.0) 
9 (75.0) 
Ns 
Age (Mean & SD) 
 
30.83 (8.04) 77.42 (6.10) <0.001 
BMI (Mean & SD) 
 
22.49 (2.36) 26.36 (3.28) 0.003 
Physical Activity 
Low 
Medium 
High 
 
5 (41.7) 
5(41.7) 
2 (16.7) 
 
1 (8.3) 
10 (83.3) 
1(8.3) 
0.97 
Smoking status 
Yes 
No 
Occasionally 
Rarely 
 
 
0(0) 
11 (91.7) 
0(0) 
1 (8.3) 
 
0(0) 
12 (1000 
0(0) 
0(0) 
Ns 
Alcohol intake 
Yes 
No 
Occasionally 
Rarely 
 
 
3 (25.0) 
2 (17.7) 
4 (33.3) 
3 (25.0) 
 
5 (41.7) 
3 (25.0) 
2 16.7) 
2 (16.7) 
0.67 
Data are means ± SD or n (%) (n=12); BMI – Body Mass Index; P values were obtained from χ2 test for categorical variables; Ns- Not 
significant 
3.1.4.2 Cognitive tasks 
 
Using two-way ANOVA, a significant difference was observed between the two age groups (p<0.001), both at 
baseline and 6h, for performance on cognitive tests. After consumption of the juice, there was no significant 
difference from baseline values within the groups or by dose-timing (Table 3-3).  
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Table 3-3:  Mean baseline measurements and mean difference of cognitive assessments over 6 hours according 
to group 
 
 3 x 100mL QGPJ (0,1,3h) 1 x 300mL QGPJ 
Cognitive Task Baseline 
Mean (SD) 
6h mean difference Baseline 
Mean (SD) 
6h mean difference 
 
Younger adults (18-45) 
 
Speed of processing  
(measured by letter and 
pattern comparison)a 
 
Stroop effect 
  
Switch costb 
(measured by task switching) 
 
 
RAVLT (total)c 
 
RAVLT (20m delay)c 
 
Reaction time 
 
 
n=12 
 
2.39(0.51) 
 
 
 
18.42(7.63) 
 
46.58(13.43) 
 
 
 
54.00(9.41) 
 
11.00 (2.79) 
 
501.98 (36.28) 
 
 
 
-0.16 
 
 
 
0.91 
 
-0.88 
 
 
 
-1.75 
 
-0.10 
 
12.85 
 
n=12 
 
2.10(0.48) 
 
 
 
19.42(5.31) 
 
45.46(19.66) 
 
 
 
51.50(9.78) 
 
11.00(2.87) 
 
555.31 (87.75) 
 
 
 
0 
 
 
 
0 
 
0.84 
 
 
 
-0.34 
 
-1.78 
 
0.08 
 
Older adults (65+) 
 
Speed of processing  
(measured by letter and 
pattern comparison)a 
 
Stroop effect 
  
Switch costb 
(measured by task switching) 
 
 
RAVLT (total)c 
 
RAVLT (20m delay) 
 
Reaction time 
 
n=12 
 
3.33(0.90) 
 
 
 
35.58(16.21) 
 
73.00(24.62) 
 
 
 
39.00(8.07) 
 
4.56(3.21) 
 
682.54 (70.24) 
 
 
 
0.33 
 
 
 
1 
 
8.59 
 
 
 
3.17 
 
0.17 
 
10.61 
 
n=12 
 
3.24(0.60) 
 
 
 
47.16(18.98) 
 
69.21(19.21) 
 
 
 
38.17(7.73) 
 
5.11(3.72) 
 
781.67 (148.22) 
 
 
 
0.06 
 
 
 
3.75 
 
5.16 
 
 
 
4.34 
 
-2.50 
 
-15.01 
aPattern and letter comparison = number of correct answers in 90 secs; bTask switching = time taken to complete task; cRAVLT – Rey 
Auditory Verbal learning Test (total) and (20min delay) = number of words recalled 
 
 
3.1.4.3 24h ambulatory blood pressure 
 
Hourly cardiovascular responses recorded during each of the 24h test periods are shown, according to plum 
juice delivery mode in Figures 3-1 to 3-8. Comparison is made between the dosing regimen (single and triple 
doses) and age groups with an interaction factor (dosing regimen x age-group). Figure 3-1 shows a more 
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obvious drop in systolic blood pressure of the older adults with the single dose compared to the triple dose 
(Figure 3-5). This observation was not evident with the younger adults, as shown in Figures 3-1 and 3-5. There 
was no significant dose-timing effect observed for change in blood pressure following plum juice consumption 
in the 24h period using the linear mixed model for longitudinal data (Table 3-4).  
 
Area under the curve (AUC) was calculated for the cardiovascular parameters (systolic, diastolic, MAP and HR) 
for the first 6h (Table 3-5 and Figures 3-9 – 3-12). For both age groups, using an independent sample t-test, BP 
was significantly lower than baseline (p < 0.05) at different time points up to 6 h following consumption of the 
plum juice. The greatest significant BP reduction was observed at 2h for both age groups and was more obvious 
for systolic BP in the older group with a mean difference of 12.83mm Hg (SD; 16.51, p=0.001) from baseline. 
For the single dose, z-test analysis of the AUC calculations for the younger adult group showed a significant 
effect of the juice on diastolic BP, MAP and HR (p-values = 0.008, 0.012 and 0.025, respectively). Similarly, a 
significant effect was seen for the older group: systolic BP, diastolic BP, MAP and HR (p-values = 0.035, 0.028, 
0.017 and 0.006 respectively). For the younger age-group on the triple dose, significant effects were observed 
for diastolic BP and MAP (p-values = 0.008 and 0.013, respectively) with a borderline significance on the HR 
(p-value = 0.06). In the older group, significant effects of the triple dose were observed for diastolic BP (p-value 
= 0.00007) and a borderline effect for systolic BP (p-value = 0.063). Plum juice consumption had a significant 
effect on systolic BP, which was predicted by dose or age group but no interaction term effect (dose x age 
group) and for MAP, predicted by only age-group. No significant effect was observed on other cardiovascular 
parameters (Table 3-4). 
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Table 3-4: Effect of dose-timed plum juice consumption on cardiovascular parameters across age groups 
 
Parameter 
 
Mean ± SEa p-values 
SBP 
Intercept 
 
Dose-timeb 
1 x 300mL 
3 x 100mL 
 
Groupc 
Younger (n=12) 
Older (n=12) 
 
Interaction (group*dose) 
Younger * 1x300mL 
Younger * 3x100mL 
 
Older * 1x300mL 
Older * 3x100mL 
 
DBP 
Intercept 
 
Dose-time 
1 x 300mL 
3 x 100mL 
 
Group 
Younger (n=12) 
Older (n=12) 
 
Interaction (group*dose) 
Younger * 1x300mL 
Younger * 3x100mL 
 
Older * 1x300mL 
Older * 3x100mL 
 
MAP 
Intercept 
 
Dose-time 
1 x 300mL 
3 x 100mL 
 
 
Group 
Younger (n=12) 
Older (n=12) 
 
Interaction (group*dose) 
Younger * 1x300mL 
Younger * 3x100mL 
 
Older * 1x300mL 
Older * 3x100mL 
 
 
123.7 ± 0.05 
 
 
122.3 ± 0.60  
125.2 ± 0.67 
 
 
115.0 ± 0.66 
132.8 ± 0.61 
 
 
114.2 ± 0.84 
115.8 ± 1.00 
 
130.3 ± 0.87 
134.5 ± 0.87 
 
 
72.9 ± 0.36 
 
 
72.5 ± 0.49 
73.3 ±0.54 
 
 
72.2 ± 0.53 
73.6 ± 0.49 
 
 
72.0 ± 0.68 
72.4 ±0.81 
 
73.0 ± 0.69 
74.1 ± 0.70 
 
 
90.2 ± 0.37  
 
 
89.4 ± 0.49 
90.9 ±0.54 
 
 
 
86.4 ± 0.54 
94.0 ± 0.50  
 
 
85.7 ± 0.68 
87.0 ± 0.83 
 
93.1 ± 0.70 
94.9 ± 0.70 
 
 
<0.0001^ 
 
 
0.001^ 
 
 
 
<0.0001^ 
 
 
0.154 
 
 
 
 
 
 
 
<0.0001^ 
 
 
0.25 
 
 
0.11 
 
 
 
 
0.62 
 
 
 
 
 
<0.0001^ 
 
 
0.077 
 
 
 
 
<0.0001^ 
 
 
 
0.75 
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Parameter 
 
Mean ± SEa p-values 
HR 
Intercept 
 
Dose-time 
1 x 300mL 
3 x 100mL 
 
Group 
Younger (n=12) 
Older (n=12) 
 
Interaction (group*dose) 
Younger * 1x300mL 
Younger * 3x100mL 
 
Older * 1x300mL 
Older * 3x100mL 
 
 
72.6 ± 0.36 
 
 
72.5 ± 0.49 
72.7 ± 0.54 
 
 
72.9 ± 0.54 
72.4 ± 0.49 
 
 
72.8 ± 0.69 
73.0 ± 0.82 
 
72.2 ±0.70 
72.5 ± 0.70 
 
<0.0001^ 
 
0.69 
 
 
 
0.76 
 
 
 
0.91 
Data are means ± SE (n=12 per group); ^ Significant at p<0.05; aMeans and p-values were obtained from linear mixed model; bDose-time 
represents either a single dose of 300mL or 3 portions of 100mL taken at 0h, 1h and 3h; c“Younger” means younger age-group and “older” 
means older age-group; SBP – Systolic blood pressure; DBP- Diastolic blood pressure; MAP- Mean arterial pressure; HR- Heart rate 
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Table 3-5: Change in cardiovascular parameters of participants following consumption of different doses of 
QGP juice 
 
 
Cardiovascular parameters 
AUCa (0-6 h), mmHg 
 
3 x 100mL QGP (0,1,3h) 
 
1 x 300mL QGP 
 
Younger adults (18-45) 
 
Systolic BP 
 
Diastolic BP 
 
Mean Arterial Pressure 
 
Heart Rate 
 
 
n = 12 
 
-49.36 ± 131.26 
 
-123.45 ± 122.27* 
 
-96.80 ± 12.75* 
 
-113.50 ± 208.69† 
 
 
n = 12 
 
-44.45 ± 125.29 
 
-140.55 ± 175.93* 
 
-125.40 ± 136.31* 
 
-164.42 ± 253.64* 
 
Older adults (65+) 
 
Systolic 
 
Diastolic 
 
Mean Arterial Pressure 
 
Heart Rate 
 
 
n = 12 
 
-172.50 ± 321.86 † 
 
-156.00 ± 136.28 * 
 
-97.67 ± 278.55 
 
-84.08 ± 195.42 
n =12 
 
-191.00 ± 313.93* 
 
-121.33 ± 190.81* 
 
-149.92 ± 217.91* 
 
-136.17 ± 171.35* 
 
Data are AUC for mean change in cardiovascular parameters ± SD (n=12 per group) 
aAUC – area under the curve; BP- blood pressure; QGP – Queen Garnet plum 
* Z-test analysis showed statistically significant effect of the juice on the measured parameter. 
† Z-test analysis showed borderline significant effect of the juice on the measured parameter. 
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Figure 3-1: Single dose hourly systolic blood pressure of participants by age group over 24 hours after 
consumption of QGPJ. Values are means n=12 with SE as error bars. 
 
 
Figure 3-2: Single dose hourly diastolic blood pressure of participants by age group over 24 hours after 
consumption of QGPJ. Values are means n=12 with SE as error bars. 
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Figure 3-3: Single dose hourly mean arterial blood pressure of participants by age group over 24 hours after 
consumption of QGPJ. Values are means n=12 with SE as error bars. 
 
Figure 3-4: Single dose hourly heart rate of participants by age group over 24 hours after consumption of QGPJ. 
Values are means n=12 with SE as error bars. 
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Figure 3-5: Triple dose hourly systolic blood pressure of participants by age group over 24 hours after 
consumption of QGPJ. Values are means n=12 with SE as error bars. 
 
Figure 3-6: Triple dose hourly diastolic blood pressure of participants by age group over 24 hours after 
consumption of QGPJ. Values are means n=12 with SE as error bars. 
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Figure 3-7: Triple dose hourly mean arterial blood pressure of participants by age group over 24 hours after 
consumption of QGPJ. Values are means n=12 with SE as error bars. 
 
Figure 3-8: Triple dose hourly heart rate of participants by age group over 24 hours after consumption of QGPJ. 
Values are means n=12 with SE as error bars.  
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Figure 3-9: Change in systolic blood pressure (0-6h) following consumption of QGP juice.  
 
Values are expressed as AUC for mean change in systolic blood pressure from baseline per hour up to 6h. Bars represent the sum of AUC 
for ∆SBP (0-6h) ± SE (n=12 per age group). AUC, Area Under the curve; QGPJ, Queen Garnet plum juice; SBP, Systolic blood pressure 
 
 
Figure 3-10: Change in diastolic blood pressure (0-6h) following consumption of QGP juice.   
 
Values are expressed as AUC for mean change in diastolic blood pressure from baseline per hour up to 6h. Bars represent the sum of AUC 
for ∆DBP (0-6h) ± SE (n=12 per age group). AUC, Area Under the curve; QGPJ, Queen Garnet plum juice; DBP, Diastolic blood pressure 
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Figure 3-11: Change in MAP (0-6h) following consumption of QGP juice.  
 
Values are expressed as AUC for mean change in MAP from baseline per hour up to 6h. Bars represent the sum of AUC for ∆MAP (0-6h) ± 
SE (n=12 per age group). AUC, Area Under the curve; QGPJ, Queen Garnet plum juice; MAP, mean arterial pressure 
 
 
 
Figure 3-12: Change in heart rate (0-6h) following consumption of QGP juice.  
Values are expressed as AUC for mean change in HR from baseline per hour up to 6h. Bars represent the sum of AUC for ∆HR (0-6h) ± SE 
(n=12 per age group). AUC, Area Under the curve; QGPJ, Queen Garnet plum juice; HR, heart rate. 
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3.1.5 Urinary excretion of anthocyanins and anthocyanin metabolites 
 
The anthocyanin content of the batch of QGP utilised for our study was 123mg/100g [13]. The consumption of 
QGP juice as a single oral dose of 300mL or in 3 x100mL servings over 3h resulted in the appearance of both 
intact/non-metabolised QGP anthocyanins (cyanidin-3-glucoside and cyanidin-3-rutinoside) and at least five 
identified anthocyanin metabolites in the volunteers’ urine samples (Table 4). The excretion rates and urinary 
anthocyanin/metabolite profiles were similar (p>0.05) between age groups and dosing regimen. 
 
 
Table 3-6: Urinary excretion of anthocyanins and anthocyanin metabolites in different age groups following the 
consumption of QGPJ as a single oral dose of 300 mL or as three 100 mL servings 
  
Dosing 
(anthocyanins) 
 
Absolute excretion 
(µg/24 h)1 
 
Relative excretion 
(%)2 
 
 
Relative excretion 
of main 
metabolites (%)3  
 
Younger age 
group (n=12) 
 
1x300 mL 
(369 mg) 
 
 
811 ± 702 
 
 
0.22 
 
80 
3x100 mL 
(123 mg/dose) 
 
759 ± 358 0.21 74 
Older age group 
(n=12) 
1x300 mL 
(369 mg) 
 
871 ± 602 0.24 80 
3x100 mL 
(123 mg/dose) 
 
693 ± 458 0.19 75 
Data are means ± sd; 1sum of cyanidin-3-glucoside, cyanidin-3-rutinoside, cyanidin-3-glucoside monoglucuronide, cyanidin 
monoglucuronide, peonidin-3-glucoside, peonidin monoglucuronide and pelargonidin monoglucuronide; 2excreted amount vs. ingested 
dose; 3excreted amount of peonidin-3-glucoside and peonidin monoglucuronide as the main metabolites vs. absolute excretion; compounds 
were analysed by HPLC-PDA-MS and quantified by an external cyanidin-3-glucoside calibration curve [187]. 
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3.2 Discussion 
 
Following consumption of a single dose of 300mL QGPJ, an acute reduction in SBP (p=0.035), DBP (p=0.028), 
MAP (p=0.017) and HR (p=0.006) was observed in the older age group. A similar trend was also observed for 
the triple dose with the absence of an effect on SBP. This acute effect was more pronounced in the older age 
group and at 2h with a mean difference of 12.83mm Hg from baseline. Significant effects on DBP (p<0.001) 
and MAP (p=0.013) were also observed in the younger age group on the single dose and DBP (p<0.001), with a 
borderline effect on SBP (p=0.06) on the triple dose. The acute significant reduction in blood pressure at 2h 
corresponds with evidence on the maximum absorption and bioavailability of anthocyanins that occurs within 
2h post consumption [226]. Anthocyanin concentrations in the body have been observed to reach peak levels 
between 1-2h and begin to clear from 6h, falling back to baseline levels as they get excreted from the body up to 
48h postprandially [47]. The synergistic effect of other nutrients in the QGP cannot be overlooked. There is a 
possibility that the observed blood pressure lowering effect may have been as a result of this synergistic effect, 
as well as the presence of potassium in the QGP fruit [13] which is an electrolyte known to lower blood pressure 
in humans [227]. Despite lack of a significant effect of dose by the different age groups on blood pressure, the 
greater reduction in blood pressure in response to plum juice consumption in older adults may be explained by 
their higher baseline blood pressure levels [196]. However, further adequately powered studies are needed to 
confirm these findings. In the 6h following the QGPJ consumption, no significant effect was observed on the 
SBP of the younger age group. Similar observation has also been made in a previous study [228] where it was 
observed that the PacDASH (Pacific Kids Dietary approach to stop hypertension) trial did not affect overall diet 
quality which was measured by SBP change among other parameters but had a significant effect on DBP by the 
end of the intervention, by 12.2 mmHg. There is a possibility that the absence of a significant effect on SBP 
could be associated with age, with interventions having a more pronounced effect among older populations 
and/or those more prone to age-related vascular stiffening associated with an increased risk of developing CVD.  
 
There was an observed dose-timing and group effect on SBP but not on other blood pressure parameters, 
however, this was no longer significant after inclusion of an interaction term (age-group x dose-timing).  
Previously, a similar study observed an acute reduction in blood pressure (SBP, DBP and HR) after 
consumption of anthocyanin-rich cherry juice, which was found to be dose-timing dependent [214]. The 
difference between the two studies may be explained by a much higher concentration of anthocyanins in the 
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QGP juice (123mg/100mL vs 69mg/100mL, respectively), resulting in a physiological threshold that may have 
been reached in each of the three single 100mL doses. 
 
A possible explanation/mechanism of the observed blood pressure lowering effect of QGPJ could lie in the 
molecular structure of its main in vivo anthocyanin metabolites. Methylation of cyanidin glycosides by catechol-
O-methyltransferase (COMT) results in the production of peonidin based metabolites which are the main 
urinary anthocyanin metabolites after QGPJ ingestion. This reaction also results in a structural modification of 
the B-ring in the flavonoid skeleton which is structurally analogous to apocynin, an established vasoactive drug 
[229-231]. Mono-O-methylated anthocyanins/flavonoids can act as inhibitors of NADPH oxidase and as a result 
can improve vasodilatory processes [231]. Another possible explanation for the blood pressure lowering effect 
of anthocyanins and/or other polyphenols present in the plum juice is their potential to inhibit the oxidation of 
Low-Density Lipoproteins (LDLs), a major risk factor for atherosclerosis, through free-radical scavenging and 
removal of metal ions from catalytic sites via chelation [232]. One study tested this theory and observed that 
when cells were incubated with OxLDL (100 µg/mL) for 24h, there was an increase in cell death while the 
additions of mulberry water extracts and mulberry anthocyanin-rich extracts beyond the concentrations of 0.1 
and 0.05 mg/mL, respectively, significantly increased the survival of these cell macrophages. In addition, the 
authors observed that 1 mg/mL of mulberry water extract and 0.1 mg/mL of mulberry anthocyanin-rich extract 
suppressed the lipid accumulation by approximately 55% and 58%, respectively [233].  
 
Even though anthocyanins have been hypothesized to exert beneficial effects on cognitive functioning, results 
from our study show that a 300mL serving of QGPJ, regardless of dose-timing or age of participants, had no 
significant acute effect on various domains of cognitive function. Although previous studies have found no 
significant acute effect of anthocyanins from fruit sources on cognitive processes [216, 234], the QGPJ used in 
the present study had a significant higher content of anthocyanins and therefore it was hypothesized that it might 
induce acute cognitive benefits. In addition, two different cognitive tests that have been shown to be sensitive 
and target different domains were utilised, namely the Stroop and the Reaction time tasks [217, 235]. Extensive 
research has been carried out on the long term effect of flavonoid supplementation on cognition [217] with less 
attention on their acute effects. Recently, there has been an increase in the body of evidence on the acute effects 
of flavonoids on cognitive processes such as attention, working memory and psychomotor speed in a general 
population [236]. The precise mechanism by which anthocyanins affect cognition is still not clear but seems to 
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be dependent on the exposure period. Acute effects on cognition are believed to be as a result of increased 
cerebrovascular blood flow and possibly monoamine oxidase (MAO) inhibition which has been shown to 
improve cognitive performance [18, 237]. Following consumption of high anthocyanin fruit/juice, evidence 
shows that peaks in cerebral blood flow, vasodilation, and anthocyanin metabolite availability is detectable 
within 2h post consumption [238]. Following blueberry supplementation, plasma anthocyanins and their 
metabolites were observed to reach peak levels in plasma at 1–2h and 6h [55]. An investigation on the 
bioavailability of anthocyanins observed an association between colonic microbiota metabolism of anthocyanins 
and a significant increase in the content of generated polyphenols in the brain. There is a possibility that the 
peak levels observed at 6h is as a result of re-uptake of polyphenols from the colon [239, 240]. For this reason, 
repeat cognitive tasks were administered 6 h post consumption of the plum juice in our study. The absence of a 
significant effect could be attributed to the timing of cognitive task administration, possibly missing the initial 
peak action time. Previous research has reported conflicting results regarding the influence of flavonoids on 
cognition in younger and older people. In one study, anthocyanin-rich blueberry fruit supplementation in 
younger and older adults resulted in improvements in different acute cognitive domains, whereby a significant 
improvement in updating ability (constant monitoring and tracking of working memory representations) was 
reported for younger adults, while improvements in immediate word recognition in older adults were identified 
[241]. In relation to cocoa flavonoids, consumption of dark chocolate for one week significantly improved 
endothelial function and reduced BP in younger hypertensive patients, but not in older populations [242]. 
Overall there is little information that compares responses between younger and older adult populations thus 
more work comparing these groups is required to elucidate any age-related differences in biological response.  
 
The urinary recovery of intact anthocyanins and anthocyanin metabolites that had an intact flavonoid skeleton 
(glucuronides, sulfates and methylated forms) was between 693 and 871 ug/24 h in the current study, 
corresponding to 0.19 – 0.24% of the ingested anthocyanin dose. These ranges are consistent with those reported 
in human studies for urinary excretion rates of anthocyanins and conjugated/methylated metabolites after 
consumption of anthocyanin-rich food sources (0.01 – 5.10%) [21, 48, 107]. The bioavailability of anthocyanins 
has been reported to be low however a recent review indicates that it may be higher than previously reported 
[243]. Evidence from the review showed that the majority of ingested anthocyanins do reach the large intestine. 
Here, they are catabolised by the microbiota, producing an array of phenolic components that are absorbed, and 
some metabolised to phase II conjugates [243]. Furthermore, our finding that methylated and glucuronidated 
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derivatives of cyanidin-based anthocyanins were the main urinary metabolites is also in agreement with others 
[187, 244, 245]. The in vivo glucuronidation, sulfatation and methylation of anthocyanins by UDP-
glucuronosyltransferases, sulfotransferase and COMT in the intestinal epithelial cells, liver and kidney is a 
common metabolic pathway of dietary anthocyanins and other polyphenolic compounds [246]. 
 
The presence of pelargonidin monoglucuronide, when QGPJ does not contain any (detectable) pelargonidin 
based anthocyanins, could be explained by the in vivo xenobiotic and gut bacterial metabolism of 
anthocyanins/flavonoids. This includes addition and removal of methyl and hydroxyl groups (pelargonidin is 
lacking one hydroxyl group compared to cyanidin) [31]. This was also reported in a different study in which 
significant amounts of pelargonidin based metabolites were detected in the urine of 17 study subjects following 
consumption of blueberry juice which also did not contain any detectable pelargonidin glycosides [31]. Inter-
conversion of anthocyanins due to xenobiotic and bacterial metabolism was suggested by these authors. In the 
current study, there were no significant differences in the urinary anthocyanin/metabolite excretion profiles 
either between the age groups or according to the different dosing regimens (1x300 mL dose or 3x100 mL 
servings).  
 
The main objective with the dose-timing design was to estimate the response according to the dose given. It is 
worth noting that there were no adverse reactions recorded. Throughout the course of the study, the juice 
provided was well tolerated and there were no reports of any adverse effects, however the tolerability to the 
study protocol was not objectively measured. As there is large observed inter-individual variation in the 
absorption, metabolism and excretion of polyphenols [41], the use of a cross-over study design is appropriate 
since participants act as their own controls [247]. 
 
A notable limitation of our study is the absence of a placebo arm. A placebo (control) arm is essential in dietary 
intervention studies that investigate the magnitude of effect related to a dietary factor of interest. In the case of 
anthocyanins, Johnson et. al. (2015)[248] included a placebo control group in their  blueberry powder (469mg of 
anthocyanins/day) study and identified an intervention effect of a 7mmHg and 5mmHg drop in SBP and DBP 
respectively after 8 weeks (P<0.05 and P<0.01, respectively). The main purpose of our acute study in which 
each participant acted as their own control was to identify whether different dosing regimens of a high 
anthocyanin fruit juice resulted in differences for ether cognitive performance and/or BP. Information related to 
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the dose-timing administration of an intervention is an important consideration in clinical trial designs in free-
living participants. Furthermore, neither intact anthocyanins nor their common metabolites such as glucuronides, 
sulfates or methylated forms are usually detectable in urine of placebo/control groups, as was demonstrated in a 
pilot study of QGPJ [107]. Food or beverages used for placebo/control treatments are usually anthocyanin-free 
or contain only negligible amounts of these pigments. Previous chronic flavonoid trials have instructed 
participants to consume an amount of food or beverage over the period of a day, but without specific guidelines 
on whether this needs to be consumed in totality at a single setting or whether smaller portions can be spread 
across the day. Nonspecific information on timing of the test food or beverage may relate to a poor 
understanding of how dose-timing may affect biological responses.  
 
Another notable limitation is the absence of a blinding strategy. This, in addition to cognitive testing time, could 
have resulted in the absence of a significant effect on cognitive performance after consumption of the plum 
juice. A consideration for future studies could be to test cognitive effects at 2 h and 4-6 h post consumption in 
order to reflect metabolic processes and thus consolidate available evidence. Another important consideration 
for future clinical trials may be to screen for individuals with arterial narrowing who may benefit most from 
blood vessel dilation related to  dietary interventions [249, 250]. There is a possibility that a greater BP response 
would result in more pronounced benefit to cognitive functioning, which was not evident in the current study. In 
addition, it is recommended that blood and fecal samples are included in future human studies in order to allow 
a more comprehensive analysis of in vivo metabolites, specifically generated by the gut microbiota and thereby 
elucidate the mode of action of these plant bioactives. 
 
3.3 Conclusion 
 
In conclusion, this study hypothesis was rejected as there were no differences according to two dose-timing 
regimens of consumption of QGPJ. An acute BP-lowering effect of anthocyanin-rich plum juice was similarly 
observed for both dose-timing regimens, while no cognitive effects were observed for either dose, nor were 
differences in anthocyanin metabolite excretion evident between younger and older adults. Anthocyanin 
metabolites were bioavailable in the urine following consumption, but no differences were observed in the 
absorption rate and metabolism of anthocyanins between young and older adults, as assessed in urinary 
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biomarkers. It is important that the mechanism of action is studied further to better understand how 
anthocyanins exert protective effects on BP and how this reduction effect can be sustained over time, as well as 
to determine effects on cognition in longer-term consumption studies. The greater BP reduction observed in 
older participants indicates that future studies should focus on this age group where elevated BP is more 
prevalent, by using a placebo-controlled design. As a first step, an important consideration relates to further 
understanding the metabolism and subsequent actions of anthocyanins in the colon. This could shed some light 
on the possible association between anthocyanin intake and observed beneficial health effects. With evidence 
showing that anthocyanins are further broken down in the colon, it is worth understanding the plausible 
mechanism and how this could be incorporated into future trials.  
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4 Chapter 4 
4.1 A SYSTEMATIC LITERATURE REVIEW ON THE EFFECT OF 
ANTHOCYANINS ON GUT MICROBIOTA AND METHODS OF 
MICROBIOTA DETERMINATION 
  
In order to further the understanding of anthocyanin metabolism and absorption, the role of gut microbiota needs 
to be examined. The gut microbiota plays a significant role in anthocyanin metabolism. Evidence has shown that 
in the gut, anthocyanins are metabolised and, in the process, modulate bacterial species and exert bioactive 
effects through this interaction. A systematic literature review was undertaken to determine the level of current 
evidence for the association between anthocyanin intake and changes in gut microbiota. Findings from this 
review showed that anthocyanins induced a significant proliferative effect on Bifidobacterium spp., known for 
their wide use in probiotics and for the treatment of Irritable Bowel Syndrome (IBS). There was also an 
observed inhibition of Clostridium histolyticum, which have been shown to be pathogenic in humans. 
Nonetheless, very limited research has been carried out in the area of anthocyanins and gut microbiota and 
further clinical trials in humans are needed to confirm changes to gut microbes. 
 
The majority of this chapter is the substantive content of the published article: (Appendix F) 
 
Igwe E.O., Charlton K.E., Probst Y.C., Kent K., Netzel M.E. (2018) A systematic literature review of the effect 
of anthocyanins on gut microbiota populations. J Hum Nutr Diet. https://doi.org/10.1111/jhn.12582 
 
Specific role/authorship of all the authors: EI, KC and YP designed the study. EI and MN contributed to the 
literature search. EI produced the summary tables and EI and KK produced the first draft of the manuscript. All 
Authors contributed to writing and editing the manuscript and approved of the final version of the paper 
submitted for publication  
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4.1.1 Introduction 
 
The metabolism of anthocyanins has been well reviewed [48]. Briefly, anthocyanins consumed through the diet 
have shown to be poorly absorbed by the body, with only a small proportion of intact anthocyanins able to pass 
through the gastrointestinal wall using active transporters like the sodium-dependent glucose transporter 1 
(SGLT1) and facilitative glucose transporter 2 (GLUT 2) [251]. Anthocyanins that are absorbed in the GI tract 
are mainly found as methylated, sulphated or glucuronidated forms but also as intact glycosides in very low 
concentrations in biological fluids such as blood (plasma) and urine (10 to 2000 nM) [48]. Even though 
bioavailability of intact anthocyanins in the body is reportedly low, a considerable amount of (food) matrix-
bound anthocyanins can reach the large intestine and the colon. Here they undergo further intensive metabolism 
and degradation and are absorbed into the blood stream, with some of the subsequent metabolites showing 
potential to be more biologically active than the intact anthocyanins [48, 252]. The recent interest in the gut 
microbiota and its role in human health has implications for furthering the understanding of the effect of 
anthocyanins on gut microbiota, and subsequent health benefits [253].  
 
The gut microbiota, which is the microbe population living in the intestine, contain tens of trillions of 
microorganisms, and is made up of at least 1000 different species of identified bacteria [254]. The majority of 
the bacteria in the gut are categorised under seven phyla, namely Firmicutes, Bacteroidetes, Proteobacteria, 
Fusobacteria, Verrucomicrobia, Cyanobacteria and Actinobacteria with the Firmicutes and Bacteroidetes phyla 
making up over 90% of the human gut microbiota [255, 256]. Some of the essential functions of the gut 
microbiota include vitamin production, regulation of lipid metabolism, short chain fatty acid production as fuel 
for epithelial cells and regulation of gene expression [257] as well as an important functional role in the  gut-
brain axis relationship [258]. A heathy gut, which comprises of effective digestion and absorption of food, 
absence of GI illness, normal and stable intestinal microbiota, and effective immune status, is required in order 
to sustain a host homeostasis [259]. Irregularities and imbalances in the microbiota at different ages have been 
linked to different diseases and metabolic conditions across the lifespan, ranging from allergies in young infants 
to Inflammatory Bowel Disease in young adults [260]. Research on the gut microbiota continues to shed light on 
the health effects of changes to the gut microbiota modulated by diet. 
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Different techniques have been described for the determination of gut microbiota. Advancement in the 
taxonomical composition of the gut microbiota was limited until the 21st century due to bacteriological culture 
being the only method available to determine its composition. Even to date, only about 30% of the gut 
microbiota has been cultured [255]. Further understanding of the human gut has been improved by advanced 
techniques independent of bacteriological culture. Prior to these advancements, culture and biochemical typing 
were the gold standards for identification of bacteria species but have now been overtaken by methods that are 
able to produce a more representative information of the overall microbiota [261]. Examples of some of these 
techniques are sequencing of the 16S rRNA gene or its amplicons, fluorescence in situ hybridization (FISH), 
quantitative polymerase chain reaction (qPCR), denaturing gradient gel electrophoresis (DGGE) and terminal 
restriction fragment length polymorphism (T-RFLP). With these methods researchers are able to obtain 
qualitative and quantitative information on the diversity of the gut microbiota, as well as detect changes in the 
gut microbiota in relation to an intervention or disease [262]. Improved scientific methods of gut microbiota 
determination have also presented the issue of suitability of the different techniques used, and how the results 
can be compared to one another. 
 
Alterations of the gut microbiota have been shown to induce and promote or reduce the risk of chronic diseases. 
This hypothetical mechanism has been applied to the field of obesity and obesity-related non-alcoholic fatty 
liver disease in relation to both prebiotics / probiotics [263, 264]  and anthocyanins [265] as gut modifiers. With 
this question in mind, given this rapidly advancing area of research in gut health, a systematic literature review 
has been undertaken to summarise the current evidence on the effect of anthocyanins on the gut microbiota. The 
included studies are also assessed for the different techniques used in microbiota determination. It is 
hypothesised that supplementation of the diet with anthocyanin rich foods promotes the proliferation of healthy 
anaerobic bacterial populations, while inhibiting the pathogenic species, as evidenced using a range of gut 
microbiota determination techniques. 
 
4.1.2 Methods 
 
A systematic literature review was conducted according to recommendations of the PRISMA (Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses) statement and checklist [110] (Figure 4-1).  
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Scientific databases including Scopus, PubMed, ScienceDirect, Web of Science, and MEDLINE were searched 
up to June 2017. A combination of search terms with truncations included the following keywords: 
anthocyanins and gut microbiota or colon microbiota (see Appendix B for search strategy). The review was 
registered on PROSPERO (International prospective register of systematic reviews) as CRD42017073750 [266]. 
Eligibility criteria for included studies (Table 4-2): 
1. carried out either in vitro, on animal or conducted in human subjects; 
2. quantified the effect of anthocyanin on gut microbial population and described the method used; 
3. utilised anthocyanin extracts or anthocyanin-rich foods with anthocyanin (individual compounds or 
total) content measured and stated; 
4. assessed changes in gut microbiota associated to anthocyanin metabolism in the gut; 
5. reported in the English language for reasons of time efficiency and cost of translation not being feasible 
for this review. 
 
Exclusion criteria 
Studies were excluded if: 
1. they measured the stability of anthocyanins in the gut without quantifying effects on gut microbial 
population; 
2. there was no measure of anthocyanin content in food/beverage source. One study [267] met this criteria 
but was included because anthocyanin content was measured indirectly through the use of anthocyanin 
metabolites in the urine and was the only included clinical trial; 
3. they measured total polyphenols or flavonoids in general and not specifically the subclass of 
anthocyanins. 
Review articles were excluded from the search but were considered for hand searching. Hand searching of 
reference lists was undertaken for all included studies and review articles. All selected abstracts and citations 
were exported from the scientific databases to the reference management software ENDNOTE X7 (Thompson 
Reuters, New York, NY, USA). Following extraction and selection of publications according to the above 
eligibility criteria a tabular summary was developed for this review which included the population, design, 
intervention, anthocyanin dosage, health outcomes and results.  
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Figure 4-1 PRISMA flowchart for study selection  
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4.1.3 Results 
 
The database searches returned 542 articles and one additional study was identified through hand searching of 
reference lists. Following removal of duplicates and screening of records, 28 full text articles were evaluated 
and only six studies were eligible and therefore included in the review using the PICOS criteria [268] (Figure 4-
1). The included studies are summarised in Table 4-3 and briefly described below. 
 
4.1.3.1 In vitro studies 
Three in vitro studies were included in this review. Anthocyanins were tested individually or in a mixture, in the 
case of enocianin, a commercial food colouring from Vitis Vinifera grape peel which contains a mixture of 
anthocyanins including malvidin-3-glucoside (200 mg/L and 20 mg/L respectively), delphinidin-3-glucoside (60 
mg/L and 6mg/L respectively), petunidin-3-glucoside (85 mg/L and 8.5 mg/L respectively), peonidin-3-
glucoside (traces), and cyanidin-3-glucoside (traces). With high and low concentrations reflecting different 
levels of intake, anthocyanins showed proliferative effects on beneficial bacterial populations and inhibitory 
effects on pathogenic species. Incubation of malvidin-3-glucoside with human faecal slurry at 0 (control), 5, 10 
and 24 h, showed a significant, (p<0.05), increase in total bacteria at 24h. Significant proliferative effects were 
also observed in the bacteria species with beneficial effects such as Bifidobacterium spp. and Lactobacillus spp. 
known for their wide use in probiotics and for the treatment of ulcerative colitis, Irritable Bowel Syndrome 
(IBS) and constipation [269]. A reduction, although not statistically significant, was observed in the potentially 
harmful Clostridium histolyticum following 24 h incubation. For enocianin, a statistically significant increase 
(p<0.05) was observed in Lactobacillus spp. and Bifidobacterium spp. following all incubation durations. 
Bacterial levels were significantly higher than those observed with maldivin-3-glucoside, however, no 
significant change was observed in C.coccoides- Eubacterium rectale group which are known for the critical 
roles they play in immune homeostasis [270] or the pathogenic C. histolycum group [271].  
Similar effects have also been observed with purple sweet potato anthocyanin extracts (cyanidins and 
pelargonidin based anthocyanins) using faecal samples. Following fermentation at 0, 6, 12, and 24 h, a 
significant increase (p<0.05) was observed for the total bacterial count. In comparison to the control medium, a 
steady increase was observed in the numbers of the Bifidobacterium spp. following incubation with purple sweet 
potato anthocyanins while a significant increase was observed in the bacterial population of 
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Lactobacillus/Enterococcus spp. On the contrary, the control media had a steady increase in the Bacteroides-
Prevotella and Clostridium histolycum during fermentation, whereas in the media containing anthocyanins, 
levels were significantly reduced (p<0.05).[272]  
On the release, metabolism, and effect on gut microbial growth of cyclodextrin encapsulated anthocyanins 
(cyanidin-3-glucoside, delphinidin-3-glucoside and malvidin-3-glucoside) on faecal slurry, between 0 and 24h, 
malvidin-3-glucoside showed no significant effect on the population of Bifidobacterium spp., Clostridium 
coccoides/Eubacterium rectale group, Lactobacillus/Enterococcus spp., C. histolycum group, bacteroides spp., 
or Clostridium cluster IX. However, a significant increase was observed for the members of the domain 
Bacteria (EUBmix probe). Cyanidin-3-glucoside and delphinidin-3-glucoside on the other hand showed a 
significant (p<0.05) inhibition of the C. histolycum group [273]. 
All three in vitro studies utilised the FISH technique for enumeration of bacterial populations. 
 
4.1.3.2 Animal studies 
 
Using six different berries (blackberry, blackcurrant, black raspberry, blueberry, Concord grape, and maqui 
berry) with structurally diverse anthocyanin profiles, Overall et. al. (2017) [274] supplemented the diets in a 
mouse model of polygenic obesity. Anthocyanins from these individual berries was normalised to 400µg/g food 
of total anthocyanins and supplemented with animal chow for each berry category. Six-week old mice were fed 
LFD (Low-fat diet) or HFD (High-fat diet) for six weeks to initiate the development of obesity in the HFD 
animals. Thereafter, the HFD animal group were randomised to different berry supplemented diets for a further 
12 weeks. Faecal samples were collected from the cages, weighed, and pooled at different time points (weeks 4, 
8, 9 and 12) and analysed at the end of the study. Using quantitative real-time PCR, analysis of the bacterial 
phyla relative abundance in the faecal samples showed that berry supplementation with blackberry and black 
raspberry did not change the gut microbial population shift that was observed with either LFD or HFD. 
Supplementation with Concord grape showed a significant increase of the Actinobacterial populations from 2% 
to 8% in comparison to HFD controls which were similar in kcal/g but without anthocyanin supplementation. 
Blueberry and blackcurrant supplementation also showed a significant increase in the populations of obligate 
anaerobes Bacteroidetes from 7% to 10%-12% and Actinobacteria from 2% to 9%-15% which are some of the 
bacteria species beneficial to humans. Translating the anthocyanin consumption in these animal studies to the 
 
 
98 
 
human context , the authors suggested it was equivalent to consuming 2.4 mg/kg/day or 145 mg/day of total 
anthocyanins for an average adult [275] which could be achieved by daily consumption of 1–2 servings of fresh 
anthocyanin-rich berries [276]. 
Similarly, Lacombe et. al. (2013) [277] examined the effect of dietary supplementation of lowbush wild 
blueberries (LWB) on the colonic microbial population of Sprague Dawley rats. Following control diets or 
LWB-supplemented diets for six weeks, analysis of the colon contents of the rats using shotgun sequencing 
showed a significant reduction in the relative abundance of the genera Lactobacillus and Enterococcus 
associated with the berry intervention. There was also a significant (p<0.05) two-fold increase in the relative 
abundance of Bifidobacteriaceae and Coriobacteriacaea and the phylum to which they belong, Actinobacteria, in 
the LWB-supplemented group.  
 
4.1.3.3 Human clinical trials 
 
A randomised crossover clinical trial tested the association between changes in faecal microbiota following 
wine interventions. Nine male participants were randomized to receive daily 275 mL of alcoholised red wine or 
dealcoholized red wine or 100mL of gin for 20 days. Participants’ usual baseline dietary habits and pattern and 
lifestyle were maintained, and additional alcoholic beverages were avoided for the duration of the study. At 
baseline, and following each intervention period, faecal samples were collected from participants. No significant 
differences in daily energy and dietary intake were observed between baseline and after each intervention. 
Quantification of the microbial content of faecal samples was done using quantitative real-time PCR. Results 
showed that in comparison to gin, both red wine and dealcoholized red wine significantly (p = 0.001) increased 
the faecal concentration of Bifidobacterium, Enterococcus and Eggerthella lenta. Although the anthocyanin 
content of the red wine intervention used in this study was not measured prior, results showed that the lowest to 
the highest changes in Bifidobacteria tertiles was associated with a higher excretion of four phenolic metabolites 
related to anthocyanin metabolism in participants[267].  
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Table 4-1: PICOS criteria for inclusion and exclusion of studies 
 
 
Parameter Inclusion Exclusion 
   
Participants 
 
 
Intervention 
 
 
Comparator 
 
 
 
Outcomes 
 
 
Study design 
Humans, animals and cell 
cultures (In vitro) 
 
Quantified anthocyanins 
 
 
Negative controls or different 
foods/diets/nutrients 
 
 
Changes in gut microbiota 
 
 
Randomised and non-
randomised experiments 
None 
 
 
Other polyphenols or flavonoids 
 
None 
 
 
 
Stability of anthocyanins in the 
gut 
 
None  
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Table 4-2: Summary of studies included in the systematic review 
 
Reference Population/ Sample In vitro / in 
vivo 
Design 
(Intervention/control) 
Anthocyanin Dosage 
mg/100g of food 
(reported dosage) 
Method of 
microbiota 
determination 
Result 
In vitro studies 
 
Hidalgo, et al 
(2012) [271] 
 
 
 
 
 
 
Zhang, et al. 
(2016) [272] 
 
 
 
 
 
Flores, G., et al 
(2015) [273] 
 
 
Animal studies 
Overall, et al. 
(2017) [274] 
 
 
 
 
Lacombe, et al 
(2013) [277] 
 
 
 
 
pH-controlled, stirred, 
batch-culture 
fermentation system 
reflective or 
mimicking of the 
distal human large 
intestine conditions  
 
Fresh faecal samples 
from 8 healthy 
volunteers (25-30y) 
 
 
 
 
Fresh faecal samples 
from 3 healthy 
volunteers 
 
 
Seventy-six 6-wk old 
male mice/ faecal 
sample (cage 
collected) 
 
 
Nine males, three-
week old Sprague-
Dawley/ colon content 
samples (faeces)  
 
 
In vitro 
 
 
 
 
 
 
 
In vitro  
 
 
 
 
 
 
In vitro  
 
 
 
 
In vivo 
(Animal 
study) 
 
 
 
In vivo 
(Animal 
study). 
 
 
 
Enocianin- commercial 
food colouring from Vitis 
Vinifera grape peel 
anthocyanin-rich extract / 
malvidin-3-glucoside 
(individual anthocyanin) 
 
 
Purple sweet potato 
anthocyanins / 
Fructooligosaccharide 
(FOS) (prebiotic) 
 
 
 
Individual anthocyanins / 
a negative control (w/out 
anthocyanins) 
 
 
Berry supplementation / 
High fat diet (without 
berry supplementation) 
 
 
 
Blueberry-enriched diet, 
(AIN93+8% w/w 
Lowbush Wild Blueberry 
powder 
 
 
34.5 mg (345mg/L) 
 
 
 
 
 
 
 
706mg (7.06mg/g) 
treatment: 1% (w/v) 
 
 
 
 
 
2mg (20mg/L) 
 
 
 
 
0.04mg 
(1.14mg/mouse/day)  
 
 
 
 
(24.06 ± 5.2mg/day) 
 
 
 
 
 
Fluorescent in 
situ 
hybridization 
(FISH) 
 
 
 
 
Fluorescent in 
situ 
hybridization 
(FISH) 
 
 
 
Fluorescent in 
situ 
hybridization 
(FISH) 
 
Quantitative 
real-time 
PCR 
 
 
 
Microbiome 
shotgun 
sequencing 
 
 
 
Anthocyanins significantly enhanced the 
growth of Bifidobacterium spp. and 
Lactobacillus-Enterococcus spp. This 
increased proliferation was higher after 
enocianin treatment. p<0.005 
 
 
 
Purple sweet potato anthocyanins induced 
proliferation of Bifidobacterium and 
Lactobacillus/Enterococcus spp. and inhibited 
the growth of Bacteroides-Prevotella and 
Clostridium histolyticum. They did not affect 
the total bacteria count. 
 
Significant growth of the domain Bacteria 
and slight inhibition of the Clostridium 
histolyticum group 
 
 
Significant increase in obligate anaerobic 
bacterial and Actinobacteria population in 
the gut (relative abundance). 
 
 
Significant increase in the relative 
abundance of Actinomycetales, and several 
novel genera under the family 
Bifidobacteriaceae and Coriobacteriaceae 
and significant reduction in the relative 
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Reference Population/ Sample In vitro / in 
vivo 
Design 
(Intervention/control) 
Anthocyanin Dosage 
mg/100g of food 
(reported dosage) 
Method of 
microbiota 
determination 
Result 
 
 
 
 
 
Human clinical 
trial 
Boto-Ordóñez, 
et al (2014) 
[267] 
 
 
 
 
 
 
 
 
 
9 adult men (45-50y)/ 
fresh faecal samples  
 
 
 
 
 
 
 
 
 
 
In vivo 
(Randomised 
crossover-
controlled 
trial (3 
consecutive 
periods of 20 
days each)) 
 
 
substituting for dextrose) 
/ Control diet (AIN93) 
without blueberry 
supplementation for 6 
weeks 
 
 
Randomised crossover-
controlled trial (3 
consecutive periods of 20 
days each); 
Red wine (RW)/ 
dealcoholized red wine 
(d-RW) / gin 
 
 
 
 
 
 
 
9.72mg in RW and d-
RW/ nd in gin (272mL 
(26.44mg 
anthocyanin)) 
 
 
 
 
 
 
 
 
 
Quantitative 
real-time 
PCR 
 
abundance of Lactobacillus and 
Enterococcus. 
 
 
 
 
 
Significant change in bacteria species 
(Bifidobacterium, enterococcus, and 
eggerthella lenta) concentration following 
RW and d-RW intervention (p<0.001) 
 
RW- Red wine; d-RW-dealcoholized red wine; nd-not detectable
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4.1.4 Discussion 
 
Findings from this systematic review support the hypothesis that consumption of foods high in 
anthocyanins promotes the proliferation of healthy anaerobic bacterial populations, while inhibiting the 
pathogenic species. Specifically, the presence of anthocyanins significantly increased the microbial 
population of Bifidobacterium spp. and Lactobacillus-Enterococcus spp. This observation was consistent in 
in vitro, animal and human studies [267, 271, 272, 277]. These gram-positive bacteria species have been 
shown to exert beneficial effects in the treatment of diarrhoea and other specific diseases including 
inflammatory bowel disease (IBD), necrotizing enterocolitis and colorectal cancer [278].  
 
A number of factors including diet, age and antibiotics are important determinants of the gut microbiota 
profile, and the influence of these factors continue to change throughout the lifetime [279]. The most 
significant of these factors is diet. In relation to anthocyanin consumption, a diet rich in fruit and 
vegetables has been shown to significantly alter the gut microbiota. Included studies showed that 
anthocyanins have proliferative and inhibitory effects on bacteria species. However, some studies have not 
observed increases in total microbial populations when samples were incubated with anthocyanins. Zhang, 
et al. (2016) [272] suggested that anthocyanins contained in purple sweet potatoes, including anthocyanin 
monomers, may enhance both inhibition and proliferation of different bacteria species at similar rates and 
thereby not affect total overall bacteria count. In addition Flores et al (2015) [273] attributed this to the 
amount of anthocyanin used in their intervention study (20mg/L of batch culture) which could have been 
too low to exert any significant effects. Contrary to these observations, with higher concentration 
(200mg/L) of anthocyanins, Hidalgo et. al. (2012) [271] observed a significant (p<0.05) proliferative and 
inhibitive effect in microbiota population which was more evident in samples that were supplemented with 
a mixture of anthocyanins showing the synergistic effect of anthocyanin subclasses. Another possibility is 
that the observed simultaneous proliferative effect on the beneficial bacteria and inhibitory effect on 
harmful bacteria by anthocyanins could explain the absence of any significant change in total bacterial 
population as there exists a natural balance between beneficial and harmful bacteria in the gut [280]. 
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Even though observations in in vitro models may not be extrapolated to in vivo systems, comparison of 
composition and concentration of anthocyanins across studies which had a significant effect on gut 
microbiota showed that lower concentrations with a variety of anthocyanins (Malvidin-, delphinidin-, 
petunidin-, peonidin- and cyanidin-glycosides) [271] had as much effect as higher concentration with only 
one class of anthocyanins (cyanidins glycosides) [272]. Although anthocyanins were not the highest 
concentration of flavonoids or polyphenols in wine [267], it is important to note that anthocyanins, not 
other polyphenols, was associated with the increased level of Bifidobacteria in faecal samples. This was 
due to the observed increase in microbial metabolites in urine presumably derived from anthocyanins. The 
anthocyanin content of all interventions used in the included studies was determined using High 
Performance Liquid chromatography (HPLC) coupled to different detectors. HPLC has been identified as 
the most reliable method of measuring total anthocyanin content as well as individual anthocyanins in 
foods and biological matrices in comparison to the colorimetric method that measures only total 
anthocyanins [281].  
 
With these observed beneficial effects, the exact mechanism of action of anthocyanins in the gut remains 
unclear. Overall et. al., (2017) [274] observed an increased oxygen tension in all gut compartments 
associated with high-fat diets which was attenuated by supplementing the diet with berries and berry 
anthocyanins. As a result, they suggested anthocyanins may reduce oxygen tension in the gut lumen and 
therefore promote the proliferation of oxygen-sensitive bacterial population. However, in the small 
intestine, there exists high level of oxygen which limits bacterial growth, such that only fast growing, 
facultative anaerobes with the ability to bind to epithelial/mucus are believed to survive [282]. This 
highlights the difference in microbiota composition along the lower GI tract and an important consideration 
in sampling. 
 
On the issue of sampling, all the studies, but one, included in this review utilised faecal samples for the 
quantification of anthocyanin effects on gut microbiota. In place of faecal samples, rectal mucosal biopsy 
has been proposed as a better alternative in gut microbiota research in terms of assessment but not 
participant burden [283]. Durbán et al. (2011) [284]  did a comparative study on the bacterial community 
composition between faecal samples and rectal mucosal biopsies. Samples were collected from an un-
prepped healthy population. Comparison of the two samples showed a significant difference in the bacterial 
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diversity between faecal and rectal mucosal samples from the same participant. Another study compared 
healthy subjects to IBS subjects, where they observed that there was a reduction in bacterial abundance and 
diversity in mucosal samples in comparison to stool samples from the same participants [285]. There is a 
possibility that significant differences exist in the microbial community across the six major subdivisions 
of the human colon (cecum, ascending colon, transverse colon, descending colon, sigmoid colon, and 
rectum). However, the degree to which composition and functions differ remain unclear. Studying the 
microbial diversity of the human colon, Eckburg et. al. (2005) [255] observed significant inter-individual 
variability and differences between faecal and mucosa community composition. This discrepancy 
highlights the importance of sampling sites and raises the suggestion that rectal mucosal biopsy samples 
are more appropriate than faecal samples and should be used instead or together with faecal samples [262]. 
Regardless, faecal samples are still preferred over rectal mucosa biopsy due to ease of collection and being 
less invasive. 
 
Another important consideration in gut microbiota research is the methods of determination and 
quantification. Although bacterial culture, which was the gold standard in the past, is inexpensive, it 
produces a limited representation of the gut microbiota diversity and results in undervaluation of real 
changes. Culture independent techniques have become popular and are now the most commonly used 
techniques [286]. Most of the different culture independent techniques are based on the analysis of the 
16rRNA gene. The 16rRNA genes are highly protected across bacterial species. They also have distinctive 
characteristics that allows for identification of different species. [262]. Studies included in this review 
employed different techniques including the Fluorescence in situ hybridization (FISH), quantitative 
polymerase chain reaction (qPCR) and shotgun sequencing in the determination and quantification of the 
gut microbiota. These techniques have different pros and cons. The qPCR for example, although fast, is 
unable to identify unknown species and has an amplification bias in that the primer set used in multi-
template PCR is required to have a shared sequence across the targets. As often is the case, this shared 
sequence is absent in the targets. When a primer has one incongruity with some targets, the amplification 
efficiency is significantly reduced and as a result, a large bias in the amplification will occur [287]. Even 
though the FISH technique has no PCR bias, it is dependent on probe sequences which mean that it is also 
unable to identify unknown species. The shotgun sequencing on the other hand, although more adequate 
than the aforementioned techniques, is expensive and analysis of data involves a complex software [262]. 
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The major limitation of the PCR and FISH methods in comparison to the shotgun sequencing is their 
inability to identify unknown species. This limitation does not seem to have affected study results as 
changes in bacteria species were measured with already known species, hence addressing this limitation. 
The availability of various methods requires deciding the suitability of a given methodology in gut 
microbiota research. This decision will be dependent on the depth of analysis. So far, the shotgun 
sequencing techniques produces the most potent data including projections of microbiota function [262]. 
Although a comparative study of 16S amplicon and shotgun sequencing on water samples found that less 
than 50% of phyla identified via 16S amplicon sequencing were recovered from shotgun sequencing while 
also identifying ~27% more families [288]. 
 
A notable strength of this systematic review is the side by side comparison of different methods of 
microbiota determination as well as effects of anthocyanins. At the time of writing this article, to our 
knowledge, this systematic review is the first to determine the effect of anthocyanins on gut microbiota, 
while comparing different methods of microbiota determination. Another possible strength is the specific 
focus on anthocyanins and their effect on gut microbiota. The synergistic effect of compounds in food 
(nutrients) presents some difficulty in clearly defining causal association in epidemiological research. It is 
important to note that the presence of procyanidin polymers in anthocyanin containing foods such as 
berries and some nuts may also contribute to some of the reported microbiome activity [289]. Procyanidin 
polymers act as microbial substrates similar to anthocyanins; as a result, synergy might explain some of the 
observed effects. However, there is limited evidence on the absorption and metabolism of procyanidins due 
to their polymeric nature and high structural complexity which further limit the plausible explanation of 
their mechanism of action in health [289]. Although nutrients are not consumed in isolation, determining 
the specific effects of particular nutrients is an important aspect of nutrition research.  
 
As an emerging area of research in the last decade, there are very few in vitro and animal studies and even 
fewer clinical trials that have been carried out. Consequently, there are limitations in the comparison of 
results and generalisation of conclusions due in part to the diverse sources of anthocyanins, methods of gut 
microbiota determination and quantification as well as the possibility of synergistic effects of anthocyanins 
and/with other phytochemicals and nutrients present in the food sources resulting in the observed benefits. 
Another notable limitation of this review is the different control diets/samples used which restricts the 
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generalisation of results. Although a limitation, it is important to note that these controlled samples/diets all 
had in common the absence of anthocyanins demonstrating the modulatory effects of these natural plant 
pigments. 
 
 
4.1.5 Conclusion 
 
In conclusion, research on the gut (microbiota) as a metabolic organ is still emerging and characterisation 
of bacteria species present in the gut is ongoing. Results from this review observed beneficial effects such 
as significant proliferative effect on Bifidobacterium spp., known for their wide use in probiotics and for 
the treatment of Irritable Bowel Syndrome and inhibition of Clostridium histolyticum, which have been 
shown to be pathogenic in humans.  Research on the possible effect of anthocyanins on gut microbiota 
population is still in its early stages and conclusions and generalisations cannot be made due to the limited 
evidence base and varied techniques employed in studies. This is also due to differences in anthocyanin 
sources, composition, digestive stability, metabolism and biotransformation of anthocyanins in either a 
food matrix or supplement isolated. This also makes it difficult to understand or elucidate the exact 
mechanism by which anthocyanins may exert these effects. Therefore, the complete effect and exact mode 
of action of anthocyanins on gut microbiota needs more research clarification through well-designed 
human clinical trials. Further research is required to reach a consensus on anthocyanin dose and form, as 
well as using a uniform approach to control intervention and background diets. In addition, it is imperative 
to advance the understanding of the direct or indirect beneficial effects of anthocyanins on bacterial growth 
through research. An important consideration would be to measure concurrently these observed effects on 
gut microbiota, as well as other health effects, for example vascular function (BP) and cognition to further 
understand complex in vivo processes such as the gut-brain axis relationship. Determination of key 
techniques to measure [290] and confirm these findings is also vital in this field. 
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5 CHAPTER 5 
 
5.1 EFFECT OF CONSUMPTION OF FRUIT ANTHOCYANINS ON 
BLOOD PRESSURE, COGNITION AND GUT MICROBIOTA 
POPULATION IN OLDER ADULTS OVER 8 WEEKS 
 
 
This chapter describes an 8-week randomised clinical crossover trial that was conducted to determine the 
effect and within subject variance on cognition and 24hr ambulatory blood pressure in older adults without 
cognitive impairment (55+ years) following daily consumption of 200mL QGPJ (approx. 50mg/L 
anthocyanin/day) or raspberry cordial (control). Secondary outcomes included inflammatory markers (C-
reactive protein), Brain derived neurotrophic factor (BDNF), changes in anthropometrics and physical 
function, and gut microbiota (16S rRNA gene sequencing). Twenty-eight participants (55+ years) were 
recruited and over 5 clinic visits, data were collected on all outlined parameters. Each study arm lasted for 
8 weeks with a 4-week washout period. Order of assignment to intervention arm was randomly allocated. 
Cognition, BP and urine samples were measured at every visit while blood samples and faecal samples 
were collected at baseline, end of 1st arm and end of 2nd arm. Across treatment periods, no significant 
difference was observed on the different domains of cognition measured, blood pressure nor anti-
inflammatory biomarkers. No intervention effect was found for genera or classes of gut microbes, but there 
was a trend towards significance in total bacterial count between the control arm and the intervention arm 
(P= 0.06). In this group of healthy older adults, anthocyanins provided from QGPJ did not have any 
significant effects on cognition, blood pressure and other measured parameters but may have an effect on 
gut microbiota population. Although results from the acute study (Chapter 3) are not comparable to this 
study based on experimental design (acute vs chronic intervention), it is important to note that the 
anthocyanin concentration of the QGPJ utilised for this study was considerably lower than that used for the 
acute study (263mg/100mL vs 50mg/L). This could have been due to seasonal variations, as well as 
processing and storage conditions. 
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5.1.1 Introduction 
 
As scientific evidence emerges showing that anthocyanins are more bioavailable than originally perceived 
[243], the colon has become an emerging area of research as an active site for further metabolism of 
ingested anthocyanins  [253]. Some of the subsequent anthocyanin metabolites are believed to be more 
biologically active than intact anthocyanins [48, 252] and are possibly responsible for some of the observed 
beneficial effects on cognition (gut-brain axis) and vascular function (blood pressure). Research on the 
colonic metabolism of anthocyanins has been faced with limitations, including the wide inter-individual 
variability in the metabolic fate of anthocyanins. This poses the largest methodological challenge thus far 
in determining the health effects associated with anthocyanin consumption [207]. Absorption of 
anthocyanins in the upper gastrointestinal tract is very low, possibly due to their digestive stability and 
binding interaction within the food-matrix [291]. As a result, a considerable amount of intact anthocyanins 
can reach the intestinal microbiota which cleave conjugated moieties, resulting in aglycones. These 
aglycones undergo ring fission to produce low molecular metabolites including phenolic acids and 
hydroxycinnamates which are then reabsorbed into the bloodstream where they are biologically active [44, 
292]. Evidence from in vitro studies suggest that bacterial metabolism of anthocyanins in the colon 
involves the cleavage of glycosidic linkages and the breakdown of the anthocyanidin heterocycle [252, 
293]. 
 
The field of research related to the influence of the gut microbiota on a large array of chronic diseases 
including obesity and type 2 diabetes mellitus [294], IBD [295], IBS [296] and allergies [297], has 
increased exponentially in recent years. The gut microbiota profile is also known to possess an important 
functional role in metabolism, immunity and maintenance of a healthy human gut [298] as well as in 
regulating the gut-brain axis [258]. The gut-brain axis (GBA) involves a two-way communication between 
the central and the enteric nervous system that links emotional and cognitive centres of the brain, with 
peripheral intestinal functions. It has been shown that even though intact anthocyanins possess protective 
health effects, their further metabolism and absorption in the colon leads to the generation of bioactive 
metabolites. In turn, these metabolites also regulate the growth of specific beneficial bacteria in the 
intestinal microbiota. An example is an observed increase in the concentration of faecal Bifidobacterium as 
a result of anthocyanin microbial metabolites following anthocyanin supplementation [267]. Bifidobacteria 
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are gram-positive, polymorphic rod-shaped bacteria normally found in the gastro-intestinal tract of humans 
and animals [299]. In healthy breastfed babies these bacteria are the dominant microbial group and their 
levels remain relatively stable, tending to decrease with advancing age when bacteria belonging to 
Bacteroidetes and Firmicutes phyla are more dominant in adulthood [300]. In recent years, this microbial 
genus has been studied extensively due to both its important role within the human intestinal microbiota 
and the widespread use of Bifidobacterium strains in probiotic food products.  
 
With the gut now considered as an important metabolic site for anthocyanins, as well as other nutrients, 
there is a better understanding of the potential mechanism of action of anthocyanins and the significant role 
of the gut microbiota in this process. In acute and longer term studies, anthocyanins have been shown to 
have significant clinical benefits on different domains of cognition [201] and blood pressure [61, 301].  
These effects have been observed in studies using different dietary sources of anthocyanins [201], and in 
individuals with mild to moderate cognitive impairment [201] and hypertension [248]. However, 
information in non-cognitively impaired older adults is limited and the current 8-week randomised 
controlled trial was designed to address this gap. 
 
The design of this trial was informed by the synthesis of current evidence as reported in the systematic 
literature reviews (Chapters 2 and 4) in this thesis, as well as results from our acute dose-timing trial 
(Chapter 3). There was limited evidence on the longer-term clinical effects of anthocyanins in healthy older 
adults and even less clinical trial evidence on anthocyanin effect on gut microbiota. As a result, the aim of 
this trial was to determine the effect, and within subject variance, on primary measures of cognition and 
ambulatory blood pressure in healthy older adults following a daily consumption of QGPJ or a control 
beverage. Changes in the gut microbiota during the trial were also measured, in order to better understand 
the mechanism of clinical effects. This study hypothesised that consumption of QGPJ for 8 weeks would 
have significant positive effects on cognitive function and BP, compared to a control cordial. 
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5.1.2 Methods  
 
This study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all 
procedures involving human subjects were approved by the University of Wollongong (UOW) Human 
Research Ethics Committee, New South Wales, Australia (HE16/278). This study was registered with the 
Australian New Zealand Clinical Trials Registry (ACTRN12617000220369). Written informed consent 
was obtained from all eligible participants. 
 
Study design 
A randomised, crossover clinical trial ran for a period of twenty weeks. Participants were randomly 
allocated to one of two arms (8 weeks on each with a washout period of 4 weeks). The intervention arm 
received QGPJ and the control arm received Raspberry cordial, with similar vitamin C content (Table 5-1).  
Participants were advised to consume 200mL per day (1 bottle) of the provided beverage for the duration 
of the study. The duration of the trial was based on a previous trial by members of the research team using 
high anthocyanin cherry juice [61] which detected changes in measured variables as early as 6 weeks. 
 
In comparison to the acute study where a single dose of 300mL was administered, a dose of 200mL was 
used in this longer term crossover study as consumption was for 8 weeks and 200mL per day was deemed 
to be a feasible amount that would encourage compliance for the intervention period [61, 302]. A smaller 
quantity of anthocyanins provided in the reduced quantity of juice will potentially allow translation to 
habitual dietary intakes and facilitate practical dietary messaging. 
 
Sample size and inclusion criteria 
The sample size for this study was calculated using GPower [303]. Our pilot study as well as a similar 
previous study [61] found effects of anthocyanin supplementation on blood pressure and memory of a 
moderate size therefore the aim of this study was to detect a moderate effect of 0.3. To obtain a power of 
0.90, n = 30 participants are needed, which includes 10% expected dropout. The cross-over design allows 
each participant to act as their own control, thus improving power of the study. 
Based on sample size calculation, participants aged 55 years and above were recruited. Exclusion criteria 
included individuals with: 
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1. Uncontrolled hypertension; 
2. Type 2 diabetes mellitus; 
3. Any unstable physical or mental health condition including dementia that might confound results; 
4. Inability to provide informed consent; 
5. Inability to communicate in the English language. 
Uncontrolled hypertension, Type II diabetes miletus and any unstable physical or mental health condition 
were not directly assessed at pre-screening interview, but participants were asked about their last regular 
medical check-up sessions and whether they had been diagnosed with any of the above prior to enrolment. 
 
Table 5-1: Nutrient composition of the two study beverages 
 
  
QGPJ (per 100mL)a 
 
 
Raspberry cordial (per 100mL)c 
 
Anthocyanins 
 
Energy (kj) 
 
Protein (g) 
 
Total fat (g) 
 
Total carbohydrate (g) 
 
Sugars (g) 
 
Dietary fibre (g) 
 
Sodium (mg) 
 
Vitamin C (µg) 
 
 
5b 
 
213 
 
1.1 
 
0.1 
 
6.4 
 
8.7 
 
<0.1 
 
4.8 
 
<0.05 
 
- 
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0 
 
0 
 
6.5 
 
6.5 
 
<0.1a 
 
4 
 
<0.05a 
aData from Santhakumar et. al. (2015)[85]; bAnalysed by University of Wollongong and University of 
Queensland Chemistry laboratories;  cNutrient content from label. 
 
 
Study Procedure 
The QGPJ was donated by Nutrafruit Pty Ltd., while the cordial control beverage (Golden Circle 
Raspberry cordial) was purchased from a major supermarket chain at a single time-point. The QGPJ was 
supplied in 20L containers frozen at -20oC. It was stored frozen in -20oC freezer for about 8 months prior to 
the start of the study. At the start of the trial, the plum juice was thawed (in the refrigerator), bottled in 
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unmarked 200mL plastic containers and frozen again at -20oC to be delivered to participants. The juice was 
obtained from two seasonal batches of processing and combined to provide uniform anthocyanin 
composition for all participants. The juice variant was analysed by two laboratories for anthocyanin content 
using the colorimetric analysis method (University of Wollongong) and the HPLC method (University of 
Queensland). 
 
A random allocation schedule prepared by an independent statistician was used to assign participants to 
either arm. Researchers were blinded to the allocation but due to taste and physical differences, participants 
were able to determine that there was a difference between the beverages. Participants were required to 
consume one 200mL bottle of juice daily (approx. 50mg/L) and compliance was recorded from 
unconsumed returned juice bottles every fortnight. An independent research assistant packed the 
appropriate beverage in a labelled sealable cooler bag to be delivered to participants’ home on a fortnightly 
basis. No change to regular diet was advised and dietary intake was assessed using estimated 3-day food 
diaries and 24-h diet recall questionnaires. 
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Figure 5-1: Study design 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data collection 
The primary outcome measure was change from baseline in blood pressure parameters (SBP, DBP, MAP, 
HR and PP) and cognition measured by 5 different cognitive tasks. Secondary outcome measures included 
change from baseline in inflammatory biomarkers in blood samples (BDNF and CRP) and gut microbiota. 
Data collection was performed over 5 visits to the clinical trials research facility: baseline, 4 weeks, 8 
weeks which was the end of arm 1 as well as 4 weeks and 8 weeks of arm 2 after crossover. (Figure 5-2). 
Participants were required to arrive at the research facility after fasting for 10-12 hours for baseline and 8-
week data collection visits which involved collection of fasting blood samples. On clinic days, participants 
were provided with a standardised breakfast (cereal, milk, muffin, and tea/coffee) after blood sample 
collection and before the administration of the battery of cognitive tasks. For the 4-week visits, participants 
had their usual breakfast at home prior to attending the testing facility.  
Randomisation 1st treatment period 
8WEEKS 
Wash-out period 
4WEEKS 
2nd treatment period 
8WEEKS 
Participants 
included 
Raspberry Cordial 
QGP juice 
Raspberry Cordial 
QGP Juice 
Visit 1 
-Consent  
-Demographics 
-PA questionnaire 
-Cognitive function 
tasks  
-Anthropometrics  
-Physical functions 
-Blood sample  
-24-h and spot BP 
-Urine samples 
-Gut sample 
-Dietary intake 
(3DFR) 
 
Visit 2 
-Cognitive function 
tasks  
-Anthropometrics  
-Physical functions 
-24-h and spot BP 
-Urine samples 
-Dietary intake 
(24hDR) 
 
Visit 3 
-Cognitive function 
tasks  
-Anthropometrics  
-Physical functions 
-Blood sample  
-24-h and spot BP 
-Urine samples 
-Gut sample 
-Dietary intake 
(24hDR) 
 
Visit 4 
-Cognitive function 
tasks  
-Anthropometrics  
-Physical functions 
-24-h and spot BP 
-Urine samples 
-Dietary intake 
(24hDR) 
 
Visit 5 
-Cognitive function 
tasks 
-Anthropometrics  
-Physical functions 
-Blood sample  
-24-h and spot BP 
-Urine samples 
-Gut sample 
-Dietary intake 
(24hDR) 
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At the baseline interview, demographic and lifestyle questionnaires were completed by participants. The 
International Physical Activity Questionnaire validated by Hagströmer et al. (2006) [213] was used to 
determine habitual level of physical activity. For dietary data, participants were required to complete a 24-h 
dietary recall questionnaire, as well as a 3-day estimated food record all food and beverages consumed over 
2 weekdays and 1 weekend day. For baseline and follow-up appointments, anthropometric measures 
including weight, height, waist and hip circumference, as well as physical measure (30-second sit-to-stand, 
and grip-strength) were collected.  
 
A battery of five cognitive tests, including The Rey Auditory Verbal Learning test (RAVLT), the verbal 
fluency task, Digit-span backwards task, the Stroop task, and counting span, was carried out to assess 
mental functioning of participants as shown in the table 5-1 below. For each cognitive task, accuracy and 
response time were recorded. Evidence shows that anthocyanins may have protective effects on cognition 
in both acute and chronic conditions. Different studies have utilised different measures to assess these 
effects [201]. Some of these protective effects on cognition have been shown to be more sensitive on 
specific domains of cognition including verbal learning and memory, speed of processing and executive 
function. As a result, specific cognitive tasks targeting these domains were chosen as study instruments 
[236]. 
 
Enrolment, randomisation and retention of participants are described in Figure 5.2 below. Following 
dropouts, data for one participant was excluded from ambulatory blood pressure analysis due to significant 
changes in blood pressure medication and physical activity after completing the first arm of the trial. 
 
Two blood pressure measurements (24h and office) were taken. Twenty-four-hour ambulatory blood 
pressure was taken using Welch Allyn ABPM (Welch Allyn, NSW, Australia; Model 7100) and office BP 
measured according to standard protocols [304] using Welch Allyn Spot Vital Signs LXi DXEmed Com.  
The blood samples collected were spun in a normal centrifuge for 15min at 3000rpm and the serum 
collected in 2mL sterile tubes and stored at -80oC for batch analysis by an independent laboratory (Cardinal 
Bioresearch Pty Ltd.) for BDNF (Brain-derived neurotrophic factor) and CRP levels. Serum BDNF was 
analysed using an R&D Systems Duo ELISA kit. (Intra assay CV 3% and Inter assay CV 4%, Lowest 
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Detectable Dose 5ng/mL) and serum hsCRP was analysed using a BioBase immunoturbidimetric assay. 
The assay was run on a BioBase BK400 chemistry analyser. (Intra assay CV 3.5% and Inter assay CV 5%, 
Lowest Detectable Dose 0.2 ng/mL). 
 
Faecal samples were collected using commercial uBiome™ (San Francisco, USA) gut kits. The uBiome gut 
analysis uses 16S-sequencing on the Illumina Next Generation Sequencing platform that delivers sequence 
data [262]. 16S is a ribosomal gene present in bacterial DNA that enables classification of bacteria at the 
genus level and in addition filters out genetic material from humans and other organisms. Of the three 
bacterial rRNA genes (16S, 5S and 23S), the 16S rRNA gene provides the most tractable combination of 
conserved sites for PCR primers and is therefore preferable to the other rRNA genes for phylogenetic 
identification [262]. This method of sequencing is commonly employed in gut microbiota studies creating 
less heterogeneity in studies for comparison. Trained assessors measured grip strength using a digital Jama 
handgrip dynamometer (Lafayette Instruments, Indiana USA). Participants were seated with their elbow 
bent at 90oC. With a neutral wrist position, the dynamometer handle was held at position II, with the 
dynamometer supported underneath [305] and grip strength recorded for both left and right hands, and 
hand dominance noted. 
 
Urine analysis was conducted in a similar manner as the pilot study (Chapter 3) using a solid-phase 
extraction (SPE) cartridge (Sep-Pak C18, Waters Corporation, Milford, MA, USA) according to Felgines et 
al. (2003) [46] and Netzel et al. (2012) [187]. Briefly, acidified urine samples were thawed and maintained 
for 60 min at room temperature before SPE extraction to obtain the maximal yield of the coloured 
flavylium cations. The SPE cartridge was activated with 10 mL of methanol and equilibrated with 10 mL 
of 12 mM aqueous HCl before use. Subsequently, 5 mL of acidified urine was applied to the equilibrated 
cartridge. The cartridge was then washed with 10 mL of 12 mM aqueous HCl, and anthocyanins were 
eluted with 2 mL of 12 mM HCl in methanol. The extracts were filtered (0.2 µm syringe filters; Palls, 
Cheltenham, VIC, Australia) before UHPLC-PDA-ESI-MS/MS analysis. 
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Figure 5-2: Enrolment, Randomization, and Retention of Study Participants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Washout (4 weeks) 
Cordial (control) 
(200mL/d) 
n = 14 
 
QG Plum Juice 
(200mL/d) 
n = 14 
 
Withdrawn 
n = 1 
1 – Had an accident 
 
Withdrawn 
n = 2 
2 – Illness 
 
Assessed for Eligibility 
N = 42 
 
Randomised 
n = 31 
 
Excluded 
N = 12 
• Not meeting inclusion criteria 
(n=3) 
• Declined to participate (n=6) 
•  Other reasons (n=3) 
 
 
  
 
1st Intervention 
(8 weeks) QG Plum Juice 
(200mL/d) 
n = 16 
 
No Intervention 
n = 14 
 
Completed 
n = 14 
 
2nd Intervention 
(8 weeks) 
Cordial (control) 
(200mL/d) 
n = 15 
 
No intervention 
n = 14 
 
Completed 
n = 14 
 
CROSSOVER 
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Table 5-2: Cognitive tasks description 
 
 
Measurements Application Scoring 
 
The Rey Auditory Verbal 
Learning test (RAVLT) [219] 
 
This test measures verbal 
learning and memory. It 
requires the participant to learn 
a list of words over 5 
presentation-test trial 
sequences. 
 
 
Each correct word that is 
identified is associated with a 
score. This score is added, with 
a higher score indicating 
greater memory capabilities.  
The verbal fluency task [306] This task is a sensitive measure 
of executive dysfunction and 
control processes. The task 
requires the participant to 
produce as many words 
starting with a particular letter 
or category as possible in one 
minute. 
 
This task assigns each word 
that is produced a score of 1. 
This score is added, where a 
higher score indicates high 
executive function. 
Digit-span backwards task 
[307] 
This task requires the 
participant to recall a small set 
of digits in reverse order and 
assesses short-term memory 
storage and executive control 
processes. 
The longer the set of digits that 
are successfully recalled 
implies better memory 
processes.  
 
Stroop task [222] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Counting span [308] 
 
Participants are provided with 
a sheet on which the 
words green, yellow, red, 
and blue are printed (20 in 
total). Each word is shown in 
either congruent or incongruent 
ink colours (e.g., the word 
“blue” printed in red). 
Participants are instructed to 
read out the actual colour and 
not the printed word as quickly 
as possible. This task assesses 
executive function.  
 
 
Participants are presented 
slides with grey and blue 
shapes (squares and circles) 
and are asked to count the 
number of blue circles on each 
slide. After a certain number of 
slides (starting with a span size 
of 2 and going up to 6), 
participants are asked to 
remember the number of 
circles they counted for each 
card, starting with the first card 
and going in order. 
 
The amount of time taken 
(seconds) to complete each set 
of words was recorded. 
 
 
 
 
 
 
 
 
 
 
 
 
The responses are typed into 
free recall boxes. 
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5.1.2.1 Data analysis 
 
Statistical analysis was carried out using Statistical Package for the Social Sciences (SPSS) software 
(version 22.0, Chicago IL, USA). Normal distribution of the continuous variables was assessed using the 
Shapiro-Wilk test, histogram, Q-Q plot and skewness and kurtosis. Continuous data are presented as mean 
± SD. Differences between baseline and 4 and 8 weeks of each study arm were analysed using paired 
sample t-tests for continuous variables and Chi-square for categorical variables. 
 
Repeated measures ANOVA was used to determine the effect of time, treatment and time*treatment 
interactions for cognition and blood pressure measurements at 4 and 8 weeks, and markers of inflammation 
at baseline and 8 weeks. Alpha was set at 0.05 for statistical significance. Eta-squared (η2) values were also 
calculated to quantify the difference between the interventions. The Cohen’s f effect size estimates were 
characterised as small (0.10), medium (0.25) and large (0.40) [309]. The statistical analysis controlled for 
potential cofounders, including age and gender, physical activity and use of blood pressure medication. 
Treatment order was also included as the between subject factor. 
Dietary anthocyanin intake was determined from the dietary assessments using an Australian anthocyanin 
database [310] available within the dietary analysis FoodWorks software system (Version 8, 2009, Xyris 
pty ltd, Spring Hill, QLD, Australia) (See Chapter 6.1 for description of database). All participants were 
included in the final data analysis (i.e. intention-to-treat). Linear discriminant analysis effect size (LEfSe) 
tool [311] was used to analyse gut microbiota data. 
 
Analysis of urine samples by UHPLC-PDA-ESI-MS/MS 
Analysis were carried out on a Shimadzu Nexera X2 UHPLC-PDA-ESI-MS/MS system (Shimadzu, 
Rydalmere, NSW, Australia). The system consisted of a system controller (CBM-30A), three pumps (LC-
30AD), an autosampler (SIL-30AC), column heater (CTO-20AC), photodiode-array (PDA) detector (SPD-
M30A) and two degassers (DGU-20A3R and DGU-20A5R). Chromatographic separation was carried out on 
a Waters Acquity UPLC BEH C18 column (100 x 2.1 mm i.d., 1.7 µm) at a column temperature of 60°C 
and flow rate of 0.25 mL/min. PDA spectrum was scanned from 200-800 nm and anthocyanin compounds 
were monitored at 520 nm. LC mobile phase A consisted of acetonitrile, deionized water and formic acid 
(92:7:1, v/v/v) and B of 1% formic acid in acetonitrile. The elution was programmed with 0% A as initial 
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isocratic hold for 1 min followed by a linear gradient from 0-8% B for 12 min, then increasing to 50% in 5 
min followed by a cleaning and equilibration step before the next injection. The Nexera X2 UHPLC system 
was coupled with a Shimadzu LCMS-8050 triple quadrupole mass spectrometer. The ESI source was 
operated with nitrogen as nebulizer gas at a flow of 2 L/min and drying gas at a flow of 10 L/min, 
respectively. Desolvation line (DL) temperature was 250 C and heat block temperature was set at 400 C. 
Selected ion monitoring (SIM) and product ion monitoring at a collision energy of -20V and full MS scans 
in positive mode were in the range of m/z 100-1200.  
 
5.1.3 Results 
Thirty-one participants (14 males and 17 females) were recruited, 28 (90.3%) of whom completed the trial. 
Three participants withdrew; two, due to illness and one due to involvement in an accident (see Figure 5-
2). The average washout period for participants was 5 weeks (4-7 weeks), a deviation from the original 4-
week washout period due to schedule clashes and illnesses. Four weeks was chosen according to 
recommendations for crossover trials to have a washout period at least five times the half-life of the 
treatment with the maximum half-life in the study [312]. Even though the half-life of the main anthocyanin 
(cyanidin-3-glucoside) present in QGPJ [85, 107] has been shown to range between 12 and 51h [49], 4 
weeks was chosen in order to allow enough time for dissipation of treatment effects. 
 
Baseline 
Baseline characteristics of participants are summarised in Table 5-2 below, with no significant differences 
in any variables according to order of randomisation. 
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Table 5-3: Baseline characteristics of the study population 
 
Baseline characteristics Full group n=31(%) aIC sequence (n=16) bCI sequence (n=15) p-
value 
Gender 
Male 
Female 
 
Age (mean ± SD) 
 
BMI (mean ± SD) 
 
Waist-Hip ratio (mean±SD) 
 
Level of education 
Secondary 
TAFE/Diploma 
University degree 
Post-grad 
 
Marital status 
Married 
Divorced  
Widowed 
 
Physical activity 
High 
Medium  
Low  
 
 
BP medication 
Yes 
No 
 
24 ABPM (mean ± SD) 
SBP 
DBP 
MAP 
HR 
PP 
 
Spot Blood Pressure 
SBP 
DBP 
PR 
 
Hand grip strength (mean 
± SD) 
Right  
Left  
 
Sit-to-stand (mean ± SD) 
 
Cognitive Assessment 
(mean ± SD) 
RAVLT total (I-V) 
RAVLT delayed recall 
 
14 (45) 
17 (55) 
 
70 ± 10 
 
26 ± 4 
 
0.88 ± 0.09 
 
 
4 (13) 
9 (29) 
4 (13) 
14 (45) 
 
 
22 (71) 
5 (16) 
4 (13) 
 
 
14 (45) 
12 (39) 
5 (16) 
 
 
 
7 (23) 
24 (77) 
 
 
129 ± 12 
80 ± 8 
102 ± 9 
72 ± 9 
49 ± 9 
 
 
131 ± 19 
75 ± 9 
74 ± 14 
 
 
 
30.1 ± 10.3 
26.8 ± 10.6 
 
19 ± 7 
 
 
 
43 ± 12 
8 ± 4 
 
6 (37) 
10 (63) 
 
69 ± 10 
 
25 ± 4 
 
0.86 ± 0.09 
 
 
1 (6) 
4 (25) 
4 (25) 
7 (44) 
 
 
14 (88) 
2 (12) 
0 (0) 
 
 
7 (44) 
4 (25) 
5 (31) 
 
 
 
1 (6) 
15 (94) 
 
 
126 ± 11 
79 ± 7 
100 ± 8 
72 ± 10 
47 ± 10 
 
 
127 ±20 
74 ± 9 
79 ±16 
 
 
 
29.3 ± 9.6 
25.1 ± 9.8 
 
19 ± 8 
 
 
 
44 ± 11 
8 ± 3 
 
8 (53) 
7 (47) 
 
70 ± 10 
 
27 ± 4 
 
0.89 ± 0.10 
 
 
3 (20) 
5 (33) 
0 (0) 
7 (47)  
 
 
8 (53) 
3 (20) 
4 (27) 
 
 
7 (47) 
8 (53) 
0 (0) 
 
 
 
6 (40) 
9 (60) 
 
 
132 ±12 
81 ± 9 
104 ± 9 
72 ± 8 
51 ± 8 
 
 
136 ± 18 
77 ± 9 
69 ± 9 
 
 
 
30.9 ± 11.2 
28.6 ± 11.5 
 
18 ± 5 
 
 
 
41 ± 14 
8 ± 4 
 
ns 
 
 
ns 
 
ns 
 
ns 
 
ns 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ns 
 
 
 
 
 
 
ns 
 
 
 
 
 
ns 
 
 
 
ns 
 
ns 
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Baseline characteristics Full group n=31(%) aIC sequence (n=16) bCI sequence (n=15) p-
value 
RAVLT 20m delayed 
recall 
 
Digit Span (mean ± SD) 
 
Letter fluency (mean±SD) 
 
Category fluency 
(mean±SD) 
 
Counting span (mean±SD) 
 
Stroop (secs) (mean±SD) 
 
Inflammatory biomarkers/ 
nerve growth factor 
hsCRP 
BDNF 
 
 
8 ± 4 
 
 
7 ± 3 
 
14 ± 6 
 
17 ± 6 
 
 
9 ± 4 
 
12 ± 6  
 
 
 
1.56 ± 1.67 
37.67 ± 10.44 
9 ± 4 
 
 
7 ± 3 
 
14 ± 6 
 
18 ± 6 
 
 
8 ± 4 
 
14 ± 7 
 
 
 
1.44 ± 1.22 
35.44 ± 12.54 
8 ± 5 
 
 
7 ± 3 
 
14 ± 7 
 
15 ± 6 
 
 
10 ± 3 
 
10 ± 4 
 
 
 
1.70 ± 2.11 
40.21 ± 6.99 
 
 
 
ns 
 
ns 
 
ns 
 
 
ns 
 
ns 
 
ns 
aIC- intervention- then control order; bCI- control then intervention order; RAVLT-Rey auditory verbal learning test; 24-ABPM – 24-
h Ambulatory Blood Pressure Monitor; SBP-systolic blood pressure; DBP-diastolic blood pressure; MAP-mean arterial pressure; HR-
heart rate; PP-pulse pressure; PR-pulse rate; hsCRP- high sensitivity c- reactive protein; BDNF- Brain-derived neurotrophic factor 
 
 
Cognition and physical measurements 
There was no observed significant difference from baseline or between groups in cognition or physical 
tests (Table 5-3). Calculated p values were greater than 0.05 (Table 5-4). In addition, calculated eta squared 
(η2) for effect sizes for the different cognitive tasks were as follows: RAVLT total (I-V) = 0.024; RAVLT 
delayed recall =0.012; RAVLT 20m delayed recall = 0.018; Digit Span = 0.019; Letter fluency = 0.00; 
Category fluency= 0.065; Counting span = 0.00 and; Stroop (secs) = 0.06. 
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Table 5-4: Crossover analysis of cognitive and physical function variables  
 
 Mean (SD) p-values of associated ANOVA analysis  
4-weeks 8-weeks Treatment 
effect 
Time effect Treatment* 
time effect 
 
RAVLT total (I-V) 
Baseline 
Plum juice 
Cordial 
 
RAVLT delayed 
recall 
Baseline 
Plum juice 
Cordial 
 
RAVLT 20m 
delayed recall 
Baseline 
Plum juice 
Cordial 
 
Digit Span 
Baseline 
Plum juice 
Cordial 
Letter fluency  
Baseline 
Plum juice 
Cordial 
 
Category fluency  
Baseline 
Plum juice 
Cordial 
Counting span 
Baseline 
Plum juice 
Cordial 
Stroop (secs) 
Baseline 
Plum juice 
Cordial 
Hand grip 
strength 
Right  
Baseline 
Plum juice 
Cordial 
Left  
Baseline 
Plum juice 
Cordial 
Sit-to-stand  
Baseline 
Plum juice 
Cordial 
 
 
43(12) 
48 (11) 
48 (13) 
 
 
 
8 (4) 
9 (4) 
9 (4) 
 
 
 
8 (4) 
9 (3) 
9 (5) 
 
 
7 (3) 
8 (2) 
8 (3) 
 
14 (6) 
15 (6) 
16 (7) 
 
 
17 (6) 
15 (5) 
19 (7) 
 
9 (4) 
9 (3) 
10 (3) 
 
12 (6) 
11 (5) 
10 (6) 
 
 
 
30.1 (10.3) 
32.4 (11.0) 
31.3 (10.6) 
 
26.8 (10.6) 
29.3 (10.7) 
28.6 (11.3) 
 
19 (7) 
21 (8) 
21 (9) 
 
 
 
49 (11) 
49 (12) 
 
 
 
 
9 (4) 
9 (4) 
 
 
 
 
9 (4) 
9 (4) 
 
 
 
8 (2) 
8 (2) 
 
 
16 (6) 
15 (6) 
 
 
 
16 (6) 
18 (7) 
 
 
10 (3) 
10 (3) 
 
 
10 (5) 
9 (5) 
 
 
 
 
31.9 (11.1) 
31.7 (11.0) 
 
 
29.2 (11.3) 
27.6 (10.1) 
 
 
21 (7) 
22 (9) 
 
0.69 
 
 
 
 
0.49 
 
 
 
 
 
0.41 
 
 
 
 
 
0.23 
 
 
 
 
0.73 
 
 
 
 
0.58 
 
 
 
0.35 
 
 
 
0.08 
 
 
 
 
 
0.90 
 
 
 
0.53 
 
 
 
0.34 
 
0.74 
 
 
 
 
1.0 
 
 
 
 
 
0.77 
 
 
 
 
 
0.14 
 
 
 
 
0.63 
 
 
 
 
0.47 
 
 
 
0.90 
 
 
 
0.72 
 
 
 
 
 
0.59 
 
 
 
0.81 
 
 
 
0.12 
 
0.44 
 
 
 
 
0.43 
 
 
 
 
 
0.72 
 
 
 
 
 
0.49 
 
 
 
 
0.94 
 
 
 
 
0.20 
 
 
 
0.96 
 
 
 
0.08 
 
 
 
 
 
0.88 
 
 
 
0.30 
 
 
 
0.12 
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Ambulatory blood pressure and anti-inflammatory biomarkers 
Similar to cognitive outcomes, there was no observed significant effect observed in 24-h 
ambulatory blood pressure (Table 5-4) or anti-inflammatory biomarkers (Table 5-5). 
 
Table 5-5: Crossover analysis of 24-h Ambulatory blood pressure data 
 
 Mean (SD) p-values of associated ANOVA analysis  
4-weeks 8-weeks Treatment 
effect 
Time 
effect 
Treatment by 
time effect 
 
SBP 
Baseline 
Plum juice 
Cordial 
 
DBP 
Baseline 
Plum juice 
Cordial 
 
MAP 
Baseline 
Plum juice 
Cordial 
 
Heart rate 
Baseline 
Plum juice 
Cordial 
 
Pulse pressure 
Baseline 
Plum juice 
Cordial 
 
 
 
129 (12) 
125.9(10.0) 
124.2 (11.3) 
 
 
80 (8) 
78.5 (7.8) 
76.1 (7.0) 
 
 
102 (9) 
100.1 (7.9) 
98.1 (8.1) 
 
 
72 (9) 
70.7 (10.4) 
69.0 (8.8) 
 
 
49 (9) 
47.6 (8.0) 
48.0 (8.5) 
 
 
 
127.3(9.5) 
122.5 (7.7) 
 
 
 
77.9 (7.8) 
76.1 (7.0) 
 
 
 
100.5 (7.6) 
97.4 (6.3) 
 
 
 
70.9 (8.3) 
70.5 (8.7) 
 
 
 
49.5 (9.7) 
46.4(7.5) 
 
0.73 
 
 
 
 
0.41 
 
 
 
 
0.75 
 
 
 
 
0.37 
 
 
 
 
0.77 
 
0.97 
 
 
 
 
0.92 
 
 
 
 
0.93 
 
 
 
 
0.06 
 
 
 
 
0.97 
 
0.44 
 
 
 
 
0.86 
 
 
 
 
0.71 
 
 
 
 
0.62 
 
 
 
 
0.39 
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Table 5-6: Crossover analysis of nerve growth factor / inflammatory biomarkers (BDNF and CRP) 
 
 Mean (SD) p-values of associated ANOVA analysis  
 8-weeks Treatment effect Treatment by 
baseline 
    
 
BDNF (ng/mL) 
Baseline 
Plum juice 
Cordial 
 
CRP (mg/L) 
Baseline 
Plum juice 
Cordial 
 
 
 
 
37.67 (10.44) 
33.61 (12.13) 
33.71 (11.52) 
 
 
1.56 (1.67) 
2.66 (4.02) 
2.19 (2.20) 
 
 
 
0.70 
 
 
 
 
0.17 
 
 
 
 
 
0.67 
 
 
 
 
0.16 
 
 
 
 
 
Gut microbiota 
Analysis of gut microbiota data showed that there were no biomarkers associated with QGP juice 
consumption over eight weeks. There were no significant differences observed for Bifidobacterium and 
Clostridium genera. These bacteria genera have previously been shown to be affected by anthocyanin 
supplementation [53].  Analysis of total bacteria count showed a trend towards significance in the 
comparison of total bacteria from baseline to week 8 in the control arm. This trend was not observed 
between baseline and intervention (Figure 5-3). 
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Figure 5-3: Total bacterial count across baseline, and week 8 of intervention and control arms (error bars 
are SE) (n=31) 
 
 
 
 
 
 
Figure 5-4: Relative abundance of Bifidobacterium and clostridium genera in gut sample across study arms 
(according to linear discriminant analysis effect size; LefSe). 
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Urinary analysis  
Cyanidin-3-glucoside and cyanidin-3-rutinoside, the main QGP anthocyanins, as well as cyanidin 
monoglucuronide, peonidin monoglucuronide and peonidin-3-rutinoside, the most common 
methylated/conjugated metabolites of cyanidin-based anthocyanins, were tentatively identified in some 
urine samples after QGPJ consumption (Table 5-7). However, further evaluation was not undertaken since 
the concentrations of these anthocyanins and metabolites were below the limit of quantification. No other 
conjugated or methylated anthocyanin forms could be detected. Furthermore, no intact anthocyanins or 
common anthocyanin metabolites could be identified in the control samples (consumption of cordial). 
 
 
Table 5-7: UHPLC-PDA-ESI-MS/MS characterization of QGP anthocyanins and metabolites detected in 
human urine after the consumption of QGP juice 
 
 
Compounds Precursor ions (m/z) 
[M+H]+ 
Empirical molecular 
formula 
Fragments 
Proposed identity 
Cyanidin-3-glucoside 449.15 C21H21O11
+ 287.05 
Cyanidin monoglucuronide 463.10 C21H19O12
+ 287.05 
Cyanidin-3-rutinoside  595.15 C27H31O15
+ 449.10, 287.05 
Peonidin monoglucuronide 477.10 C22H21O12
+ 301.10 
Peonidin-3-rutinoside 609.15 C28H33O15
+ 463.15, 301.10 
 
 
Dietary data 
Analysis of participants’ background diet is presented in Table 5-8 below. The mean intake of dietary 
anthocyanins was 142.69mg/day with a median of 34.15mg/d (IQR =280.33) and energy intake of 
9302kJ/day.  
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Table 5-8: Dietary data analysis of participants from estimated 3-day food diary data 
 
 
Nutrient/day 
 
Full group (n=31)  
mean ± SD 
(median(IQR)) 
 
 
aIC sequence (n=16) 
mean ± SD 
(median(IQR)) 
 
bCI sequence (n=15) 
mean ± SD 
(median(IQR)) 
 
 
p value+ 
 
Anthocyanin (mg) 
 
 
Energy (KJ) 
 
 
Carbohydrate 
 
 
Protein 
 
 
Total Fat 
 
 
Saturated Fat (g) 
 
 
Dietary fibre (g) 
 
 
Sodium (mg) 
 
 
Potassium (mg) 
 
 
Magnesium (mg) 
 
 
Calcium (mg) 
 
 
Iron (mg) 
 
 
Omega 3 (g) 
 
 
142.69 ± 217.58 
(34.15(280.33)) 
 
9302.9 ± 3035.89 
(9065 (3245)) 
 
209.66 ± 62.71 
(193.6 (81.93) 
 
94.59 ± 24.87 
(87.4 (50.5)) 
 
94.92 ± 42.92 
(86.9 (59.72)) 
 
30.76 ± 10.55 
(29.6 (12.85)) 
 
32.23 ± 12.73 
(30.25 (20.55)) 
 
2304.36 ± 815.33 
(2118.39 (972.22)) 
 
3746.13 ± 1192.90 
(3642.36 (1146.08)) 
 
404.21 ± 189.00 
(379.04 (231.79)) 
 
1056.97 ± 431.95 
(912.71 (471.96)) 
 
13.83 ± 7.00 
(11.82 (7.29)) 
 
2.45 ± 1.82 
(1.83 (1.75)) 
 
 
152.42 ± 264.77 
(35.05(149.75)) 
 
9716.74 ± 3536.54 
(9209 (4310.5)) 
 
201.37 ± 55.45 
(185.05 (62.65) 
 
93.49 ± 33.69 
(80.50 (59.45)) 
 
107.77 ± 51.44 
(94.45 (59.8)) 
 
30.96 ± 11.38 
(31.4 (17.45)) 
 
34.39 ± 15.16 
(33.5 (22.2)) 
 
2266.09 ± 752.97 
(2095.15 (1013.92)) 
 
3744.75 ± 1372.60 
(3478.31 (1171.54)) 
 
418.47 ± 243.15 
(354.89 (344.22)) 
 
978.89 ± 432.43 
(858.26 (395.33)) 
 
14.14 ± 6.57 
(11.82 (10.00)) 
 
3.21 ± 2.25 
(2.68 (2.72)) 
 
132.97 ± 167.40 
(27.35(287.83)) 
 
8889.06 ± 2503.24 
(9040.95 (3347.4) 
 
217.96 ± 70.31 
(213.65 (86.93)) 
 
95.69 ± 24.35 
(92.40 (49.5)) 
 
82.06 ± 28.70 
(78.5 (30.93)) 
 
30.56 ± 10.09 
(28.05 (8.95)) 
 
30.08 ±9.86 
(28.5 (18.1)) 
 
2342.63 ± 900.30 
(2150.07 (968.08)) 
 
3747.51 ± 1035.12 
(3807.56 (1396.32)) 
 
389.94 ± 120.96 
(427.91 (237.05)) 
 
1135.05 ± 432.89 
(977.80 (456.62)) 
 
13.53 ± 7.64 
(11.55 (6.72)) 
 
1.69 ± 0.77 
(1.41 (1.06)) 
 
ns++ 
 
 
ns 
 
 
ns 
 
 
ns 
 
 
ns 
 
 
ns 
 
 
ns 
 
 
ns 
 
 
ns 
 
 
ns 
 
 
ns 
 
 
ns 
 
 
0.024 
aIC- intervention- then control order; bCI- control then intervention order; ns- not significant; +t-test; ++Wilcoxon signed-rank test 
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5.1.4 Discussion 
 
This study hypothesised that consumption of anthocyanin-containing plum juice for 8 weeks would have 
significant positive effects on cognitive function and BP, compared to a control cordial. However, in a 
group of healthy older adults, there were no observed effects on blood pressure, cognition or measured 
inflammatory biomarkers. The significance levels measured using p value less than 0.05 and effect size 
measured using eta squared (η2) did not show any significant effects of the intervention.  Results from this 
study add to the evidence that in healthy older adults without cognitive decline, supplementation with fruit 
anthocyanins may provide no beneficial effects [313, 314].   
Anthocyanins have been shown to exert protective effects on cognition even in the presence of other 
polyphenols. Evidence from animal studies continue to show promising results [315] however, clinical trial 
evidence have not been in agreement. A randomized, double-blind, placebo-controlled study compared the 
safety and efficacy of encapsulated low dose enhanced wild blueberry extract (WBE111) in healthy older 
adults (65-80 years). Two doses of wild blueberry powder (500mg and 1000mg) were compared to a 
formulated wild blueberry extract, Thinkblue™ wild Blueberry Extract (111mg). The anthocyanin doses 
across the three interventions were 1.35, 2.7 and 7mg/dose/day respectively. The authors observed 
significantly better episodic memory performance following WBE111 at 3 months and lower SBP 
following intervention with WBE111 in comparison to placebo even though one of the doses of wild 
blueberry powder (1000mg) contained more total polyphenols than the WBE supplementation 
(70mg/dose/day vs 50mg/dose/day) [316]. Other studies using grape or blueberry (87mg of anthocyanins 
per 100g and 1920mg/100g respectively) observed significant effects on episodic and working memory 
[317, 318] as well as in a study using encapsulated grape and blueberry extract mix [319] and individuals 
with mild-moderate cognitive impairment [61]. Similar to the findings of our study, Bensalem et. al. (2018) 
did not report benefits of anthocyanin supplementation in healthy older adults. However, memory benefits 
were seen following stratification of participants according to baseline cognitive characteristics, with 
memory benefits seen in those with poorer function initially [319]. In addition, Different study populations 
and anthocyanin sources also limits comparison and generalizability between the two studies. 
 
Our study findings are consistent with similar studies on healthy older adults using a crossover study 
design [320, 321] as well as a parallel study design using elderberries [322]. In one of the studies [321] 
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80 mg of anthocyanin extract from bilberry (blueberry) (Vaccinium myrtillus) and black currant (Ribes 
nigrum) were consumed in capsule form. While it is possible to encapsulate anthocyanins [323], which 
may make anthocyanin-consumption easier to control by improving compound stability, the bioactive 
benefits of extracting and isolating specific flavonoids via encapsulation has been questioned [324], as this 
process may adversely impact bioavailability. 
 
Comparison across studies that report significant positive effects and those that have not found 
anthocyanin-related health benefits suggest the following four important differences: longer duration of 
intervention (3- 6 months); food source of anthocyanin (usually blueberry anthocyanins); study design 
(parallel vs cross over); and cognitive function (individuals with mild cognitive impairment vs no cognitive 
decline). Positive studies have tended to use fruits that contain a wide range of anthocyanin sub-classes (i.e. 
blueberries and grapes), while the fruit vehicle (plum) in the current study mostly contained cyanidins 
[325]. The synergistic effect of multiple anthocyanin sub-groups found in blueberries could also account 
for these observed effects. To further demonstrate a synergistic effect of a combination of anthocyanin sub-
groups, a study that compared enocianin, (a commercial grape extract food colouring that contains a variety 
of anthocyanins) with a pure malvidin-3-glucoside extract reported a more significant proliferative effect 
on gut bacteria by enocianin [271]. The synergistic effect of both nutrients and bioactive non-nutrient 
components within a food matrix has been highlighted by Jacobs and Tapsell (2007) [326]. This is an 
important consideration in planning and executing nutrition research that is relevant for translation into 
dietary guidance.  
 
A recent meta-analysis on the effect of anthocyanin-rich foods on cardiometabolic biomarkers found that 
berries and red grapes/wine significantly reduced BP. These effects were detected in overweight/obese 
individuals but not in normal weight individuals [327]. Available evidence suggests that in healthy older 
individuals, lower levels of anthocyanin supplementation do not seem to have significant effects over the 
short term (≤ 2 months) on either blood pressure or cognition. A study using anthocyanin-rich blood orange 
juice (50mg of anthocyanins/500mL) did not observe any effect on blood pressure in healthy people (25-
84yr) over 4 weeks [320]. On the other hand, a study of dementia patients (69mg of anthocyanins /100mL 
of cherry juice)  [61] and post myocardial infarction patients [328] reported significantly reduced blood 
pressure over 12 weeks. Another important consideration for study design is the differential effects seen in 
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acute vs longer-term interventions. In acute settings, positive effects have been observed on cognition and 
BP both in children and adults [201, 214, 301] and also in longer-term studies on individuals with mild to 
moderate cognitive impairment [61, 201]. However, these acute effects in healthy older adults are not 
generally seen chronically [320] except in studies where blueberries have been supplemented over a longer 
term (3-6 months). There is no clear explanation for this observation except for the difference in duration, 
anthocyanin vehicle, study design and possibly metabolism. Evidence has suggested that chronic intake of 
flavonoids do not result in increased levels of metabolites in the tissues compared to single doses, which 
shows that brain levels are likely reflective of acute intake and may not accumulate in the long term [329]. 
There is also a possibility that the amount of anthocyanin in the plum juice used in this study could have 
affected study results. Anthocyanin content of the plum juice used in the acute dose-timing study (Chapter 
3) was 123mg/100mL but for this current study, the anthocyanin content of the QGPJ was much lower, 
approximately 50mg/L. Additionally, the lower concentration of anthocyanins in the QGPJ utilised in this 
study could explain the lower concentrations of anthocyanin metabolites observed in the urinary analyses, 
which were below the limits of quantification.  
 
In line with the absence of any significant effects on cognition, no changes in the brain derived 
neurotrophic growth factor and the inflammatory biomarker, hsCRP were observed following anthocyanin 
supplementation. BDNF is an important growth factor for synaptic plasticity and learning and memory 
[330, 331] while C-reactive protein (CRP) is a broad marker for presence of inflammation in the body. Our 
hypothesis was that anthocyanins would exert protective effects on memory and cognition through a 
subsequent increase in BDNF levels, amongst other pathways. In animal models, anthocyanins have been 
shown to increase BDNF levels [73] but there is little available evidence from human clinical trials. The 
only available evidence is from an acute trial [241] which showed stable BDNF plasma levels following 
blueberry anthocyanins supplementation in adults compared to a reduction associated with consuming a 
control drink. It is important to note that baseline CRP and BDNF concentrations were within normal 
ranges (CRP < 3mg/L) and BDNF generally between 8–46 ng/mL [332]) which may explain the lack of 
change in these biomarkers. It has been suggested that anthocyanin-rich interventions tend to exert 
beneficial effects on the cardiovascular system in participants with clinically diagnosed diseases compared 
to healthy subjects, where no significant effects are observed [322]. A review of anthocyanin effects on 
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CRP levels from clinical trials also observed that purified anthocyanins or anthocyanin-rich extract 
supplementation did not have any significant impact on CRP levels [333].  
 
In terms of effects of anthocyanins on gut microbiota, anthocyanins may have a significant proliferative 
effect on Bifidobacterium spp., known for their wide use in probiotics and for the treatment of Irritable 
Bowel Syndrome (IBS) as well as an inhibitory effect on the pathogenic strain Clostridium histolyticum 
[53]. Our study did not find an intervention effect on these genera of gut bacteria however, but there was an 
observed reduction in total bacteria in the control arm which was borderline significant. A review on the 
effects of sweeteners on the gut microbiota showed that some artificial sweeteners reduced bacteria counts 
in vivo in animal models [334]. Although the sugar content of the cordial and QGPJ were comparable, 
there is a possibility that the consumption of raspberry cordial may affect the gut microbiota population in 
a different manner. Studies on the effect of anthocyanins on gut microbiota have observed proliferative and 
inhibitory effects on different bacteria species but the effect on total bacteria count has not been consistent 
[53] and they may have proliferative and inhibitory effects of a similar magnitude in different species 
[272]. There is also the possibility that the observed borderline effect on gut microbiota from this study 
could be attributed to a synergistic effect of other significant bioactive phenolic compounds present in the 
intervention juice. One of such nutrients is the hydroxycinnamic acids which are present in plums in higher 
quantities than anthocyanins [180]. Research on hydroxycinnamic acids shows significant biological 
activities, however, the low bioavailability of hydroxycinnamic acids continues to limit research translation 
[335]. Evidence from pre-clinical and clinical studies suggest that due to their resistance to substrates in the 
small intestine namely Lactase-Phlorizin Hydrolase (LPH) and Cytosolic β-glucosidase (CBG), they cannot 
be absorbed in the small intestine but are transported to the colon where the colon microbiota cleave the 
conjugating moieties, with resultant beneficial effects on the microbiota [35, 336]. 
 
The absence of significant effects on the primary outcome measures could also be associated with 
background nutrition. Anthocyanin intake in the Australian population has been estimated at between 1.4 -
24.17mg/d (Chapter 6.2). However, the mean intake of dietary anthocyanins in the habitual diet of the 
current study population was 142mg/d (median (IQR) = 34.15(280.33)). This was higher than intakes 
reported in other Australian studies [337, 338]. A higher intake of background dietary anthocyanin may 
hinder any possible additional benefits from anthocyanin supplementation as evidence has shown 
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significant associations between habitual anthocyanin intake and reduced disease risks in longitudinal 
studies [231, 339, 340]. Processing and storage times could have also affected anthocyanin stability in the 
intervention juice and, subsequently, the absence of any significant changes in measured variables. In 
comparison to the acute dose-timing study (Chapter 3) in which the study beverage was stored for about 2 
months (frozen) prior to the start of the trial which lasted for 4 weeks, this study beverage was stored for 
about 8 months (refrigerated and frozen) while the study duration was 8 months. Due to the short growing 
season of plums in Australia, and the extended period of time typically required in clinical trials to recruit 
sufficient numbers of participants, we endeavoured to standardise the provided juice by using two 
combined batches that had been processed. This necessitated the juice to be kept in storage under 
controlled conditions for a relatively long time. Evidence shows that processing of fruits to juice, especially 
in high temperatures significantly degrades anthocyanins [341]. In addition, the thawing and freezing 
process involved in bottling the juice could have also caused significant degradation of the plum juice 
anthocyanins [342]. This degradation effect together with the low stability of anthocyanins in general could 
have significant effects on research findings hence limiting generalisation of research findings [343]. 
 
The research team endeavoured to match the study beverages in nutrient content except for anthocyanins. 
However, there was considerable difference in the energy content between the beverages. There are no 
indications that this observed difference could have affected study results.  
One of the main strengths of this study is the crossover design. Participants acted as their own control 
which accounted for inter-individual variances and thereby increasing statistical power. In crossover trials, 
3 types of baseline measurements have been described: those taken before the start of the first arm, those 
taken at the end of the first arm and before the start of the second arm, and those taken at the end of the 
second arm. The first type has been described as a true baseline as there is always the possibility that carry-
over effects may be present in the second and third type [344]. In addition, as comparisons are within each 
trial participant, it has been suggested that different baseline measurements are not compulsory. Hence for 
this study baseline measurements were recorded only once at the start of the trial.  
 
There were few dropouts in this study and juice consumption compliance was satisfactory. As with food 
interventions, blinding of participants was not possible. Other limitations in this study may include the lack 
of characterization of microbial metabolites of in the plasma and the relatively short duration of 
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intervention. The major consideration in the design of anthocyanin food-based research is related to 
preservation of the anthocyanin content in test foods. Losses in anthocyanin content of juice due to the 
bottling process (thawing and refreezing) and other storage considerations present real challenges. 
 
5.1.5 Conclusion 
 
In conclusion, anthocyanin supplementation provided in a food matrix of plum juice did not have any 
significant effect on cognition, BP, or nerve growth factor/ inflammatory markers (BDNF and CRP) over 8 
weeks but may have an effect on the gut microbiota population in healthy older individuals. Future 
research may consider stability of anthocyanins while focusing on supplementation with other available 
fruits with different anthocyanin profiles in longer-term (3-6 months) crossover studies in order to confirm 
the absence of a chronic effect from fruit anthocyanins at this level of concentration. 
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6 CHAPTER 6 
6.1 DEVELOPMENT OF AN AUSTRALIAN ANTHOCYANIN 
DATABASE AND SECONDARY DATA ANALYSIS OF 
CURRENT ANTHOCYANIN INTAKE IN THE AUSTRALIAN 
POPULATION 
 
To accurately measure nutrient intake in population studies, food composition databases tailored to specific 
regions need to be developed. As stated in Chapter 1, the available databases are not region-specific which 
limits measurement of anthocyanin intake in epidemiological research. The aim of this section of Chapter 6 
was to describe the first stage development of an Australian anthocyanin food composition database 
focusing on fruit and vegetables. Development of an anthocyanin food composition database relies on the 
availability of analytical food data. In the case of Australian fruits and vegetables, there was limited data 
available for their anthocyanin content using a systematic literature review approach. As a result, 
imputations (conversion to Australian values using the moisture conversion factor) from other polyphenol 
datasets was necessary.  
 
 
The majority of this section of chapter 6 is the substantive content of the published articles: (Appendix D)  
 
Igwe, E., Neale, E., Charlton, K.E., Morton, K. and Probst, Y.C., 2017. First stage development of an 
Australian anthocyanin food composition database for dietary studies–A systematic process and its 
challenges. Journal of Food Composition and Analysis, 64, pp.33-38. 
 
Specific role/authorship of all the authors: All authors were involved in the development of the 
Australian anthocyanin database. All authors were involved in the planning the project. EI and KM 
conducted the systematic literature reviews for the anthocyanin content of Australian foods. EN, KC and 
YP advised on methods for data merging (USDA and Phenol-Explorer) and entry into a single database. 
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All Authors contributed to writing and editing the manuscript and approved of the final version of the paper 
submitted for publication 
 
Following the first stage development of the Australian anthocyanin database, the database was 
incorporated into the commercially available FoodWorks software for nutritional analyses (version 9). 
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6.1.1 Part 1: First stage development of an Australian anthocyanin food 
composition database for dietary studies – A systematic process 
 
6.1.1.1 Introduction 
 
In order to translate clinical trial findings to dietary messages, it is important that the amount of 
anthocyanin intake is accurately measured in both epidemiological and experimental studies. This would 
allow translation of this evidence into dietary messages for overall health improvement. For this purpose, a 
number of specific and general polyphenol databases, including the USDA Database for the Flavonoid 
Content of Selected Foods and the European Phenol-Explorer, exist for the measurement of polyphenol 
(anthocyanin) intake [345, 346]. Comparing these two databases for the estimation of dietary polyphenol 
intake in Polish adults, significant discrepancies were demonstrated in the amount of flavonoid intake 
between the USDA and Phenol-Explorer databases (525 mg/day vs 403.5 mg/day, respectively p<0.001) 
[347]. Epidemiological studies commonly utilise either of these databases for the measurement of 
polyphenol intakes.  Such discrepancies between databases may lead to differing conclusions regarding the 
amount of anthocyanins in the human diet and potential dose responses [338, 347, 348].   
 
Within the USDA and Phenol Explorer databases, analytical data are not country or region specific but are 
reported as mean values for all available data for a particular food. As a result, there is the possibility that 
this can lead to inaccurate measurement of polyphenol intakes in specific populations. Evidence has shown 
that differences in climate, soil conditions and methods of plant harvesting among other factors are major 
determinants of natural variation in the amounts of nutrients contained in foods [89, 90]. For example, the 
levels of anthocyanin in fruit may be directly proportional to the amount of sunlight exposure. Anthocyanin 
levels in grapes have been observed to substantially increase with grape bunch exposure to sunlight in 
comparison to shading [349]. Average monthly hours of sunshine over the year has been shown to be 
significantly different in various fruit producing regions of the world [350]. Focusing on this difference in 
climate and harvesting practices as an example, the amount of micronutrients in apples are found to differ 
substantially between the USDA [351] and the Australian Food, Supplement and Nutrient Database 
(AUSNUT) [352] (Table 6-1). For these reasons, it is important that databases tailored to specific regions 
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of the world are developed to facilitate better measurement of anthocyanin intakes in population level 
studies.  
 
In utilising the available databases for epidemiological studies, another drawback is the 
underrepresentation of native fruit and fruit hybrids specific to particular regions. For example, there is 
limited data for some common Australian native fruit including quandong, riberry and fingerlimes which 
are known to have high levels of anthocyanins [353]. 
In summary, the underrepresentation of fruit specific to particular regions in existing databases, as well as 
the differences in climate and harvesting practices between regions warrants the development of an 
anthocyanin food composition database specific to different regions. 
The aim of this study was, therefore, to describe the first stages of the development of an Australian 
anthocyanin food composition database using fruit and vegetables as a preliminary step in the systematic 
development process.   
 
6.1.1.2  Methods 
 
The development of an Australian anthocyanin database involved an expansion of the existing Australian 
Food and Nutrient database (AUSNUT) 2011-13 database to include anthocyanin content. The AUSNUT 
2011-13 database contains over 5,700 foods and beverages reported by Australians and was developed for 
use in the 2011-13 Australian Health Survey [354].  
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Table 6-1: Micronutrient comparison between USDA and AUSNUT food composition database values of 
apple 
 
AUSNUT* values USDA+ values 
Preformed vitamin A (retinol) (µg) 0 3 
Beta-carotene (µg) 10 27 
Provitamin A (b-carotene equivalents) (µg) 13 
 
Vitamin A retinol equivalents (µg) 2 0 
Thiamin (mg) 0.022 0.017 
Riboflavin (mg) 0.013 0.026 
Vitamin C (mg)  4 4.6 
Dietary folate equivalents (µg) 13 3 
*AUSNUT – Australian Food and Nutrient Database +USDA – U.S Department of Agriculture 
Source: [351, 355]. 
 
 
As a first stage development, the main focus was fruit and vegetables as these are the major food groups 
with high levels of anthocyanins. The most reliable method to measure anthocyanin content in foods has 
been identified as High-Performance Liquid Chromatography (HPLC). When evaluating 
spectrophotometric methods for antioxidant compound measurement, the colorimetric methods were found 
to be unreliable as reactions could be different for individual compounds within a sub-group (anthocyanins, 
flavonols or flavan-3-ols) and were not specific to one family [281]. For this reason, only data generated 
using HPLC methods of analysis were included.  
 
The proposed methodology for estimating the anthocyanin content of Australian foods was adapted from a 
systematic approach that was developed and used for the estimation of added sugar content in Australian 
foods via an expansion of the AUSNUT database  [356].  
 
Step by step systematic approach to estimating anthocyanins in foods 
 
A step by step process was developed for estimating the anthocyanin content of Australian fruit and 
vegetables. The first four steps were objective while the rest were considered subjective.  
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Step 1: Classification of food groups: Food groups were coded into three different categories; plant-based 
foods, non-plant-based foods and composite foods (made up of plant-based and non-plant-based foods). 
The difference between the non-plant-based food and the composite food group is that the majority of the 
former were assigned zero values while in the latter; fewer foods were assigned a zero value (Table 6-2). 
The grouping system developed for the AUSNUT 2011-13 database classifies foods according to a major 
(2-digit) based on key ingredients, followed by sub-major (3-digit) and minor food (5-digit) groups. Using 
this classification system, there are 24 major food groups covering all the reported foods eaten by 
Australians, as shown in Table 6-2.   
 
Step 2: Assignment of zero values: Zero values were assigned to non-plant-based food and composite food 
groups with careful attention being paid not to assign 0 values to foods that contained ingredients from the 
plant-based food groups. 
 
Step 3: Conduct a systematic literature search for analytical data: A systematic literature search of 
electronic databases was conducted (Scopus, Web of Science, Medline, PubMed central, ProQuest, and 
Science Direct) using a combination of search terms; “anthocyanin*”, “Australia*”, “Fruit*”, “vege*”, and 
“analy*”. Studies were included if they had analysed the anthocyanin content in Australian fruit and 
vegetables. Additional literature searches using USDA and Phenol-Explorer databases were conducted to 
identify fruits and vegetables with available anthocyanin analytical values. Searches used scientific and 
common names to identify all relevant foods in the USDA and Phenol-Explorer databases. 
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Table 6-2: Major food groups in the Australian Food and Nutrient Database (AUSNUT) 
 
 
Plant based food groups 
 
Non-Plant based food groups Composite food groups 
   
 
16. Fruit products and dishes 
 
22. Seed and nut product and 
dishes 
 
24. Vegetable products and 
dishes 
 
25. Legume and pulse products 
and dishes 
 
 
 
14. Fats and oils 
 
15. Fish and seafood products 
 
 
17. Egg products and dishes 
 
 
18. Meat, poultry and game 
products and dishes 
 
19. Milk products and dishes 
 
30. Special dietary foods 
 
 
34. Reptiles, amphibia and 
insects 
 
 
 
11.Non-alcoholic beverages 
 
12.Cereals and cereal products 
 
 
13.Cereal based products and 
dishes 
 
20. Dairy & meat substitutes 
 
 
21. Soup 
 
23. Savoury sauces and 
condiments 
 
26. Snack foods 
 
27. Sugar products and dishes 
 
28. Confectionery and 
cereal/nut/fruit/seed bars 
 
29. Alcoholic beverages 
 
31. Miscellaneous 
 
32. Infant formulae and foods 
 
33. Dietary supplements 
 
 
 
Step 4: Contact local researchers and organisations: Experts in the field of anthocyanin research were 
identified from the systematic literature search as well as web searches of organisations, groups, and 
individuals to identify where further sources of analytical anthocyanin data may be located.  These sources 
were contacted to enquire about the existence of any unpublished data for the anthocyanin content of 
Australian fruits and vegetables.  
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Step 5: Using borrowed values:  Having exhausted steps 1-4, where Australian data was not identified for 
fruit and vegetables, data will be obtained for similar foods from international databases, including the 
USDA Database for the Flavonoid Content of Selected Foods and Phenol-Explorer. To assist with the 
choice of the most appropriate foods from those databases, estimations were made by calculating a 
conversion factor to apply to the borrowed values in the Australian food anthocyanin database, considering 
deviation from average moisture content as shown below: [357] 
The conversion factor F is calculated using the following formula:  
 
𝐹 =
100 − 𝑎𝑐𝑡𝑢𝑎𝑙 𝑚𝑜𝑖𝑠𝑡𝑢𝑟𝑒 𝑐𝑜𝑛𝑡𝑒𝑛𝑡 (𝐴𝑢𝑠𝑡𝑟𝑎𝑙𝑖𝑎𝑛 𝑓𝑜𝑜𝑑 𝑐𝑜𝑚𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛 𝑡𝑎𝑏𝑙𝑒)
100 − 𝑚𝑜𝑖𝑠𝑡𝑢𝑟𝑒 𝑐𝑜𝑛𝑡𝑒𝑛𝑡 𝑎𝑠 𝑠ℎ𝑜𝑤𝑛 𝑖𝑛 𝑡ℎ𝑒 𝑈𝑆𝐷𝐴 𝑜𝑟 𝑃ℎ𝑒𝑛𝑜𝑙 − 𝐸𝑥𝑝𝑙𝑜𝑟𝑒𝑟 𝑓𝑜𝑜𝑑 𝑐𝑜𝑚𝑝. 𝑡𝑎𝑏𝑙𝑒
 
 
Moisture content of the foods in the USDA flavonoid database was obtained from the USDA National 
Nutrient Database for Standard Reference [351] and those of the Phenol-Explorer will be obtained from the 
Danish Food Composition Databank the data source indicated in the Phenol-Explorer database [358]. 
Having calculated the conversion factor, the corresponding Australian nutrient value were computed by 
multiplying specific nutrient value by the conversion factor (F). Following this computation, data from the 
USDA flavonoid database and Phenol-Explorer were mapped to determine whether to make decisions 
based on the calculated values from both databases or if further analysis is required. The choice of the 
international database from which to borrow analytical values was dependent on the similarity of the foods 
in their macronutrient content and the similarity of the food supply between Australia and the source 
country including production and processing techniques. 
 
Step 6: Compression of anthocyanin glycosides to main classes:  
In the overseas databases, anthocyanin content was listed by specific glycosides. In order to facilitate 
adequate merging of the anthocyanin values, the anthocyanin glycosides were compressed to the main 
classes of anthocyanins. For example, cyanidin 3-glucoside was classified under cyanidin. 
 
Step 7: Match values for similar foods: Following compression of anthocyanin glycosides to the main 
classes, similar species of foods were matched in anthocyanin values. For example, Fuji apple and green 
apple were matched for values. In the case whereby fresh/raw version of a particular food had a zero value, 
same value was also assigned to the cooked or processed version of same food. 
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Figure 6-1: PRISMA flow diagram for analytical article selection process 
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6.1.1.3 Results 
 
Following the four objective steps outlined above, the existing AUSNUT 2011-13 database was expanded 
to include anthocyanin content. The foods contained in the database are classified under 24 food groups 
(Table 6-2). Of these, four were grouped as plant-based foods, seven under the non-plant-based food group 
and 13 under the composite food group. There was a total of 58 individual fruits and 62 vegetables in the 
database following this method of categorisation.  
 
The systematic literature search (Figure 6-1) for analytical values of Australian fruits and vegetables 
yielded analytical values for only five Australian fruit (Table 6-3), including berries [359, 360] plums [13, 
361], apple [362], grape [363] as well as ten native Australian fruit [360, 364] and two  Australian 
vegetables, namely purple dragon carrots [365] and red cabbage [366]. Unpublished analytical data from 
local researchers at the Queensland Alliance for Agriculture and Food Innovation, University of 
Queensland, Australia were obtained for commercially available pomegranate juice, pomegranate and 
cranberry juice mix, pomegranate and blueberry juice mix, Dr Red products (Purple Shiraz and Purple 
Carrot Blend; Purple carrot blueberry punch; Blueberry punch), Nature’s Goodness (Joint Formula: Cherry 
juice concentrate with anthocyanin complex) and Sunraysia (100% Prune juice (from concentrate)). 
 
6.1.1.4 Discussion 
 
Using a systematic approach, for the first time, attempts have been made to bring together in a database the 
analytical data for the anthocyanin content of Australian foods (fruit and vegetables). The first four 
objective steps were unambiguous as the food groupings based on major ingredients were readily available; 
hence classification as plant-based or non-plant-based foods was a straightforward process. 
Even though there is currently very limited analytical data on the anthocyanin content of Australian foods 
which was evident in the few studies identified during the systematic literature search, preliminary 
comparisons of the available data on fruit with the existing polyphenol databases shows a substantial 
difference in the reported anthocyanin content (Table 6-4). It is expected that more data will become 
available as this area of research advances, allowing for continuous sourcing of unpublished data. 
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Expansion of the dataset will enable more precise and consistent estimation of anthocyanin intakes in 
future studies.  
 
Currently, the major focus has been on raw fruit and vegetables but as this project progresses, a number of 
considerations will be made in gathering analytical values. Food processing, for example, will be a major 
consideration as it has been shown to affect the nutritional content of foods with more effect on 
micronutrients. Blanching for example was observed to decrease the tannins and anti-radical efficiency of 
plums but increased the total polyphenol content, while osmotic dehydration had no effect on the total 
polyphenol and ferric reducing power [181]. On drying, it has been observed that some anthocyanin and 
flavonol content of plums significantly decreased  [180]. In line with this observation, the free radical 
scavenging capacity and antioxidant activity of both fresh and dried fruit samples (plum) have been 
studied. Results showed that the fresh samples had more oxygen free radical (superoxide and peroxy 
radicals) scavenging capacity than the dried samples [183].  
 
Some of the strengths of the proposed methodology are its systematic approach and the fact that local 
researchers were contacted for unpublished data in order to gather additional analytical data.  
Furthermore, upon completion of the proposed database, there is the possibility of improved study results 
based on better measurement of anthocyanin consumption.  In estimating anthocyanin intake in population 
studies, a major limitation has been the significant differences in the estimated amount of anthocyanin 
intake depending on the database used to measure anthocyanin [347]. There is a possibility that the 
combination of available databases can have a significant effect on accurate measurement of anthocyanin 
intake. Considering this, a major strength of this proposed methodology will be the combination of 
analytical data from Australian foods and borrowed data from international databases based on micro and 
macro nutrient similarity which will provide more accurate estimation [347]. 
 
A major limitation of this project was the limited availability of analytical data for Australian foods and 
thus the need to borrow international data. Some of the published analytical values only reported total 
anthocyanin content, rather than individual anthocyanins [13, 362, 363, 365, 366]. This could be seen as a 
limitation as evidence shows that specific anthocyanins vary substantially in their bioavailability [367].  In 
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addition, even though some foods were assigned a zero value on the assumption that they do not contain 
any anthocyanins, it will be important to confirm this from analytical data. 
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Table 6-3: Anthocyanin content of raw Australian fruit, sourced using a systematic literature review approach 
 
Reference Food name Food group Method of analysisa Total anthocyanin (SD) 
mg/100g fresh weight 
Individual anthocyanins 
reported 
Fredericks et al., (2013) 
[359]  
Strawberry Fruit products and 
dishes 
 
HPLC 2.02 (0.04)  Yes 
Netzel et al., (2006) [360] 
 
Blueberry   Fruit products and 
dishes 
 
HPLC/ESI-MS-MS 381.75 (6.23)  Yes 
 
Bobrich, A., et al. (2014) 
[361] 
 
 
Black diamond 
plum 
Fruit products and 
dishes 
HPLC 89.8mg Yes  
Fanning et al., (2014) [13] 
 
 
Takos et al., (2006) [362] 
 
 
Bidon et al., (2013) [363] 
Queen Garnet 
plum 
Fruit products and 
dishes 
 
HPLC 195 No 
Apple skin 
(red) 
 
Shiraz grape 
Fruit products and 
dishes 
 
Fruit products and 
dishes 
HPLC 
 
 
HPLC 
9mg/100g fruit skin 
 
 
159 (5)  
No 
 
No 
Zabaras et al., (2013) [366] Red Cabbage 
 
Vegetables HPLC/ESI-LC/MS 57.4 No 
Singh et al., (2012) [365] Purple dragon 
Carrot 
 
Vegetables  HPLC 5 (0.2)  No 
Netzel et al., (2006) [360] 
  
Muntries  (Native) fruit 
products and dishes 
 
HPLC/ESI-MS-MS 25.26 (1.24)  Yes 
Netzel et al., (2006) [360] 
 
 
Tasmanian 
pepper   
 
(Native) fruit 
products and dishes 
 
HPLC/ESI-MS-MS 607 (52)  Yes 
 
 
148 
 
Reference Food name Food group Method of analysisa Total anthocyanin (SD) 
mg/100g fresh weight 
Individual anthocyanins 
reported 
Netzel et al., (2006) [360]  Molucca 
raspberry   
(Native) fruit 
products and dishes 
HPLC/ESI-MS-MS  73.64 (0.41)   Yes 
 
 
Netzel et al., (2006) [360] 
 
 
 
Davidson's 
plum   
 
 
(Native) fruit 
products and dishes 
   
HPLC/ESI-MS-MS 38.42 (0.83)  Yes 
Netzel et al., (2006) [360] Illawarra plum   
 
(Native) fruit 
products and dishes 
 
HPLC/ESI-MS-MS 556.82 (20.73)  Yes 
Netzel et al., (2006) [360]  Cedar bay 
cherry   
 
(Native) fruit 
products and dishes 
 
HPLC/ESI-MS-MS 27.77 (0.54)   Yes 
Netzel et al., (2006) [360]  Burdekin plum   
 
(Native) fruit 
products and dishes 
 
HPLC/ESI-MS-MS 174.55(10.63)  Yes 
Netzel et al., (2007) [364] Riberry (Native) fruit 
products and dishes 
HPLC-DAD/ESI/MS-
MS 
72.39 (1.45 )  Yes  
Netzel et al., (2007) [364]  Bush Cherry  
 
(Native) fruit 
products and dishes 
 
HPLC-DAD/ESI/MS-
MS 
105.79(1.24)   Yes  
Netzel et al., (2007) [364] Finger lime  (Native) fruit  
products and dishes 
HPLC-DAD/ESI/MS- 
MS 
11.09 (0.83)  Yes 
 
Unpublished data from 
source 
 
 
pomegranate 
juice 
 
fruit products and 
dishes 
 
HPLC 
 
13b 
 
No 
Unpublished data from 
source 
 
pomegranate 
cranberry juice 
fruit products and 
dishes 
HPLC 12b No 
Unpublished data from 
source 
 
pomegranate 
blueberry juice 
fruit products and 
dishes 
HPLC 12b 
 
No 
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Reference Food name Food group Method of analysisa Total anthocyanin (SD) 
mg/100g fresh weight 
Individual anthocyanins 
reported 
Unpublished data from  Dr Red  fruit products and  HPLC 9b No 
Source 
 
(Purple Shiraz 
and Purple 
Carrot Blend) 
 
dishes    
Unpublished data from 
source 
Dr Red (Purple 
carrot  
blueberry 
punch) 
 
fruit products and 
dishes 
HPLC 40b No 
Unpublished data from 
source 
 
 
Unpublished data from 
source 
 
Dr Red 
(Blueberry 
punch) 
 
Nature’s 
Goodness 
(Joint Formula: 
Cherry juice  
fruit products and 
dishes 
 
 
fruit products and 
dishes 
HPLC 
 
 
 
HPLC 
610b 
 
 
 
14b 
No 
 
 
 
No 
 concentrate 
with 
anthocyanin 
complex)  
 
    
Unpublished data from 
source 
Sunraysia 
(100% Prune 
juice (from 
concentrate)) 
 
fruit products and 
dishes 
HPLC <<1b No 
aHPLC- High Performance Liquid Chromatography, HPLC/ESI-MS-MS High-Performance Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry, HPLC/ESI-LC/MS - High-Performance 
Liquid Chromatography/Electrospray Ionization Liquid Chromatography/Mass Spectrometry, HPLC-DAD/ESI/MS-MS - High-Performance Liquid Chromatography- Diode Array Detection /Electrospray 
Ionization Tandem Mass Spectrometry 
b Single item analysis  
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Table 6-4: Differences in anthocyanin content of similar fruit vegetables from different databases and sources 
 
Fruit/vegetable 
 
USDA database (mg/100g) Phenol-Explorer database 
(mg/100g) 
Australian dataa (mg/100g) 
Strawberry 
 
2.42 73.01 2.02 
Blueberry 
 
163.3 133.99 381.75 
Plum  
 
56.05 47.79 89.8 
Red cabbage 
 
209.95 - * 57.4 
aAustralian data from systematic literature review [310]; *- not reported 
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6.1.1.5 Conclusion            
                                                                                                                        
In conclusion, this proposed methodology provides insight for the compilation of analytical data for an 
Australian anthocyanin database for fruit and vegetables. Whilst the literature search produced very limited 
results, this was to be expected as the database is in the early stages of development and anthocyanins are 
an emerging area of research. As more analytical data becomes available from organisations and 
independent researchers, updates will be made to produce a robust database that will facilitate accurate 
measurement of anthocyanin consumption in Australian population studies and clinical trials. 
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6.1.2 Part 2: Estimated dietary anthocyanin intake and major food sources in 
Australia from the National Nutrition and Physical Activity component of 
the Australian Health Survey and association with blood pressure in older 
adults 
 
This section of Chapter 6 describes the secondary analysis of the National Nutrition and Physical Activity 
Survey (NNPAS) component of the Australian Health Survey (AHS). Following the development of the 
Australian anthocyanin database (Chapter 6.1), a secondary data analysis of the 2011-12 National Nutrition 
and Physical Activity component of the Australian Health Survey was conducted to estimate the intake of 
both total anthocyanins and their sub-groups, identify food sources of anthocyanins, as well as determine 
association between anthocyanin intake and measured BP in older adults aged 50+ years. Results showed 
that mean anthocyanins intake was 24.17±0.32mg/day in the total population. Across age-groups, berries 
were the top sources: blackberry (5-65%); cherry (2-24 %); blueberry (2-13%) and raspberry (3-12%). 
There was also an observed significant inverse association between anthocyanin intake in older adults aged 
50+ years and systolic BP (β =-0.04, p<0.01) and diastolic BP β= -0.01, p<0.01), in models that adjusted 
for covariates (age, gender, body mass index, high blood pressure (BP) diagnosis, smoking status and 
physical activity). In comparison to the world composite database, anthocyanin intake in the Australian 
population was above average (24.17±0.32mg/day vs 18.05±21.14 mg/d). Berries made up the primary 
sources thereof.  Anthocyanin intake in older adults aged 50+y was inversely associated with BP.  
 
 
The majority of this chapter section is the substantive content of the published articles:  
 
Igwe, E.O., Charlton, K.E., and Probst, Y.C. 2019. Usual dietary anthocyanin intake, sources and their 
association with blood pressure in a representative sample of Australian adults. Journal of Human 
Nutrition and Dietetics (In press).  
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6.1.2.1 Introduction 
 
Incorporating fruits and vegetables in the usual diet have been proven to exert protective effects on health. 
These observed effects have been attributed to the presence of minerals, antioxidant vitamins, 
phytochemicals and dietary fibre in these foods.  These substances, independently and as a group in fruits 
and vegetables have been associated with reduced mortality [3] weight loss [4] cardiovascular diseases and 
some cancers [6]. With these observed beneficial health effects, inter-individual variability and optimal 
intake are still significant limitations in anthocyanin research. Although the source of bioactive 
compounds, found mainly in fruits and vegetables, cannot be regarded as the primary determining factor 
responsible for inter-individual variability, evidence has shown that it could have a significant effect on 
cardiovascular and metabolic responses associated with consumption of these compounds [368, 369].  This 
could also be attributed to the synergistic effect of other diverse compounds present in the source foods.     
 
Accurate measurement of nutrient intake, in this case, anthocyanins, tailored specifically to individual 
countries and regions is an important consideration in both epidemiological and experimental studies. 
There is an observed variation in nutrient content of foods produced across different regions [89, 90] which 
has led to the development of country/region specific food composition databases. The same is also evident 
in the micronutrient databases. Currently the American USDA Database for the Flavonoid Content of 
Selected Foods and the European Phenol-Explorer, exist for the measurement of polyphenol (anthocyanin) 
intake [345, 346]. As mentioned earlier, these databases have been compared with observed discrepancies 
[347] which led to the first stage development of an Australian anthocyanin database to determine the 
amount of anthocyanins consumed by Australians [310] (Chapter 6.1). 
 
Following the development of this database, this study aimed to estimate anthocyanin intake in the 
Australian population, to describe total and individual anthocyanin intake in the Australian population 
according to sociodemographic subgroups, and to determine the major sources of total and individual 
anthocyanins in the diet. Results from this secondary analysis may provide evidence on the possible role of 
anthocyanins in reducing risks of chronic diseases in Australian older adults. 
 
 
 
154 
 
6.1.2.2 Methods 
 
This study was a secondary data analysis of the 2011–12 National Nutrition and Physical Activity Survey 
(NNPAS) data from the Australian Bureau of Statistics (ABS) using Basic Confidentialised Unit Record 
Files (CURF). No ethics approval was required for this study because it was a secondary analysis. 
However, approval to carry out a secondary analysis with the NNPAS component of the AHS data was 
obtained by the researchers from the Australian Bureau of Statistics prior to conducting this study. 
 
The National Nutrition and Physical Activity Survey 2011-12 
The NNPAS 2011-12 is a component survey of the larger 2011-12 AHS which involved a total of 12,153 
persons.  It was carried out between 29 May 2011 and 9 June 2012 in approximately 9,500 private abodes 
selected throughout non-very remote areas of Australia. Face-to-face interview (and by telephone for the 
second NNPAS interview) was used to collect data on general demographic information (including age, 
sex, marital status and country of birth) on all individuals while detailed information was collected from 
one adult and one child aged 2-17 years.  This survey covered about 97% of the people living in Australia.  
 
The study design for the 2011-12 NHS and NNPAS was a stratified multistage area sample of private 
dwellings.  To achieve the design objectives, sampling fractions according to state and territories were set 
as shown in the Table 6-5 below, which also shows the corresponding expected number of completely 
responding households.  
 
 
Table 6-5: National Nutrition and Physical Activity Survey, State/territory sample 
 
 
 NSWa Vic.b QLDc SAd WAe Tas.f NTg ACTh Aust.i 
 
Approximate sampling fractions 
 
 
1/1649 
 
1/1568 
 
1/1131 
 
1/551 
 
1/665 
 
1/208 
 
1/102 
 
1/169 
 
1/901 
Expected fully responding households 1 750 1 650 1 580 1 250 1 310 920 740 820 10020 
 
Source: ABS [370] aNew South Wales; bVictoria; cQueenland; dSouth Australia; eWestern Australia; fTasmania; gNorthern Territory; 
hAustralian Capital Territory; iAustralia  
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6.1.2.2.1 Data collection 
 
Data for the NNPAS 2011-12 was collected using face-to-face interviewer administered questionnaire. The 
questionnaire involved multiple approaches to collection. Information collected from the primary 
questionnaire included: 
• Household information - basic demographic data about usual residents of the household (e.g. sex, 
age, date of birth, birthplace, Indigenous status, marital status) and details of the relationship 
between individuals in each household. 
• Personal Adult Interview - information was collected from the selected adult about demographic, 
socio-economic and health characteristics (e.g. physical measurements, selected long-term health 
conditions, and risk factors).  
• Personal (or proxy) Child Interview - information was collected on selected demographic and 
health characteristics, including specific physical activity modules for 2-4 years and 5-17 years. 
Questions on socio-economic characteristics and smoking were not asked of children aged under 
15 years. Physical measurements were taken for children aged 2 years and older (5 years and older 
for blood pressure measurements). 
 
 
6.1.2.2.2 Estimated dietary anthocyanin intake and major food sources in 
Australian adults 
 
Estimation of anthocyanin intake occurred by applying a newly developed Australian anthocyanin database 
to the dietary records. There is a total of 5740 foods in the Australian Food and Nutrient Database 
(AUSNUT) 2011-13; of these, anthocyanin values were assigned to 318 individual foods.  
The AUSNUT 2011–13 is a food composition database of food, dietary supplement and nutrient intake 
estimates that was compiled from participants’ responses to the 2011‒12 NNPAS. For the current analysis, 
 
 
156 
 
the NNPAS data was expanded to include anthocyanin content of reported foods and total intakes were 
calculated based on the amount of food (g) consumed for each day of recall. 
Using the two separate days of 24hr dietary recall data, usual anthocyanin intake was calculated using the 
multiple source method (MSM) [371, 372]. The MSM comprises three steps. First, for each respondent in 
the study sample, the probability of consumption of the response variable on a randomly selected day was 
calculated. Secondly, the usual amount of food group intake on reported consumption days was estimated, 
and finally, the usual overall intakes were calculated by multiplying probability of consumption of the 
response variable with usual amount of intake on consumption days. Intake values were calculated within 
the MSM model assuming all participants were habitual consumers, given anthocyanins are primarily 
found in fruit and vegetables, with age and gender included as covariates. Two variables were produced in 
the MSM output; usual daily intake of anthocyanins for the total population calculated by the MSM (e.g. 
measure of habitual intake assuming population are consumers) and the usual intake of anthocyanins in 
consumers only from the 24-h dietary recall calculated by the MSM. Both variables were used in the 
statistical analysis (Figure 6-2).  
 
6.1.2.2.3 Statistical Analysis 
 
Statistical analysis was carried out using SAS (release 9.4, 2012; SAS Institute). Daily anthocyanin intake 
was calculated and expressed as mean and standard error (SE). The total population analysis was based on 
usual daily total anthocyanin intake for all participants and the consumer population analysis was based on 
the usual intake of anthocyanins for consumers only. Intake of the major sub-classes of anthocyanins 
(cyanidins, delphinidins, malvidins, pelargonidin, peonidins and petunidins) was also calculated. 
Weighting factors (person weights and replicate weights produced by ABS [370]) were applied to the data 
in order to generalise results to the total Australian population at the time of the survey and to account for 
sampling discrepancies. 
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Figure 6-2: Participant flowchart for secondary analysis of the Australian Health Survey, NNPAS 
component 
 
Mean anthocyanin intake for the total population and across sub-groups (age-groups, sex, Body Mass Index 
(BMI), level of education, smoking status and level of physical activity) was calculated. Age-groups were 
categorised according to those used in the National Health and Medical Research Council Nutrient 
Reference Values (NRVs) for Australia and New Zealand [373]. For the purpose of the analysis, categories 
of BMI, education, smoking and physical activity were grouped according to the ABS classifications with 
similar classes grouped together (e.g. underweight Class 3, underweight Class 2 and underweight Class 1 
grouped as ‘underweight’) and individuals aged less than 15y were classified as ‘not applicable’ to 
maintain the integrity of the weighting factors applied [374].   
 
Linear regression analysis was used to determine the relationship between anthocyanin intake and blood 
pressure in the subgroup of adults aged 50+ y (Figure 6-2), while adjusting for age and gender (model 1) 
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and adjusting for age, gender, BMI, physical activity, smoking status and whether diagnosed with high 
blood pressure (by a health professional and/or measured BP >=140/90 mmHg) (model 2). Inclusion 
criteria for this analysis were: i) adults aged 50 years and above and ii) who had a valid blood pressure 
measurement  
Level of significance was set at 0.05 and calculated from t-test for pair-wise comparisons or ANOVA to 
determine if there are differences in any of the subgroups where appropriate. 
 
6.1.2.3 Results 
 
Dietary anthocyanin intake from the NNPAS was estimated to be 24.17 ± 0.32 mg/d for the total 
population (n = 12,153) and 37.68mg/d for the consumer population (n = 8,958). Mean intakes for total and 
subclasses of anthocyanins according to sociodemographic (gender, age-group, level of education) and 
lifestyle (BMI, smoking status and physical activity) are reported in Table 6-6. There were more adults 
than children (n = 9,341 vs 2,812) with no statistically significant difference in anthocyanin intake. 
Respondents who had high physical activity levels consumed more anthocyanins compared to those who 
had a sedentary lifestyle (30.04mg/d vs 20.42mg/d, <0.001). A similar trend was also observed for 
respondents with a Bachelor’s degree compared to those with a diploma or lower (29mg/d vs 24mg/d, t-test 
p-value <0.001). 
The top ten food sources stratified by age are shown in Table 6-7. Berries are highly concentrated sources 
of anthocyanins [310, 375] and were the top contributors to total anthocyanin intake across all age-groups. 
The top ten food sources were reported as these made up more than 50% of the total anthocyanin intake 
across all age-groups.  
 
There was a significant inverse association between measured systolic and diastolic blood pressure and 
anthocyanin intake (Table 6-8). This was evident for both systolic (β = -0.04, F (df) = 7.77 (2), R square = 
0.01, p=0.001) and diastolic (β = -0.01, F (df) = 5.72 (2), R square = 0.01, p=0.005) blood pressure (Model 
1: adjusted for age and gender). After controlling for further confounders (Model 2: age, gender, BMI, 
physical activity, high BP diagnosis, smoking status and physical activity), the association remained 
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significant (β = -0.04, F (df) = 16.8 (6), R square = 0.05, p<0.01 for systolic BP; and β = 0.01, F (df) = 5.35 
(6), R square = 0.013, p<0.01 for diastolic BP).  
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Table 6-6: Anthocyanin intakes by demographic and lifestyle factors for the Australian population (and consumer population) in 2011–12 NNPAS 
 
Stratification 
variable 
N Anthocyanins(mg/d) Cyanidins (mg/d) Delphinidin (mg/d) Malvidin (mg/d) Pelargonidin (mg/d) Peonidin (mg/d) Petunidin (mg/d) 
Mean SE P Mean SE P Mean SE P Mean SE P Mean SE P Mean SE P Mean SE P 
 
Total NNPAS 
population 
(consumer 
population)     
 
Gender 
 
Male 
 
 
Female 
 
 
Age group (yrs.) 
 
Children (≤18) 
 
 
2-3 
 
 
4-8 
 
 
9-13 
 
 
14-18 
 
 
Adults (≥19) 
 
 
19-30 
 
 
31-50 
 
 
51-70 
 
12153 
 
(8958) 
 
 
 
 
5702 
(4030) 
 
6451 
(4928) 
 
 
 
2812 
(2071) 
 
464 
(378) 
 
789 
(633) 
 
787 
(576) 
 
772 
(484) 
 
9341 
(6887) 
 
1592 
(1017) 
 
3565 
(2543) 
 
2907 
 
24.17 
 
(37.68) 
 
 
 
 
23.62 
(38.27) 
 
24.72 
(37.14) 
 
 
 
22.46 
35.25 
 
21.51 
(31.11) 
 
26.06 
(37.04) 
 
22.92 
(36.29) 
 
18.56 
(33.69) 
 
24.66 
38.38 
 
19.24 
(34.24) 
 
25.66 
(40.55) 
 
27.75 
 
0.32 
 
(0.41) 
 
 
 
 
0.41 
(0.63) 
 
0.47 
(0.67) 
 
 
 
0.58 
0.90 
 
1.40 
(1.86) 
 
1.30 
(1.78) 
 
0.91 
(1.40) 
 
0.87 
(1.74) 
 
0.35 
0.44 
 
0.68 
(1.07) 
 
0.66 
(0.91) 
 
0.65 
 
 
 
 
 
 
<0.001 
(<0.001) 
 
 
 
 
 
 
<0.001 
(<0.001) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9.33 
 
(15.22) 
 
 
 
 
9.41 
(16.04) 
 
9.27 
(14.49) 
 
 
 
10.97 
(17.96) 
 
7.54 
(11.06) 
 
12.31 
(18.60) 
 
12.02 
(20.01) 
 
9.80 
(18.13) 
 
8.87 
(14.43) 
 
8.48 
(15.73) 
 
9.58 
(15.79) 
 
8.88 
 
0.13 
 
(0.23) 
 
 
 
 
0.17 
(0.33) 
 
0.18 
(0.29) 
 
 
 
0.28 
(0.45) 
 
0.43 
(0.83) 
 
0.75 
(1.17) 
 
0.53 
(0.86) 
 
0.51 
(1.09) 
 
0.13 
(0.23) 
 
0.29 
(0.60) 
 
0.27 
(0.45) 
 
0.24 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.03 
 
(5.07) 
 
 
 
 
2.83 
(4.89) 
 
3.22 
(5.24) 
 
 
 
2.51 
(4.04) 
 
3.45 
(5.59) 
 
3.12 
(4.59) 
 
2.11 
(3.42) 
 
1.94 
(3.29) 
 
3.17 
(5.37) 
 
2.42 
(4.60) 
 
3.22 
(5.48) 
 
3.55 
 
0.07 
 
(0.12) 
 
 
 
 
0.06 
(0.11) 
 
0.13 
(0.22) 
 
 
 
0.11 
(0.18) 
 
0.28 
(0.44) 
 
0.34 
(0.52) 
 
0.12 
(0.21) 
 
0.12 
(0.22) 
 
0.07 
(0.13) 
 
0.13 
(0.25) 
 
0.14 
(0.25) 
 
0.13 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.61 
 
(14.14) 
 
 
 
 
7.46 
(14.46) 
 
7.76 
(13.85) 
 
 
 
4.86 
(9.33) 
 
6.34 
(11.18) 
 
6.51 
(11.55) 
 
4.38 
(8.54) 
 
3.06 
(6.41) 
 
8.39 
(15.52) 
 
4.62 
(10.08) 
 
8.40 
(15.84) 
 
10.97 
 
0.20 
 
(0.42) 
 
 
 
 
0.29 
(0.67) 
 
0.23 
(0.48) 
 
 
 
0.33 
(0.72) 
 
0.89 
(1.53) 
 
0.67 
(1.25) 
 
0.49 
(1.14) 
 
0.44 
(1.22) 
 
0.23 
(0.47) 
 
0.45 
(1.43) 
 
0.41 
(0.85) 
 
0.49 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.12 
 
(0.21) 
 
 
 
 
0.11 
(0.21) 
 
0.13 
(0.21) 
 
 
 
0.11 
(0.20) 
 
0.14 
(0.27) 
 
0.16 
(0.26) 
 
0.09 
(0.16) 
 
0.07 
(0.14) 
 
0.12 
(0.21) 
 
0.16 
(0.33) 
 
0.11 
(0.17) 
 
0.11 
 
0.01 
 
(0.02) 
 
 
 
 
0.01 
(0.03) 
 
0.01 
(0.02) 
 
 
 
0.01 
(0.02) 
 
0.02 
(0.04) 
 
0.02 
(0.03) 
 
0.01 
(0.02) 
 
0.01 
(0.02) 
 
0.01 
(0.02) 
 
0.04 
(0.09) 
 
0.01 
(0.01) 
 
0.01 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.12 
 
(1.99) 
 
 
 
 
1.08 
(1.98) 
 
1.16 
(2.00) 
 
 
 
0.89 
(1.58) 
 
0.99 
(1.67) 
 
1.51 
(1.87) 
 
0.83 
(1.50) 
 
0.64 
(1.25) 
 
1.18 
(2.11) 
 
0.78 
(1.61) 
 
1.19 
(2.13) 
 
1.46 
 
0.02 
 
(0.05) 
 
 
 
 
0.03 
(0.07) 
 
0.04 
(0.08) 
 
 
 
0.05 
(0.09) 
 
0.13 
(0.21) 
 
0.11 
(0.19) 
 
0.06 
(0.11) 
 
0.06 
(0.15) 
 
0.03 
(0.06) 
 
0.05 
(0.15) 
 
0.05 
(0.09) 
 
0.06 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.05 
 
(1.98) 
 
 
 
 
1.00 
(1.97) 
 
1.10 
(2.00) 
 
 
 
0.57 
(1.08) 
 
0.83 
(1.49) 
 
0.83 
(1.40) 
 
0.43 
(0.87) 
 
0.36 
(0.72) 
 
1.19 
(2.24) 
 
0.57 
(1.29) 
 
1.24 
(2.35) 
 
1.54 
 
0.04 
 
(0.08) 
 
 
 
 
0.04 
(0.09) 
 
0.06 
(0.13) 
 
 
 
0.07 
(0.14) 
 
0.16 
(0.27) 
 
0.19 
(0.31) 
 
0.06 
(0.15) 
 
0.07 
(0.18) 
 
0.04 
(0.08) 
 
0.06 
(0.16) 
 
0.07 
(0.15) 
 
0.08 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
<0.001 
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Stratification 
variable 
N Anthocyanins(mg/d) Cyanidins (mg/d) Delphinidin (mg/d) Malvidin (mg/d) Pelargonidin (mg/d) Peonidin (mg/d) Petunidin (mg/d) 
Mean SE P Mean SE P Mean SE P Mean SE P Mean SE P Mean SE P Mean SE P 
 
 
71+ 
 
 
BMI (kg/m2) 
 
< 25 
 
 
25 to < 30 
 
 
≥ 30 
 
 
Measurement 
not taken 
 
Level of 
education 
 
Not applicable 
 
 
Post-Grad  
 
 
Bachelors 
 
 
Diploma/TAFE 
Courses 
 
No Non-School 
Qualification 
 
Level not 
determined 
 
 
Smoking status 
 
Not applicable 
 
(2300) 
 
1277 
(1027) 
 
 
 
4876 
(3668) 
 
3044 
(2274) 
 
2258 
(1607) 
 
1975 
(1409) 
 
 
 
 
2180 
(1676) 
 
770 
(629) 
 
1615 
(1304) 
 
3252 
(2341) 
 
4190 
(2893) 
 
146 
(115) 
 
 
 
 
2180 
(1676) 
(40.20) 
 
24.61 
(33.64) 
 
 
 
24.38 
(37.76) 
 
25.51 
(39.10) 
 
23.23 
(37.02) 
 
22.46 
(35.68) 
 
 
 
 
23.64 
(35.87) 
 
30.09 
(44.42) 
 
29.90 
(44.07) 
 
24.61 
(39.10) 
 
20.57 
(32.99) 
 
29.06 
(41.95) 
 
 
 
 
23.64 
(35.87) 
(0.97) 
 
1.15 
(1.37) 
 
 
 
0.59 
(0.83) 
 
0.58 
(0.87) 
 
0.76 
(1.06) 
 
0.69 
(1.09) 
 
 
 
 
0.70 
(1.08) 
 
1.47 
(1.92) 
 
1.22 
(1.63) 
 
0.56 
(0.77) 
 
0.43 
(0.71) 
 
2.40 
(3.71) 
 
 
 
 
0.70 
(1.08) 
 
 
 
 
 
<0.001 
(<0.001) 
 
 
 
 
 
 
 
 
 
 
 
 
<0.001 
(<0.001) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<0.001 
(<0.001) 
 
 
(13.39) 
 
7.29 
(10.80) 
 
 
 
9.91 
(16.04) 
 
9.21 
(14.92) 
 
8.53 
(14.09) 
 
8.96 
(14.74) 
 
 
 
 
11.36 
(18.06) 
 
10.08 
(15.66) 
 
10.84 
(16.84) 
 
8.74 
(14.39) 
 
8.08 
(13.54) 
 
9.32 
(14.21) 
 
 
 
 
11.36 
(18.06) 
(0.42) 
 
0.32 
(0.48) 
 
 
 
0.21 
(0.39) 
 
0.25 
(0.41) 
 
0.30 
(0.53) 
 
0.31 
(0.56) 
 
 
 
 
0.35 
(0.61) 
 
0.57 
(0.81) 
 
0.35 
(0.54) 
 
0.21 
(0.38) 
 
0.22 
(0.44) 
 
1.04 
(1.69) 
 
 
 
 
0.35 
(0.61) 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<0.001 
 
 
 
(5.71) 
 
3.64 
(5.37) 
 
 
 
3.02 
(4.99) 
 
3.10 
(5.24) 
 
3.08 
(5.34) 
 
2.86 
(4.71) 
 
 
 
 
2.65 
(4.21) 
 
3.70 
(5.88) 
 
3.75 
(6.13) 
 
3.07 
(5.23) 
 
2.72 
(4.68) 
 
4.43 
(7.32) 
 
 
 
 
2.65 
(4.21) 
(0.27) 
 
0.22 
(0.33) 
 
 
 
0.14 
(0.22) 
 
0.09 
(0.19) 
 
0.15 
(0.28) 
 
0.13 
(0.27) 
 
 
 
 
0.14 
(0.22) 
 
0.22 
(0.40) 
 
0.27 
(0.46) 
 
0.12 
(0.19) 
 
0.07 
(0.17) 
 
0.67 
(0.35) 
 
 
 
 
0.14 
(0.22) 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<0.001 
 
 
 
(18.96) 
 
9.60 
(14.16) 
 
 
 
7.29 
(13.73) 
 
8.96 
(16.70) 
 
7.36 
(13.36) 
 
6.51 
(11.67) 
 
 
 
 
5.39 
(10.10) 
 
11.46 
(20.61) 
 
10.07 
(18.23) 
 
8.71 
(16.56) 
 
6.07 
(11.02) 
 
10.25 
(17.42) 
 
 
 
 
5.39 
(10.10) 
(0.98) 
 
0.61 
(0.99) 
 
 
 
0.30 
(0.64) 
 
0.45 
(0.96) 
 
0.46 
(0.99) 
 
0.43 
(0.92) 
 
 
 
 
0.38 
(0.81) 
 
0.86 
(1.68) 
 
0.65 
(1.27) 
 
0.35 
(0.74) 
 
0.25 
(0.59) 
 
1.60 
(3.00) 
 
 
 
 
0.38 
(0.81) 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<0.001 
 
 
 
(0.18) 
 
0.14 
(0.23) 
 
 
 
0.14 
(0.24) 
 
0.12 
(0.21) 
 
0.09 
(0.17) 
 
0.09 
(0.16) 
 
 
 
 
0.12 
(0.22) 
 
0.12 
(0.20) 
 
0.17 
(0.32) 
 
0.12 
(0.19) 
 
0.10 
(0.18) 
 
0.09 
(0.15) 
 
 
 
 
0.12 
(0.22) 
(0.02) 
 
0.05 
(0.09) 
 
 
 
0.02 
(0.03) 
 
0.02 
(0.04) 
 
0.02 
(0.04) 
 
0.01 
(0.01) 
 
 
 
 
0.01 
(0.02) 
 
0.02 
(0.02) 
 
0.04 
(0.08) 
 
0.02 
(0.03) 
 
0.02 
(0.04) 
 
0.02 
(0.04) 
 
 
 
 
0.01 
(0.02) 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<0.01 
 
 
 
(2.46) 
 
1.27 
(1.91) 
 
 
 
1.12 
(1.99) 
 
1.25 
(2.24) 
 
1.06 
(1.91) 
 
0.97 
(1.62) 
 
 
 
 
0.96 
(1.68) 
 
1.57 
(2.69) 
 
1.46 
(2.52) 
 
1.22 
(2.24) 
 
0.89 
(1.55) 
 
1.35 
(2.15) 
 
 
 
 
0.96 
(1.68) 
(0.11) 
 
0.09 
(0.16) 
 
 
 
0.04 
(0.08) 
 
0.05 
(0.10) 
 
0.06 
(0.12) 
 
0.05 
(0.10) 
 
 
 
 
0.06 
(0.11) 
 
0.10 
(0.20) 
 
0.09 
(0.17) 
 
0.04 
(0.10) 
 
0.03 
(0.06) 
 
0.17 
(0.31) 
 
 
 
 
0.06 
(0.11) 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<0.001 
 
 
 
(2.75) 
 
1.39 
(2.14) 
 
 
 
1.03 
(1.96) 
 
1.24 
(2.36) 
 
1.00 
(1.90) 
 
0.82 
(1.47) 
 
 
 
 
0.62 
(1.16) 
 
1.71 
(3.09) 
 
1.54 
(2.86) 
 
1.21 
(2.35) 
 
0.80 
(1.48) 
 
1.53 
(2.70) 
 
 
 
 
0.62 
(1.16) 
(0.16) 
 
0.15 
(0.24) 
 
 
 
0.07 
(0.13) 
 
0.06 
(0.14) 
 
0.07 
(0.18) 
 
0.06 
(0.13) 
 
 
 
 
0.09 
(0.17) 
 
0.14 
(0.28) 
 
0.13 
(0.26) 
 
0.06 
(0.14) 
 
0.04 
(0.08) 
 
0.27 
(0.53) 
 
 
 
 
0.09 
(0.17) 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<0.001 
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Stratification 
variable 
N Anthocyanins(mg/d) Cyanidins (mg/d) Delphinidin (mg/d) Malvidin (mg/d) Pelargonidin (mg/d) Peonidin (mg/d) Petunidin (mg/d) 
Mean SE P Mean SE P Mean SE P Mean SE P Mean SE P Mean SE P Mean SE P 
 
Smoker 
 
 
Ex-smoker 
 
 
Never smoked 
 
 
Physical activity 
 
Not applicable 
 
 
High 
 
 
Moderate 
 
 
Low 
 
 
Sedentary 
 
 
Not stated 
 
 
1813 
(1073) 
 
3096 
(2365) 
 
5064 
(3844) 
 
 
 
2718 
(2010) 
 
1328 
(1066) 
 
2574 
(1950) 
 
3351 
(2461) 
 
2075 
(1398) 
 
107 
(73) 
 
 
18.21 
(32.61) 
 
27.68 
(41.65) 
 
24.33 
(37.41) 
 
 
 
22.64 
(35.28) 
 
30.04 
(43.83) 
 
25.99 
(39.50) 
 
23.57 
(37.13) 
 
20.42 
(34.05) 
 
26.59 
(39.30) 
 
0.68 
(1.10) 
 
0.88 
(1.34) 
 
0.45 
(0.70) 
 
 
 
0.60 
(0.93) 
 
1.11 
(1.24) 
 
0.69 
(0.96) 
 
0.57 
(0.83) 
 
0.73 
(1.27) 
 
4.93 
(6.77) 
 
 
 
 
 
 
 
 
 
 
<0.001 
(<0.001) 
 
 
7.28 
(13.38) 
 
9.40 
(14.81) 
 
9.18 
(14.79) 
 
 
 
10.99 
(17.91) 
 
11.34 
(17.63) 
 
9.17 
(14.55) 
 
8.44 
(13.92) 
 
7.40 
(12.56) 
 
12.55 
(19.03) 
 
0.34 
(0.68) 
 
0.28 
(0.45) 
 
0.20 
(0.33) 
 
 
 
0.28 
(0.48) 
 
0.48 
(0.67) 
 
0.28 
(0.43) 
 
0.20 
(0.37) 
 
0.27 
(0.49) 
 
3.28 
(5.12) 
 
 
 
 
 
 
 
 
 
 
<0.001 
 
 
 
 
 
2.20 
(4.14) 
 
3.38 
(5.42) 
 
3.24 
(5.46) 
 
 
 
2.54 
(4.09) 
 
3.92 
(6.33) 
 
3.32 
(5.53) 
 
2.99 
(5.06) 
 
2.68 
(4.74) 
 
3.28 
(4.86) 
 
0.11 
(0.25) 
 
0.12 
(0.21) 
 
0.11 
(0.20) 
 
 
 
0.11 
(0.19) 
 
0.35 
(0.53) 
 
0.10 
(0.20) 
 
0.10 
(0.19) 
 
0.15 
(0.31) 
 
0.67 
(1.15) 
 
 
 
 
 
 
 
 
 
 
<0.001 
 
5.27 
(10.52) 
 
10.44 
(18.77) 
 
7.65 
(14.01) 
 
 
 
4.98 
(9.53) 
 
9.58 
(17.28) 
 
9.33 
(17.07) 
 
8.12 
(15.05) 
 
6.44 
(12.04) 
 
7.15 
(11.82) 
 
 
0.33 
(0.87) 
 
0.56 
(1.10) 
 
0.27 
(0.58) 
 
 
 
0.35 
(0.75) 
 
0.72 
(1.26) 
 
0.40 
(0.83) 
 
0.38 
(0.78) 
 
0.45 
(1.04) 
 
1.54 
(3.13) 
 
 
 
 
 
 
 
 
 
 
<0.001 
 
0.15 
(0.26) 
 
0.11 
(0.17) 
 
0.12 
(0.22) 
 
 
 
0.11 
(0.20) 
 
0.11 
0.20) 
 
0.13 
(0.21) 
 
0.10 
(0.19) 
 
0.15 
0.25) 
 
0.21 
(0.37) 
 
0.05 
(0.11) 
 
0.01 
(0.01) 
 
0.01 
(0.03) 
 
 
 
0.01 
(0.02) 
 
0.01 
(0.02) 
 
0.02 
(0.04) 
 
0.01 
(0.03) 
 
0.04 
(0.08) 
 
0.12 
(0.23) 
 
 
 
 
 
 
 
 
 
 
ns 
 
0.78 
(1.43) 
 
1.42 
(2.48) 
 
1.12 
(1.97) 
 
 
 
0.90 
(1.60) 
 
1.45 
(2.49) 
 
1.31 
(2.30) 
 
1.13 
(2.01) 
 
0.90 
(1.63) 
 
0.99 
(1.57) 
 
0.04 
(0.10) 
 
0.07 
(0.13) 
 
0.03 
(0.07 
 
 
 
0.05 
(0.10) 
 
0.09 
(0.17) 
 
0.05 
(0.10) 
 
0.05 
(0.09) 
 
0.05 
(0.13) 
 
0.17 
(0.32) 
 
 
 
 
 
 
 
 
 
 
<0.001 
 
0.73 
(1.47) 
 
1.52 
(2.82) 
 
1.06 
(1.96) 
 
 
 
0.57 
(1.09) 
 
1.47 
(2.73) 
 
1.39 
(2.62) 
 
1.08 
(2.01) 
 
0.86 
(1.62) 
 
1.00 
(1.78) 
 
0.05 
(0.13) 
 
0.09 
(0.18) 
 
0.05 
(0.10) 
 
 
 
0.08 
(0.15) 
 
0.14 
(0.24) 
 
0.07 
(0.15) 
 
0.06 
(0.12) 
 
0.07 
(0.17) 
 
0.22 
(0.45) 
 
 
 
 
 
 
 
 
 
 
 
<0.001 
p values significant at <0.05 using ANOVA 
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Table 6-7: Top ten food sources of anthocyanins in the diet of the Australian population, by age-group 
 
  
% total anthocyanin intake per age group 
 
Age (years) 
n 
2-3 
464 
4-8 
7891 
9-13 
787 
14-18 
7722 
19-30 
1592 
31-50 
3565 
51-70 
2907 
71+ 
1277 
 
1. 
 
 
2. 
 
 
3. 
 
 
4. 
 
 
 
5. 
 
 
 
6. 
 
 
 
7. 
 
 
 
8. 
 
 
 
9. 
 
 
 
10 
 
 
 
Sum 
 
Blackberry, 
raw 
 
Raspberry, 
raw 
 
Blueberry, 
raw 
 
Grape, 
raw3 
 
 
Cabbage, 
red, raw 
 
 
Cherry, 
raw 
 
Raspberry, 
purchased 
frozen 
 
Plum, 
unpeeled, 
raw 
 
Eggplant4 
 
 
 
Blueberry, 
purchased 
frozen 
 
36.6 
 
 
12.8 
 
 
10.3 
 
 
8.6 
 
 
 
8.8 
 
 
 
4.0 
 
 
3.4 
 
 
 
3.2 
 
 
 
2.7 
 
 
 
1.4 
 
 
 
91.8 
 
Blackberry, 
raw 
 
Blueberry, 
raw 
 
Grape, raw3 
 
 
Cherry, raw 
 
 
 
Raspberry, 
purchased 
frozen 
 
Plum, 
unpeeled, raw 
 
Blueberry, 
purchased 
frozen 
 
Eggplant4 
 
 
 
Raspberry, 
raw 
 
 
Apple, pink 
lady, 
unpeeled, raw 
 
65.2 
 
 
8.3 
 
 
4.9 
 
 
2.6 
 
 
 
2.4 
 
 
 
2.4 
 
 
2.1 
 
 
 
2.0 
 
 
 
1.3 
 
 
 
0.9 
 
 
 
92.1 
 
Blackberry, 
raw 
 
Blueberry, raw 
 
 
Grape, raw3 
 
 
Cherry, raw 
 
 
 
Eggplant4 
 
 
 
Plum, 
unpeeled, raw 
 
Raspberry, raw 
 
 
 
Raspberry, 
purchased 
frozen 
 
Apple, red 
skin, unpeeled, 
raw 
 
Pear, unpeeled, 
raw, not further 
defined 
 
37.5 
 
 
12.7 
 
 
11.2 
 
 
7.3 
 
 
 
7.0 
 
 
 
4.8 
 
 
3.2 
 
 
 
2.6 
 
 
 
1.6 
 
 
 
1.3 
 
 
 
89.2 
 
Cherry, raw 
 
 
Eggplant,4 
 
 
Grape, raw3 
 
 
Raspberry, 
purchased 
frozen 
 
Blueberry, raw 
 
 
 
Cabbage, red, 
raw 
 
Plum, 
unpeeled, raw 
 
 
Blueberry, 
purchased 
frozen 
 
Apple, red 
skin, 
unpeeled, raw 
 
Pear, 
unpeeled, raw, 
not further 
defined 
 
23.9 
 
 
15.7 
 
 
14.9 
 
 
8.9 
 
 
 
8.5 
 
 
 
5.9 
 
 
5.4 
 
 
 
2.0 
 
 
 
1.7 
 
 
 
1.5 
 
 
 
88.5 
 
Grape, raw,3 
 
 
Cherry, raw 
 
 
Cranberry, 
raw 
 
Eggplant,4 
 
 
 
Plum, 
unpeeled, 
raw 
 
Bean, black,5 
 
 
Raspberry, 
purchased 
frozen 
 
Blueberry, 
raw 
 
 
Wine, red 
 
 
 
Raspberry, 
raw 
 
15.4 
 
 
8.5 
 
 
8.2 
 
 
5.3 
 
 
 
4.9 
 
 
 
4.5 
 
 
3.9 
 
 
 
3.8 
 
 
 
3.8 
 
 
 
3.2 
 
 
 
61.6 
 
Eggplant,4 
 
 
Blackberry, 
raw 
 
Cherry, raw 
 
 
Blueberry, 
raw 
 
 
Raspberry, 
raw 
 
 
Cranberry, 
raw 
 
Grape, black 
sultana, raw 
 
 
Radish, 
peeled or 
unpeeled, raw 
 
Raspberry, 
purchased 
frozen 
 
Wine, red, 
sparkling 
 
8.1 
 
 
7.4 
 
 
5.7 
 
 
5.1 
 
 
 
4.9 
 
 
 
4.8 
 
 
4.6 
 
 
 
4.4 
 
 
 
4.3 
 
 
 
4.1 
 
 
 
53.5 
 
Eggplant,4 
 
 
Grape, raw,3 
 
 
Blackberry, 
raw 
 
Wine, red 
 
 
 
Blueberry, 
raw 
 
 
Cherry, raw 
 
 
Plum, 
unpeeled, raw 
 
 
Raspberry, 
raw 
 
 
Blueberry, 
purchased 
frozen 
 
Cabbage, red, 
raw 
 
23.1 
 
 
9.1 
 
 
8.4 
 
 
7.8 
 
 
 
7.1 
 
 
 
6.3 
 
 
4.7 
 
 
 
2.9 
 
 
 
2.6 
 
 
 
2.4 
 
 
 
74.4 
 
Eggplant,4 
 
 
Wine, red, 
 
 
Cherry, raw 
 
 
Blueberry, 
raw 
 
 
Blackberry, 
raw 
 
 
Plum, 
unpeeled, raw 
 
Raspberry, 
purchased 
frozen 
 
Grape, 
Thompson, 
 
 
Radish, raw 
 
 
 
Raspberry, 
raw 
 
26.4 
 
 
10.3 
 
 
8.3 
 
 
7.1 
 
 
 
5.1 
 
 
 
4.9 
 
 
4.7 
 
 
 
3.4 
 
 
 
3.2 
 
 
 
2.9 
 
 
 
76.3 
1n=2 excluded due to implausible dietary consumption data, 2n=1 excluded due to implausible dietary consumption data, 3Combination of Grape, raw, Grape, red, raw, and Grape, Thompson, seedless; 4Eggplant, peeled or unpeeled, fresh or frozen, raw; 5Bean, black, dried, boiled, microwaved or steamed, drained 
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Table 6-8: Association between anthocyanin intake and change in blood pressure in adults aged 50+yrs 
 
 
BP 
parameters 
Anthocyanin intake in all population (consumer population) 
Effect size (regression coefficient and 95% Confidence Interval) per unit (mg) increase 
 
Model 11  
n=4184 (3327) 
Model 22 
n=4184 (3327) 
Regression 
coefficient 
95% CI p value Regression 
coefficient 
95% CI p value 
 
Systolic BP 
 
 
Gender 
 
 
BMI 
 
 
High BP 
diagnosis 
 
Smoking 
status  
 
Physical 
activity 
 
 
Diastolic BP 
 
 
Gender 
 
 
BMI 
 
 
High BP 
diagnosis 
 
Smoking 
status  
 
Physical 
activity 
 
 
-0.04 
(-0.03) 
 
-2.50 
(-2.51) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.01 
(0.01) 
 
-1.56 
(-1.31) 
 
-0.06, -0.01 
(-0.05, -0.01) 
 
-4.28, -0.72 
(-4.45, -0.58) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-0.01, 0.02 
(-0.01, 0.02)  
 
-2.51, -0.62 
(-2.40, -0.22) 
 
0.001* 
(0.002)* 
 
0.01 
(0.01) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.005* 
(0.03) 
 
0.002 
(0.02) 
 
-0.04 
(-0.03) 
 
-2.67 
(-2.68) 
 
0.06 
(0.1) 
 
-7.92 
(-7.38) 
 
0.70 
(1.06) 
 
0.09  
(0.15) 
 
 
0.01 
(0.01) 
 
-1.52 
(-1.30) 
 
0.06 
(0.06) 
 
-0.77 
(-0.54) 
 
-0.24 
(-0.19) 
 
-0.09 
(-0.04) 
 
-0.06, -0.01 
(-0.05, -0.01) 
 
-4.40, -0.94 
(-4.62, -0.74) 
 
-0.002, 0.12 
(-0.004, 0.1) 
 
-9.80, -6.05 
(-9.63, -5.12) 
 
-0.06, 1.46 
(0.11, 2.01) 
 
-0.61, 0.78 
(-0.63, 0.92) 
 
 
-0.01, 0.03 
(-0.01, 0.02) 
 
-2.49, -0.54 
(-2.42, -0.18) 
 
0.03, 0.09 
(0.02, 0.11) 
 
-1.76, 0.22 
(-1.64, 0.55) 
 
-0.64, 0.16 
(-0.68, 0.30) 
 
-0.53, 0.35 
(-0.49, 0.42) 
 
<0.01* 
 (<0.01)* 
 
0.003* 
(0.01)* 
 
0.06 
(0.07) 
 
<0.001* 
(<0.001)* 
 
0.07 
(0.03)* 
 
0.80 
(0.7) 
 
 
<0.01* 
 (0.02)* 
 
0.002* 
(0.02)* 
 
<0.001* 
(0.01)* 
 
0.12 
(0.33) 
 
0.24 
(0.44) 
 
0.68 
(0.88) 
1 Model 1 covariates = age (included as a class variable) and gender; 2Model 2 covariates = age (included as a class variable), gender, 
BMI, hypertension diagnosis, Physical activity and smoking status; * Significant at p<0.05; values in bracket represent analysis for 
consumer population. 
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6.1.2.4 Discussion 
 
Using nationally representative dietary survey data, this study reports an observed wide distribution of 
anthocyanin intake in the Australian population. The estimated mean intake was 24.17 ± 0.32mg/d which is 
midway between estimates reported for other populations that range between 2.9 and 42.79mg/d (Table 6-
9), and was above average in comparison to the world composite database [376]. There were variations in 
anthocyanin intake across subgroups analysed, for example a higher anthocyanin intake in the 51-70y age-
group (27.75 ± 0.65 mg/d) compared to the lowest consumption (18.56 ± 0.87 mg/d) in the 14-18y age-
group (p<0.001). Adults with a post-graduate qualification had higher anthocyanin intakes (30.09 ± 1.47 
mg/d) compared to those without school qualifications (20.57 ± 0.43mg/d) (p<0.001), while highly active 
adults (30.04 ± 1.11mg/d) had higher intakes compared to sedentary respondents (20.42 ± 0.73mg/d) 
(p<0.001). These results are consistent with previous reports on the significant association between socio-
demographic and lifestyle factors and fruit and vegetable consumption [377-380]. Surprisingly, ex-smokers 
reportedly consumed significantly higher daily anthocyanins (27.68 ± 0.88 mg/d), more than both smokers 
(18.21 ± 0.68 mg/d) and non-smokers (24.33 ± 0.45 mg/d). Zamora-Ros et al.(2010) [381] similarly 
reported that  ex-smokers consumed more anthocyanins (11.16mg/d) than non-smokers (10.62mg/d).  
 
Estimation of anthocyanin intake in the Australian population is an important preliminary step in 
understanding anthocyanin-health relationships. Despite increased research interest on the observed health 
benefits of anthocyanins provided by food and beverages, the accompanying increased prevalence of 
consumption of processed foods translates to a reduced consumption of dietary anthocyanins [382]. In the 
1970s, average daily dietary anthocyanin intake in the USA. was estimated at 215 mg/d in the summer and 
180 mg/d during winter [383]. Current estimates show that dietary anthocyanin intake ranges between 3-
43mg/day across countries and tends to be higher in Southern compared to Northern European countries 
(Table 6-9).  
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Table 6-9: Reported anthocyanin intake (mg/d) in population studies by country 
 
Country (reference) Sample size Age/Gender1 Dietary assessment Total anthocyanin 
intake (mg/d) 
 
Australia (this study) 
 
 
Australia [337] 
 
 
12,153 
 
 
10,851 
 
 
≥2yrs 
 
 
≥2yrs. 
 
 
2 x 24h DR (MSM 
method) 
 
24h DR 
 
 
24.17 
 
 
1.4 
 
Australia [338] 
 
79 
 
≥49yrs 4-day WFR 
 
7.0 
 
China [384] 
 
1393 
 
35-75 
 
FFQ 
 
282 
 
Europe [385]  35-74yrs. FFQ (GA2LEN)  
Denmark 268   7.5 
Finland 122   5.9 
Sweden 1,085   6.5 
UK 139   9.8 
Portugal 233   22.1 
Belgium 107   10.5 
Germany 305   5.5 
Netherlands 
(Amsterdam) 
174 
 
  8.1 
Poland 116 
 
  9.2 
 
Europe [386]  35-74yrs. 24h DR  
Greece 2,687   31.82 
Spain 3,220   31.58 
Italy 3,953 35-74yrs./F (1 out of 
5 centres) 
 42.79 
 
France 4,735   37.42 
Germany 4,415 35-74yrs./F  35.09 
The 
Netherlands 
3,980   22.56 
UK 1,280 35-74yrs./F (1 out of 
2 centres) 
 26.12 
 
Denmark 3,917   28.21 
Sweden 6,050   20.96 
Norway 
 
1,797 35-74yrs./F  26.56 
Finland [387] 
 
1950 
 
42-60yrs./M 
 
4-day food record 
 
6.2 
 
Finland [388] 
 
2007 
 
25-64yrs. 
 
48h diet recall 
 
47 
 
France [389] 
 
4942 
 
45-60yrs. 
 
≥6 24h diet recall 
 
35 
 
Spain [381] 
 
40,683 
 
35-64yrs. 
 
Diet history 
questionnaire  
 
18.88 
 
United Kingdom [390] 
 
1,997 
 
18-76yrs./F 
 
FFQ 
 
18 
 
USA [391] 
 
8,809 
 
>19yrs. 
 
24h diet recall 
 
3.1 
 
USA [392] 
 
5,420 ≥20 24h diet recall 11.48 
1 gender specified when sample size is gender specific; WFR, weighted food record; 24hrDR, 24hr dietary recall; 2excludes malvidin 
and petunidin  
 
Consumption of anthocyanin subclasses were also reported for the total and consumer populations. 
Cyanidins and malvidins were the most prevalent anthocyanins in both the general and consumer 
 
 
167 
 
populations and across subgroups. In the 51-70y age-group, malvidins were the most prevalent 
anthocyanins. This could be explained by the difference in consumption pattern of the major food 
contributors of anthocyanins in this age-group being red wine, which has a high content of malvidins. A 
similar trend was also observed in other Australian population studies [337, 338] with red wine being 
reported as a major contributor of anthocyanins in older participants. The highest contributing foods (top 
10) of dietary anthocyanin in the Australian population were berries, principally blueberries, blackberries, 
raspberries, and cherries. Berries are known to contain a very high concentration of anthocyanins [393]. 
Given this, anthocyanin research has generally focused on berries at the expense of other high anthocyanin 
foods, such as plums and eggplants which also made up some of the top 10 contributors of anthocyanins in 
the Australian population.  Accordingly, it might be worth further exploration to gather epidemiological 
evidence of the health-related benefits related to these foods.  
 
Results from this study showed a significant association between anthocyanin intake in older adults and 
lower blood pressure. This result is in agreement with current evidence from clinical and epidemiological 
studies on the effect of dietary anthocyanins on blood pressure in acute settings and over the longer term 
[214, 301, 394] . Anthocyanins have also been classified as nutraceuticals in their ability, as part of a food 
component, to provide health and medical benefits [395]. However, it is unlikely that these health benefits 
are the independent effects of anthocyanins but rather represent a synergistic effect with other polyphenols 
found in foods [396]. This emphasises the importance of studying anthocyanin food sources, consistent 
with this study, rather than isolated anthocyanin extracts. A review by Pascual-Teresa et al. (2010) [397] 
observed that evidence related to the protective effects of anthocyanins, as part of the diet,  against 
cardiovascular disease risks has been consistent over the years.  Dietary patterns  high in fruits and 
vegetables such as blueberries, apples, and leafy greens that are high in natural antioxidants and 
polyphenols (anthocyanins) have been shown to reduce the risk of high blood pressure [398] and other 
chronic diseases evident in the Dietary Inflammatory Index (DII) [399]. This evidence has been consistent 
with similar dietary patterns. Using the Dietary Inflammatory Index, Steck et. al (2014) [400] found that 
the Mediterranean diet  showed anti-inflammatory potential based on the resulting DII scores. In addition, 
the Nordic diet significantly reduced 24-h ambulatory diastolic blood pressure (DBP) and mean arterial 
pressure in comparison to a control diet based on mean nutrient intakes in Nordic countries [401]. Other  
dietary patterns that emphasise high fruit and vegetable intake (the Dietary Approach to Stop 
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Hypertension), low-carbohydrate, Palaeolithic, high-protein, low-glycaemic index, low-sodium, and low-
fat diets) were  also found to significantly reduce blood pressure (systolic blood pressure (−8.73 to 
−2.32 mmHg) and DBP (−4.85 to −1.27 mmHg)) in comparison to control/usual diets [402]. Attributable 
risk related to the polyphenols present in these diets (i.e. anthocyanins) cannot be disentangled from other 
health-promoting components of key foods included in these blood pressure lowering dietary patterns.  
 
Previous studies have estimated the dietary flavonoid intake in selected Australian populations using 
weighed food records [338] and from National Nutrition Survey (1995) data using a single 24-h dietary 
recall questionnaire [337]. Our results using the latest nationally representative survey data differ 
significantly from earlier studies with higher values reported in the current study. This is possibly due to 
differences in the method of dietary assessments, as well as the use of the MSM to calculate usual daily 
intake from two repeated 24-h dietary recalls. Differences could also be as a result of difference/change in 
population characteristics.  Our analysis indicates that the Australian population consume intermediate 
quantities of anthocyanins compared to other populations (Table 6-9), but that are similar to estimates from 
some European countries including Belgium, Norway, Sweden and Denmark [385, 386]. A need for 
tailored food composition databases for nutritional epidemiological studies cannot be overemphasised. 
Following the development of the first Australian food composition database in the mid-1980s, 
comparative analysis showed that using the UK and US databases overestimated specific nutrient contents 
by up to 60% [403]. As a result, it is imperative that databases be tailored to the specific food supply of the 
population under study. However, development of nutrient databases is fraught with incomplete coverage 
of all nutrients hence, borrowing and calculating nutrient values is a known validated method in the 
absence of analytical values [404]. 
 
To our knowledge, this is the first time that dietary anthocyanin intake in the Australian population has 
been estimated using an Australian-specific anthocyanin database, this being a major methodological 
strength. Another notable strength is the use of a representative sample of the Australian population, as 
well as the validated method (MSM) of calculating usual nutrient intake from repeated 24h dietary recalls 
[371]. Some of the limitations of this study include the use of 24-h diet recall questionnaires in the NNPAS 
(1-2).  The single 24-h diet recall has been deemed insufficient because of the retrospective method of 
dietary assessment and an inability to describe the typical diet from a single day’s intake. In addition, the 
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recall is dependent on the memory and cooperation of the participant [405]. Four repeated 24-h diet recalls 
have been recommended as the most appropriate method for large surveys,[406] while two were applied in 
the NNPAS. This study analysis applied a regression model to these data to better represent usual intake 
although no adjustments were made to potential misreporting of the data. A further limitation relates to the 
effects of processing and storage [407] which was not taken into consideration in the borrowed data used 
from USDA and Phenol-Explorer food composition databases. In addition, the omission of anthocyanin 
intake from dietary supplements is a notable limitation of this study. It is however unlikely that such 
supplements are widely used in Australia, and composition of supplements and extracts in the AUSNUT 
food composition database did not include polyphenols (anthocyanins). Finally, out of the 5,700 foods in 
the AUSNUT database, about 300 of them, which did not include recipes, were assigned an anthocyanin 
value. Each of these elements could have led to both over- and underestimation of anthocyanin intake. In 
addition, for the purpose of this study, total anthocyanins were considered to be the major anthocyanin 
subgroups (cyanidin, delphinidin, peonidin, petunidin, pelargonidin and malvidin). 
 
The cross-sectional nature of this study limits interpretation of the inverse association found between 
anthocyanin intake and blood pressure. However, evidence is beginning to emerge from experimental 
studies that support a protective role of anthocyanins on CVD risk in both young and older adults [408]. 
For two foods, plum and red cabbage, the Australian analytical data only reported total anthocyanins but 
not anthocyanin subclasses. Many fruits and vegetables that are high in anthocyanins are seasonal, 
available only in summer and autumn in Australia, therefore contribution to total intake will depend on the 
time of year that surveys are conducted. For example, red cabbage is a rich source of anthocyanins but 
accounted for less than 1% (0.2%) of total anthocyanin intake in the Australian population. This could also 
be as a result of not many people consuming red cabbage.  
 
Although different methods have been described for estimating usual intake, the MSM method involves 
similar steps to the National Cancer Institute (NCI) method but uses different modelling procedures and 
handling of non-consumers [409]. Comparison of the different methods, including those from Iowa State 
University (ISU), NCI, MSM and Statistical Program to Assess Dietary Exposure (SPADE), showed that 
with small sample sizes (n = 150), the ISU, MSM and SPADE methods were more reliable and showed 
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more precise estimates than the NCI method, mainly for the 10th and 90th percentiles. The observed 
differences between methods became less significant with larger sample sizes (n = 300 and n = 500) [410].  
 
6.1.2.5 Conclusion  
 
In conclusion, this study estimates for the first time, mean daily intake of anthocyanin in the Australian 
population, according to sociodemographic characteristics, using an Australian-specific anthocyanin food 
composition database. Given the rapidly emerging evidence base related to the beneficial effects of 
anthocyanins on cardiovascular risk factors, it is timeous to assess population-level intake of this flavonoid 
subgroup. Anthocyanin intake in the Australian population was similar to that reported in southern 
European countries, and higher than in Northern Europe and USA. Identification of major dietary sources 
of anthocyanins (blackberry, raspberry, blueberry, cherry, red cabbage, eggplant and red wine) allows for 
focused dietary messaging.  
 
It is worth noting that association does not infer causation and in the general overview of this body of 
work, results are not comparable across studies (Chapters 3, 5 and 6.2) due to the difference in study and 
experimental designs: acute crossover trial vs longer-term randomised crossover trial vs secondary analysis 
of cross-sectional data, respectively. However, results from this secondary analysis showed that there was a 
significant association between a mean intake of 24.17mg/d of anthocyanins and BP in adults aged 50+ 
years. In comparison to the acute crossover trial (Chapter 3) and longer-term RCT (Chapter 5), anthocyanin 
intake in the Australian population was lower than the amount provided in the acute trial intervention 
(369mg) but higher than the RCT intervention (50mg/L) which further limits comparison of results. 
Despite this, the current analysis of population-based data on anthocyanin intake provides a minimum 
benchmark against which to compare anthocyanin interventions in the design of future clinical trials. In 
addition, the main sources of anthocyanins identified in this nationally representative sample of Australians 
(berries) are consistent with the anthocyanin sources that have generally been provided in intervention 
studies.  It is unknown whether the research focus to date on berries has influenced consumer behaviour, or 
if the dietary survey data reflects cultural cuisine or other influences on dietary behaviour. A broader focus 
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of health-related research that extends to other anthocyanin-containing foods such as plums and other less 
studied foods with varying anthocyanin profiles may result in changes in fruit preferences in future.  
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7 CHAPTER 7 
7.1 CONCLUSIONS AND RECOMMENDATIONS 
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7.1.1 Overview of core findings 
 
The body of research presented in this thesis used a mixed method approach to address the central research 
question. This approach covered domains of: a) current knowledge synthesis (systematic literature 
reviews), b) knowledge generation (clinical trials) and, c) knowledge translation (epidemiological analysis 
to identify key dietary sources of anthocyanins in the Australian population for application of clinical trial 
data to dietary guidance). The central research question investigated was the extent to which consumption 
of anthocyanins from plums improved health outcomes, specifically the role of anthocyanins derived from 
the Queen Garnet Plum, on various domains of cognitive function, blood pressure parameters and changes 
to the gut microbiota. To contextualise these findings, the dietary anthocyanin intake of the Australian 
population was identified by applying a novel anthocyanin food composition database to national nutrition 
survey data.  
 
Anthocyanins are ubiquitously distributed in dark red and purple plant foods, with the highest 
concentration found in berries. As a result, research into the beneficial health effects of anthocyanins to 
date has focused on this food source [21]. However, the focus on berries in anthocyanin research limits 
generalisation of findings to broader dietary advice. Anthocyanin-rich foods are classified into three main 
groups according to their major type of anthocyanin aglycone complexes present in the food: namely, 
pelargonidin; cyanidin/peonidin; and multiple anthocyanins. Berries have been classified under these three 
different groups i.e. strawberries (pelargonidin), blueberries (multiple anthocyanins) and raspberries/plums 
(cyanidin/peonidin) [98] which highlights the need to generate evidence from the different anthocyanin 
group classifications. With the availability of numerous fruits and vegetables that are rich in anthocyanins 
but limited in clinical evidence, one of the main objectives of this research was to further investigate the 
beneficial health effects of anthocyanins from a different anthocyanin-rich source i.e. plum juice.  
 
As a first step, a systematic literature review was undertaken to summarise the evidence on the beneficial 
health effects of plums (Chapter 2). Results from the review showed that the largest amount of clinical trial 
evidence relates to the prevention and management of osteoporosis and overall bone health. However, 
many of the study designs were of low quality and the research conducted with non-healthy participants. 
Although a number of outcomes have been studied in animal models, there was no confirmatory clinical 
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evidence from trials in humans, thus limiting the usefulness of the current literature. For example, there 
was no available evidence from clinical trials on the effects of plum consumption on cognition even though 
this outcome has been studied using animal models and, likewise, there was only limited evidence related 
to cardiovascular responses. 
 
To address this gap in the literature on the health effects of plum consumption in humans, a pilot cross-over 
study was designed to assess the acute impact of differing doses provided by the Queen Garnet plum juice 
on cognition, blood pressure and bioavailability which was assessed by determination of urinary 
biomarkers in both younger and older adults (chapter 3). This study was conducted early on in the PhD 
work in order to further inform the design of a later clinical trial regarding the effect of consuming a 
previously demonstrated effective physiological dosage of anthocyanins [214]  in three smaller quantities 
rather than as a single dose. Queen Garnet Plum juice was provided to participants, either as a single 300 
mL dose (equivalent of 123mg anthocyanins) or as 3x100mL doses consumed over a 3h period. The cross-
over study design was used in this study in order to reduce between-subject variability, with each subject 
acting as their own control, and thus increasing the study power [411]. Results from the pilot crossover 
study demonstrated a significant reduction in blood pressure for both young and older adults following 
consumption of QGP juice, with more obvious BP reduction in the older age-group. There was no observed 
dose-timing effect, nor was there an acute effect on cognitive function. 
 
Following the completion of the acute pilot crossover study, an 8-week randomised crossover trial was 
planned. To further develop the hypothesis from the pilot trial and better elucidate proposed mechanisms of 
effect of plum juice anthocyanins, changes in gut microbiota were investigated.  Additionally, in order to 
understand and summarise the current evidence on the effect of anthocyanins on gut microbiota, a second 
systematic literature review (chapter 4) was undertaken. The gut-brain axis is influenced by the microbiota 
populations in the gut [412], and this is a rapidly emerging area. The review did not identify any 
experimental evidence on the effects of anthocyanins derived from plums, specifically on gut microbiota 
profiles, and there was a general paucity of evidence in totality for the anthocyanin-gut microbiota 
relationship. With over 1000 species of bacteria in the gut, results from this review highlighted potential 
bacteria species that might be affected by anthocyanin consumption. There was an observed proliferative 
effect on Bifidobacterium spp., known for their wide use in probiotics and for the treatment of Irritable 
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Bowel Syndrome and inhibition of Clostridium histolyticum, which has been shown to be pathogenic in 
humans. The review also informed our analysis of the gut microbiota data obtained in our RCT. 
 
An 8-week randomised crossover clinical trial was undertaken to determine the effect and within patient 
variation of daily consumption of 200mL of anthocyanin-rich Queen Garnet plum juice or raspberry cordial 
(control) on cognition and ambulatory blood pressure in healthy older adults (55+ years) (chapter 5). 
Secondary outcomes included anti-inflammatory markers (C-reactive protein and BDNF), urinary 
anthocyanin metabolites, changes in anthropometrics and physical abilities and gut microbiota. Results 
from this study showed that the acute blood pressure effects observed in the pilot study were no longer 
evident in the longer term, while a lack of effect on cognitive function remained for both studies. There 
were also no demonstrated effects on anti-inflammatory biomarkers; however, anthocyanins derived from 
QGP, may affect total population of gut bacteria, but not necessarily impact on specific gut bacteria. The 
clinical significance of this finding warrants further exploration. 
 
This study has significantly contributed to the body of evidence on the health effects of dietary 
anthocyanins. For the first time, a well-designed crossover human clinical trial has explored the effects of 
anthocyanins from plums on outcomes related to the gut-brain axis in otherwise healthy adults. Our results 
indicate that the effects seen in older adults with dementia are not translatable to healthy ageing 
individuals. Even though results from the acute trial were not comparable to the longer-term 8-week trial, 
this research highlighted issues for future considerations in anthocyanin research. 
 
The final study in this thesis comprised development of an Australian anthocyanin food composition 
database (chapter 6.1). This database development is the first step in achieving appropriate measurement of 
flavonoid intake, with anthocyanins being the first step, for use in Australian epidemiological studies, as 
well as dietary clinical trials. Following the development of this database, a secondary data analysis of 
anthocyanin intake in the Australian population was undertaken. This was done using the National 
Nutrition and Physical Activity Survey component of the Australian Health Survey (chapter 6.2). Even 
though this is the first stage in the development of an Australian-specific food composition database for 
anthocyanin content of local foods, it was adequate to measure anthocyanin intake in the Australian 
population.  Results showed an intermediate anthocyanin intake among Australians, as compared to intakes 
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in other countries that are reported in the world composite database (24.17 ± 0.32 in the current study vs 
18.05 ± 21.14 mg/day). Further progression of the Australian anthocyanin database will include updates in 
order to produce a robust database which will further facilitate measurement of anthocyanin consumption. 
In the future, efforts will be made to expand this database to include the full range of other flavonoid 
classes and subclasses. 
 
7.1.2 Strengths and limitations 
 
The different methods employed in this body of research have their strengths and limitations which are 
briefly outlined below.  These strengths and limitations have been described more comprehensively in each 
of the thesis chapters.  
 
As research on anthocyanins continues to show beneficial health effects, it is important to note that 
nutrients are not consumed individually but are consumed within food matrices within a more complex 
dietary pattern. As such, there is a possibility that any demonstrated health effects may be due to the 
anthocyanins present in foods or as a result of the synergistic effect of the anthocyanins with other nutrients 
of non-nutritive components in the same food or present in other foods consumed at the same time as part 
of a meal. As a result, there needs to be a strong evidence base from confirmatory studies. As a first step, 
anthocyanin-rich foods rather than anthocyanin standards of individual components should be utilised in 
clinical trials. For the research included in this thesis, QGPJ was utilised. The QGP was processed to juice 
using methods that minimise nutrient degradation and utilised 100% of the fruit flesh and skin.  
 
In assessing the positive health effects of anthocyanins, high levels of evidence are needed. Within this 
framework, the research presented in this thesis has summarised existing evidence but also generated novel 
findings related to consumption of anthocyanins from plums. The inter-individual variability in the 
metabolism of anthocyanins have been well documented [41] therefore the cross-over study design was 
considered best for both the acute and longer term clinical trials (Studies 2 and 4), because participants 
acted as their own control.  
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This research highlighted the limitations in precise measurement of flavonoid (anthocyanin) intake in 
population studies due to a lack of appropriate food composition databases available. Study 5 of this thesis 
addressed this knowledge gap in the first stage development of an Australian anthocyanin database in order 
to better estimate anthocyanin intake, and in the long-term flavonoid, intake in Australian population 
studies. 
 
There are a number of limitations related to this body of research on the effects of anthocyanins from QG 
plum on cognition, blood pressure, inflammatory biomarkers and the gut microbiota population. The 
research main focused on anthocyanins and used a specially bred Japanese plum hybrid that was high in 
anthocyanins as the food delivery vehicle. Extrapolation of the findings to plums in general is limited, 
therefore it may be worth conducting similar studies with regular plum varieties to confirm these findings. 
Additionally, current evidence shows that the potential positive health effects of anthocyanins from food 
may be due to their circulation in blood as phenolic acid metabolites [413]. This body of research was 
limited in resources to conduct this analysis. Hence the lack of characterisation of these plasma metabolites 
in the current body of work is a limitation.  
 
Another limitation in the body of anthocyanin research which prevents direct comparison of results across 
studies is the low stability of anthocyanins and differences in concentrations provided in clinical trials. 
Anthocyanin stability is affected by a number of factors including; temperature, pH, the structure and 
concentration of the pigment, light, co-pigments, enzymes, oxygen, metallic ions, sulphur dioxide, and 
sugar [414]. Processing, and storage have been shown to significantly degrade anthocyanins [342]. The 
processing of fruits to juice/powder usually involves high temperatures to ensure microbiological stability. 
In the case of anthocyanins which are heat sensitive, they have been shown to degrade up to 90% when 
exposed to high temperatures [343]. This is a major limitation in intervention studies in which anthocyanin-
rich foods are usually delivered in their juice or power forms [21]. This is not unusual as statistics show 
that in developed countries, 50% of plum produce are consumed in processed forms [415].This emphasises 
the need for more efficient ways of processing anthocyanin foods without degrading a significant part of its 
anthocyanin content [416].  High temperature processing of anthocyanins leads to the production of 
furfural compounds during the degradation of sugars and ascorbic acid, thereby degrading them in foods 
[415]. As anthocyanins are responsible for the red, purple and blue pigments in fruits, colour is an 
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important determinant in product quality hence minimising the pigment losses during processing is an 
important consideration in the processing and storage of anthocyanin-rich foods [417]. Long-term storage 
of anthocyanin-rich foods have also been shown to degrade anthocyanin. When plum juice, for example, 
was stored for a period of 6 months at room temperature, its anthocyanins degraded drastically up to 90%, 
with lower storage temperature (4oC) reducing the degradation process (50%) [343]. In the present body of 
work, there was a considerable difference in the storage times of study beverages used in the acute dose-
timing study (2 months frozen) compared to the 8-week RCT (10 months frozen and then refrigerated) as 
well as duration of the two trials (4 weeks vs 8 months). It is also important to note that the study juice was 
supplied in batches and as a result stored for the duration of the study.  Processing, storage as well as the 
low stability of anthocyanins has limited results comparison across anthocyanin research, as well as their 
use in the food industry [416].  
 
Additionally, in assessing the amount of anthocyanin intake in the Australian population and its association 
with blood pressure, the cross-sectional nature of the data is a major limitation which does not allow for 
determination of causality.  
 
7.1.3 Future research and recommendations 
 
This research has made a significant contrition to the area of anthocyanin research, specifically in relation 
to QGP. Nonetheless, there is a need for ongoing research to further contribute to a stronger evidence base. 
Following on from the findings of this research, a number of key points and recommendations for future 
research are highlighted below: 
 
• As a first step, this research resulted in the development of an Australian anthocyanin database, 
and further expansion of using generated analytical values for anthocyanins and flavonoids in 
general is required. The effect of processing on the flavonoid content of these Australian foods 
needs to be taken into consideration in order to progress this database development and improve 
its accuracy; 
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• Identifying the nutritive and non-nutritive composition of regular plums and prunes in comparison 
to QG plums and the effects of processing on their bioactivity are also important for future 
research in order to define the overall health effects of plums/prunes. Further clarification of the 
mechanisms of action of plum polyphenols, identification of potential adverse effects and the 
effects of dosage on outcomes is necessary to inform dietary guidelines for chronic disease 
prevention and management;  
 
• To confirm these observed effects of anthocyanins, it is recommended that further research is 
conducted using other high anthocyanin foods. This is required in order to identify the synergistic 
effects of nutrients and food matrices that may be contributing to observed effects. There is also 
the need for future studies to focus on ways to stabilise or reduce degradation of anthocyanins in 
foods from processing as a first step. In addition, measuring anthocyanin content for the duration 
of a trial to monitor anthocyanin deration over time is also an important consideration in order to 
compare and generalise conclusions across studies. 
 
 
7.1.4 Conclusion 
 
In conclusion, this body of research has summarised and addressed knowledge gaps in relation to the acute 
and longer-term health effects of dietary anthocyanins, specifically provided by a high anthocyanin variant 
of plum (Queen Garnet), as well as developed an Australian anthocyanin food composition database. A 
total of five studies were undertaken to address the research question on the acute and longer-term effects 
of consumption of anthocyanin containing plum juice on cognition and other health parameters in older 
adults.  
 
Each study constituting this thesis contributed novel and original evidence. Current evidence was 
synthesised and gaps in current literature were identified from the systematic literature reviews. As part of 
addressing these gaps and generating new evidence, two RCTs were conducted which added to the 
evidence base of anthocyanin research. Finally, a knowledge translation aspect of this thesis related to 
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identifying key sources of anthocyanin in the Australian population and amount of intake. Collectively, 
these studies progress scientific evidence around knowledge gaps on dietary anthocyanins and in a larger 
context how nutrients as part of food and diet, appropriately modified, can impact health outcomes in 
humans and influence chronic diseases. 
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9.1 Appendix A – Quality rating of included clinical studies (Chapter 2) 
Relevant quality rating criteria from The Delphi List, Cochrane Back Review Group and The CONSORT Statement [418-420]  
A eligibility criteria specified, B randomization appropriate, C treatment allocation concealed, D similarity at baseline, E outcome measures and control intervention 
explicitly described, F co-intervention comparable, G outcome measures relevant, H adverse events and I drop-outs fully described, J sample size based on a priori power 
calculation, K point estimates and measures of variability presented for the primary outcome measure, L appropriate timing giving a Total Score (TS) of 12 
 
 J Nutr 106: 923-
930[122]  
J Wom Health 
Gend-B 11: 61-68 
[115] 
Br J Nutr  112: 
55–60[128]  
Appl Physiol Nutr 
Metab 39: 730-
739[123]  
Am J Clin Nutr 76: 
1422-1427.[149]  
J Am Coll Nutr 26: 
170-181.[137]  
J Med Food 8(1): 
41-46[129]. 
J Food Nutr Res 
50: 229-236. [138]  
  
n = 160 
Dried plum (p. 
dometica) 
100g/day vs dried 
apple 
Parallel 
12 months 
 
n = 58 
Dried plum (p. 
dometica) 
100g/day vs dried 
apple 
Parallel 
3 months 
 
n = 160 
Dried plum (p. 
dometica) 
100g/day vs dried 
apple 
Parallel 
1 year 
 
n = 23 
Dried plum (p. 
dometica) 
90g/day+ 
resistance training 
(RT) vs RT 
Case-control 
6 months 
 
n = 19 
Dried plum (p. 
dometica) 
100g/day vs 
habitual dietary 
simple sugars 
Cross-over 
6 months 
 
 
n = 6 
Dried plum/dried 
plum juice (p. 
dometica) 
131g vs selected 
fruits 
Cross-over 
2 weeks 
 
n = 10 
Plum juice (p. 
salicina) 
Single dose of 
150mL vs selected 
fruit juices 
Cross-over 
18 days 
 
n = 18 
Dried plum (p. 
salicina) 
2x195g/day 
Case series 
5 days 
A Postmenopausal 
women (Osteopenic) 
Postmenopausal 
women 
Women with mild 
bone loss 
Female breast 
cancer survivors 
Postmenopausal 
women (Healthy) 
Healthy volunteers Healthy volunteers Healthy volunteers 
B Yes Yes Yes Yes  No Yes No Not applicable 
C no (not feasible) no (not feasible) no (not feasible) no (not feasible) no (not feasible) no  No Not applicable 
D Yes Yes Yes Yes  Yes Yes Yes yes 
E Yes Yes Yes Yes  Yes Yes Yes yes 
F Yes Yes Yes Yes  Don’t know Yes Yes Not applicable 
G Yes Yes Yes Yes  Yes Yes Yes yes 
H Yes Yes Yes Yes  Yes Yes Yes yes 
I Yes Yes Yes Yes  Yes Probably no Probably no Probably no 
J No No No No  No No No no 
K Yes Yes Yes Yes  Yes Yes Yes yes 
L Yes Yes Yes Yes  Yes Yes Yes yes 
TS 10 10 10 9 8 9 8 7 
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 J Food Biochem  
36: 159-170.[107] 
Am J Clin Nutr53 
(5): 1259-1265 [92]   
J Acad Nutr 
Diet112: 1158-
1168 [159]. 
Curr Top 
Nutraceut R 7: 
157-160 [165]  
J Ayub Med Coll 
Abbottabad 
22(1): 38-
31[160]  
J Funct Foods 
12: 11-22[85]  
J Funct 
Foods14: 
747-757 [166]  
Nutr Res 27: 
511-513.[161]  
Internet J 
Nutr 
Wellness7: 1-
1 [162]  
  
n = 2 
Plum juice (p. 
salicina) 
Single dose of 400 
mL vs 400mL water 
Cross-over 
1 week 
 
n = 41 
Prunes (p. dometica) 
100g/day vs 360mL 
grape juice 
Cross-over 
8 weeks 
 
 
n = 160 
Dried plum (p. 
dometica) 
100g/day vs 
dried apple 
Parallel 
12 months 
 
n = 8 
Prunes 
143g/day vs 8 diff. 
fruits 
Cross-over 
 
 
n = 259 
Prunes (p. 
dometica) 
11.5g or 23g/day 
vs water 
Parallel 
8weeks 
 
n = 21 
Plum juice (p. 
salicina) 
200mL/day vs 
prune 
juice/placebo 
Cross-over 
28 days 
 
n = 13 
Plum juice (p. 
salicina) 
200mL/day vs 
placebo 
Cross-over 
28 days 
 
n = 54 
Prune juice 
(p. dometica) 
2 
x125mL/day 
Case-series 
4 weeks 
 
n = 36 
Plum juice (p. 
dometica) 
8 ounces/day 
vs psyllium 
and apple 
juice 
Cross-over 
6 weeks 
 
A Healthy volunteers Free living men with 
mild 
hypercholesterlemia 
Postmenopausal 
women 
Healthy young men Pre-hypertensive 
patients 
Healthy 
volunteers 
Healthy 
volunteers 
Adults with 
mild GIT 
symptoms 
Adults with 
chronic 
constipation 
symptoms 
B No Not stated Not stated No Not stated Yes Yes Not 
applicable 
Yes 
C no (not feasible) no (not feasible) no (not feasible) no (not feasible) no (not feasible) Yes Yes Not 
applicable 
no (not 
feasible) 
D Yes Yes Yes Yes Yes  Yes Yes Yes Yes 
E Yes Yes Yes Yes Yes  Yes Yes Yes Yes 
F Yes Yes Yes Yes Yes Yes Yes Not 
applicable 
Yes 
G Yes Yes Yes Yes Yes Yes Yes Yes Yes 
H Probably no  Probably no Yes Yes Yes No No Yes Yes 
I Yes Yes Yes Yes Yes  Yes No Probably no  Yes 
J No No No No No No No  No No 
K Yes Yes Yes Yes Yes Yes Yes Yes Yes 
L Yes Yes Yes Yes Yes  Yes Yes Yes Yes 
TS 8 8 9 8 8 9 8 7 10 
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 Aliment Pharm Ther 
33: 822-828[163]  
Eat Behav 11(3): 
201-203[167]  
Appetite3: 564-
569 [168]  
J Am Diet Assoc 
9: 1322-
1327[169]  
J Appl Res4: 37-
43 [170]  
Res J Pharm Biol 
Chem Sci2: 1195-
1204 [171]  
J Pharm Sci 23: 
463-466. [175]  
Eur J Clin Nutr 
56:1020-
1023[176]  
  
n = 40 
Dried plum (p. 
dometica) 
2 x 50g/day vs 
psyllium 
Cross-over 
14 weeks 
 
n = 45 
Prunes (p. 
dometica) 
40 g prune pre-
load vs bread 
product 
Cross-over 
Over 1 week 
 
n = 19 
Dried plum (p. 
dometica) 
238kcal portion 
vs baked foods & 
water 
Cross-over 
 
 
n = 26 
Dried plum (p. 
dometica)  
100kcal portion 
vs low fat cookies 
Cross-over 
4 weeks 
 
n = 58 
Dried plum (p. 
dometica)  
100g/day vs 
Dried apple 
Parallel  
3 months 
 
n = 170 
Dried plum and 
flixweed (p. 
dometica)  
40-50g/day 
Parallel  
3 weeks 
 
n = 107 
Prunes (p. 
dometica) 
3 groups of either 
single dose, 
double dose or 
control 
Case-control 
8 weeks 
 
 
n = 12 
Plum juice (p. 
dometica) 
330mL vs 
selected fruit 
juices 
Cross-over 
20 days 
A Patients with 
chronic constipation 
Normal weight 
individuals 
Healthy female 
subjects 
Healthy female 
subjects 
Postmenopausal 
women 
Iranian Hajj 
pilgrims 
Healthy 
volunteers 
Healthy male 
volunteers 
B yes Yes Yes  Yes Yes  Yes yes No 
C no (not feasible) no (not feasible) no (not feasible) no (not feasible) no (not feasible) no (not feasible) no (not feasible) No 
D Yes Yes Yes Yes Yes Yes yes Yes 
E Yes Yes Yes Yes Yes Yes yes Yes 
F Yes Yes Yes Yes Yes No yes Yes 
G Yes Yes Yes Yes Yes Yes yes Yes 
H Yes Yes No No Yes Yes yes Yes 
I Probably no Probably no Yes Yes Yes Yes yes Probably no 
J no No No Yes No No no No 
K yes Yes Yes Yes Yes Yes yes Yes 
L yes Yes Yes Yes Yes Yes yes Yes 
TS 9 9 8 9 9 8 10 8 
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9.2 Appendix B - Search Strategy Sample (chapter 2 & chapter 4) 
 Medline (OVID) 
 
 
Searches 
1 "plum*1".m_titl. 
2 limit 1 to English language 
3 Prunes.m_titl. 
4 limit 3 to English language 
5 "prunus domestica".m_titl. 
6 limit 5 to English language 
7 "prunus salicina".m_titl. 
8 limit 7 to English language 
9 2 or 4 or 6 or 8 
10 (9 not "plum blossom needle").m_titl. 
11 limit 10 to English language 
12 (9 not "plum pox").m_titl. 
13 limit 12 to English language 
14 (12 not "plum curculio").m_titl. 
15 limit 14 to English language 
16 (15 not "plume").m_titl. 
17 limit 16 to English language 
 
a)  Scopus search strategy (Chapter 4) 
 
 
 
TITLE-ABS-KEY ( anthocyan*  AND  "gut microbiota" )  AND  ( LIMIT-TO ( DOCTYPE ,  "ar" )  
OR  LIMIT-TO ( DOCTYPE ,  "cp" )  OR  LIMIT-TO ( DOCTYPE ,  "ip" ) )  AND  LIMIT-TO ( 
EXACTKEYWORD ,  "Human" )  OR  LIMIT-TO ( EXACTKEYWORD ,  "Intestine Flora" )  OR  
LIMIT-TO ( EXACTKEYWORD ,  "Humans" )  OR  LIMIT-TO ( EXACTKEYWORD ,  
"Polyphenols" )  OR  LIMIT-TO ( EXACTKEYWORD ,  "Metabolism" )  OR  LIMIT-TO ( 
EXACTKEYWORD ,  "Polyphenol" )  OR  LIMIT-TO ( EXACTKEYWORD ,  "Article" )  OR  
LIMIT-TO ( EXACTKEYWORD ,  "Nonhuman" )  OR  LIMIT-TO ( EXACTKEYWORD ,  
"Anthocyanins" ) )  AND  ( LIMIT-TO ( LANGUAGE ,  "English" ) ) 
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9.3 Appendix C – Published paper: A Systematic Review on the Health 
Effects of Plums (Prunus domestica and Prunus salicina) 
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9.4 Appendix D – Published paper: First stage development of an 
Australian anthocyanin food composition database for dietary 
studies – A systematic process and its challenges 
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9.5 Appendix E – Published paper: Anthocyanin-rich plum juice 
reduces ambulatory blood pressure but not acute cognitive function 
in younger and older adults: A pilot cross-over dose-timing study 
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9.6 Appendix F – Published paper: A systematic literature review of the 
effect of anthocyanins on gut microbiota populations 
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9.7 Appendix E – Published paper: Usual dietary anthocyanin intake, 
sources and their association with blood pressure in a representative 
sample of Australian adults 
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